ý
|
Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 [Fee Required]
|
¨
|
Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 [No Fee Required]
|
Delaware
|
|
63-1261433
|
(State of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
100 Brookwood Place,
Birmingham, AL
|
|
35209
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Title of Each Class
|
|
Name of Each Exchange On Which Registered
|
Common Stock, par value $0.01 per share
|
|
New York Stock Exchange
|
Large accelerated filer
|
|
ý
|
|
Accelerated filer
|
|
¨
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
The definitive proxy statement for the
2014
Annual Meeting of the Stockholders of ProAssurance Corporation (File No. 001-16533) is incorporated by reference into Part III of this report.
|
•
|
changes in general economic conditions, including the impact of inflation or deflation and unemployment;
|
•
|
our ability to maintain our dividend payments;
|
•
|
regulatory, legislative and judicial actions or decisions that could affect our business plans or operations;
|
•
|
the enactment or repeal of tort reforms;
|
•
|
formation or dissolution of state-sponsored healthcare professional liability insurance entities that could remove or add sizable groups of physicians from or to the private insurance market;
|
•
|
changes in the interest rate environment;
|
•
|
changes in U.S. laws or government regulations regarding financial markets or market activity that may affect the U.S. economy and our business;
|
•
|
changes in the ability of the U.S. government to meet its obligations that may affect the U.S. economy and our business;
|
•
|
performance of financial markets affecting the fair value of our investments or making it difficult to determine the value of our investments;
|
•
|
changes in requirements or accounting policies and practices that may be adopted by our regulatory agencies, the Financial Accounting Standards Board, the Securities and Exchange Commission (SEC), the Public Company Accounting Oversight Board, or the New York Stock Exchange (NYSE) and that may affect our business;
|
•
|
changes in laws or government regulations affecting the financial services industry, the property and casualty insurance industry or the particular insurance lines underwritten by our subsidiaries;
|
•
|
the effects of changes in the healthcare delivery system, including but not limited to the Patient Protection and Affordable Care Act (the Healthcare Reform Act);
|
•
|
consolidation of healthcare providers resulting in entities that are more likely to self-insure a substantial portion of their healthcare professional liability risk;
|
•
|
uncertainties inherent in the estimate of loss and loss adjustment expense reserves and reinsurance;
|
•
|
changes in the availability, cost, quality or collectability of insurance/reinsurance;
|
•
|
the results of litigation, including pre- or post-trial motions, trials and/or appeals we undertake;
|
•
|
allegation of bad faith which may arise from our handling of any particular claim, including failure to settle;
|
•
|
loss or consolidation of independent agents, agencies, brokers or brokerage firms;
|
•
|
changes in our organization, compensation and benefit plans;
|
•
|
changes in the business or competitive environment may limit the effectiveness of our business strategy and impact our revenues;
|
•
|
our ability to retain and recruit senior management;
|
•
|
the availability, integrity and security of our technology infrastructure;
|
•
|
the impact of a catastrophic event, as it relates to both our operations and our insured risks;
|
•
|
the impact of acts of terrorism and acts of war;
|
•
|
the effects of terrorism related insurance legislation and laws;
|
•
|
assessments from guaranty funds;
|
•
|
our ability to achieve continued growth through expansion into other states or through acquisitions or business combinations;
|
•
|
changes to the ratings assigned by rating agencies to our insurance subsidiaries, individually or as a group;
|
•
|
provisions in our charter documents, Delaware law and state insurance law may impede attempts to replace or remove management or may impede a takeover;
|
•
|
state insurance restrictions may prohibit assets held by our insurance subsidiaries, including cash and investment securities, from being used for general corporate purposes;
|
•
|
taxing authorities can take exception to our tax positions and cause us to incur significant amounts of legal and accounting costs and, if our defense is not successful, additional tax costs, including interest and penalties; and
|
•
|
expected benefits from completed and proposed acquisitions may not be achieved or may be delayed longer than expected due to business disruption; loss of customers, employees and key agents; increased operating costs or inability to achieve cost savings; and assumption of greater than expected liabilities, among other reasons.
|
•
|
the outcome of claims that may be asserted by either the policyholders or shareholders of any of these acquired entities relating to payments or other issues associated with the acquisition of the entities and subsequent mergers into ProAssurance;
|
•
|
the operations of ProAssurance and Medmarc or ProAssurance and Eastern may not be integrated successfully, or such integration may take longer to accomplish than expected;
|
•
|
cost savings from the transactions may not be fully realized or may take longer to realize than expected; and
|
•
|
operating costs, customer loss and business disruption following one or both transactions, including adverse effects on relationships with employees, may be greater than expected.
|
•
|
members of Lloyd's are subject to levies by the Council of Lloyd's based on a percentage of the member's underwriting capacity, currently a maximum of 3%;
|
•
|
syndicate operating results can be affected by decisions made by the Council of Lloyd's over which the management of Syndicate 1729 has little ability to control, such as a decision to not approve our annual business plan, or a decision to increase the capital required to continued operations, and by our obligation to pay levies to Lloyd's;
|
•
|
Lloyd's insurance and reinsurance relationships and distributions channels could be disrupted or Lloyd's trading licenses could be revoked making it more difficult for Syndicate 1729 to distribute and market its products; and
|
•
|
rating agencies could downgrade their ratings of Lloyd's as a whole.
|
•
|
Podiatry Insurance Company of America and subsidiaries, (PICA), acquired April 1, 2009,
|
•
|
American Physicians Service Group, Inc. and subsidiaries, (APS), acquired November 30, 2010,
|
•
|
Independent Nevada Doctors Insurance Exchange, (IND), acquired November 30, 2012,
|
•
|
Medmarc Mutual Insurance Company and subsidiaries, (Medmarc), acquired January 1, 2013, and
|
•
|
Eastern Insurance Holdings, Inc., (Eastern), which was completed January 1, 2014.
|
•
|
Pursue profitable underwriting opportunities.
We pursue a strategy that emphasizes profitability, not market share. Key elements of this strategy are prudent risk selection, appropriate pricing and adjusting our business mix as appropriate to effectively utilize capital and achieve market synergies. We seek to help customers confront uncertainty through innovative loss transfer and loss mitigation solutions for liability risks, with an emphasis on healthcare. Our healthcare focus considers the risk management needs of a broad spectrum of the healthcare provider market. Often, we utilize mergers or acquisitions to expand the products we offer or the types of customers we serve.
|
•
|
Exercise underwriting and risk management discipline
. We believe we exercise underwriting and risk management discipline by adhering to underwriting guidelines across our business lines and fostering a culture that focuses on enterprise risk management and strong internal controls.
|
•
|
Assist insureds in reducing risk
. We offer training to our insureds to assist them in the use of risk reduction tools and techniques.
|
•
|
Manage claims effectively.
Our experienced claims teams have industry and insurance expertise that, with our extensive local knowledge, allows us to resolve claims in the most effective manner possible, considering the circumstances of each claim. When practical, we utilize formalized claims management processes and protocols as a means of reducing claim costs.
|
•
|
Provide superior customer service.
Our mission statement, We Exist to Protect Others, goes hand-in-hand with our corporate motto, "Treated Fairly." Both statements speak to our desire to be a strong and trusted partner that helps customers confront uncertainty through innovative loss transfer and loss mitigation solutions for liability risks, with an emphasis on healthcare. Our employees are committed to core values of integrity, respect, involvement of our insureds, collaboration, communication and enthusiasm every day.
|
•
|
Maintain a conservative investment strategy.
We believe that we follow a conservative investment strategy designed to emphasize the preservation of our capital and provide adequate liquidity for the prompt payment of claims. Our investment portfolio consists primarily of investment-grade, fixed-maturity securities of short-to medium-term duration.
|
•
|
Maintain financial stability
. We are committed to maintaining claims paying ratings of "A" or better.
|
($ in thousands)
|
|
Year Ended December 31
|
|||||||||||||||||||
2013
|
|
2012
|
|
2011
|
|||||||||||||||||
Gross Premiums Written
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Professional liability:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Physicians (1)
|
|
$
|
414,167
|
|
|
73
|
%
|
|
$
|
416,510
|
|
|
78
|
%
|
|
$
|
451,181
|
|
|
80
|
%
|
Other healthcare professionals and facilities
|
|
69,327
|
|
|
12
|
%
|
|
71,751
|
|
|
13
|
%
|
|
73,729
|
|
|
13
|
%
|
|||
Legal professionals
|
|
27,060
|
|
|
5
|
%
|
|
17,146
|
|
|
3
|
%
|
|
16,474
|
|
|
3
|
%
|
|||
All other (2)
|
|
22,803
|
|
|
4
|
%
|
|
31,024
|
|
|
6
|
%
|
|
24,511
|
|
|
4
|
%
|
|||
Medical technology and life sciences products liability
|
|
34,190
|
|
|
6
|
%
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
—
|
%
|
|||
Total
|
|
$
|
567,547
|
|
|
100
|
%
|
|
$
|
536,431
|
|
|
100
|
%
|
|
$
|
565,895
|
|
|
100
|
%
|
•
|
financial strength,
|
•
|
liability coverages tailored to meet evolving needs of our insureds,
|
•
|
excellent claims and underwriting services,
|
•
|
risk management consultation, loss prevention seminars and other educational programs,
|
•
|
regular newsletters discussing matters of interest to our insureds, including updates on legislative developments,
|
•
|
support of legislation that will have a positive effect on healthcare and legal liability issues, and
|
•
|
involvement in and support for local professional societies and related organizations.
|
•
|
Workers' compensation insurance coverages provided to employers, generally those with 1,000 employees or less. Types of policies offered include guaranteed cost policies, policyholder dividend policies, retrospectively-rated policies, deductible policies, and alternative market products.
|
•
|
Alternative market workers’ compensation solutions provided to individual companies, groups and associations (referred to hereafter as “cell participants”) whereby policies written are 100% reinsured by related segregated portfolio cells of our subsidiary domiciled in the Cayman Islands. The pool of assets and associated liabilities of each segregated portfolio cell are solely for the benefit of the cell participants, and the pool of assets of one segregated portfolio cell are statutorily protected from the creditors of the others. The underwriting results and investment income of the segregated portfolio cells are shared with the cell participants in accordance with the terms of the cell agreements. We principally receive fee revenue from the cells, and for cells in which we are a cell participant, a percentage of the profit or loss of the cell.
|
•
|
for reported claims, the nature of the claim and the jurisdiction in which the claim occurred;
|
•
|
trends in paid and incurred loss development;
|
•
|
trends in claim frequency and severity;
|
•
|
emerging economic and social trends;
|
•
|
trend of healthcare costs for claims involving bodily injury;
|
•
|
inflation and levels of employment; and
|
•
|
changes in the regulatory legal and political environment.
|
•
|
licensing requirements;
|
•
|
trade practices;
|
•
|
capital and surplus requirements;
|
•
|
investment practices; and
|
•
|
rates charged to insurance customers.
|
•
|
its reliance on insurance and reinsurance brokers and distribution channels to distribute and market its products;
|
•
|
its obligation to pay levies to Lloyds;
|
•
|
its obligations to maintain funds to support its underwriting activities; its risk-based capital requirement being assessed periodically by Lloyd's and being subject to variation;
|
•
|
its reliance on ongoing approvals from Lloyd's and various regulators to conduct its business, including a requirement that its Annual Business Plan be approved by Lloyd's before the start of underwriting for each account year;
|
•
|
its financial strength rating is derived from the rating assigned to Lloyd's, although it has limited ability to directly affect the overall Lloyd's rating; and
|
•
|
its reliance on Lloyd's trading licenses in order to underwrite business outside the United Kingdom.
|
ITEM 1B.
|
UNRESOLVED STAFF COMMENTS.
|
ITEM 2.
|
PROPERTIES.
|
|
|
Square Footage of Properties
|
|||||||
Property Location
|
|
Occupied by
ProAssurance |
|
Leased or Available
for Lease |
|
Total
|
|||
Birmingham, AL (*)
|
|
104,000
|
|
|
61,000
|
|
|
165,000
|
|
Franklin, TN
|
|
52,000
|
|
|
51,000
|
|
|
103,000
|
|
Okemos, MI
|
|
53,000
|
|
|
—
|
|
|
53,000
|
|
Madison, WI
|
|
38,000
|
|
|
—
|
|
|
38,000
|
|
Las Vegas, NV
|
|
4,640
|
|
|
—
|
|
|
4,640
|
|
(*)
|
Corporate Headquarters
|
ITEM 3.
|
LEGAL PROCEEDINGS.
|
W. Stancil Starnes
|
|
Mr. Starnes was appointed as Chief Executive Officer and President of ProAssurance in 2007 and has served as the Chairman of the Board since 2008. Mr. Starnes previously served as President, Corporate Planning and Administration of Brasfield & Gorrie, Inc., a large national commercial contractor. Prior to 2006, Mr. Starnes served as the Senior and Managing Partner of the law firm of Starnes & Atchison, LLP, where he was extensively involved with ProAssurance and its predecessors in the defense of healthcare professional liability claims for over 25 years. Mr. Starnes currently serves as a director of Infinity Property and Casualty Corporation, a public insurance holding company, where he serves on the audit, compensation and executive committees. He formerly served as a director of Alabama National Bancorporation. (Age 65)
|
|
|
|
Howard H. Friedman
|
|
Mr. Friedman was appointed as President of our Healthcare Professional Liability Group in 2014, and is also our Chief Underwriting Officer and Chief Actuary. Mr. Friedman has previously served as a Co-President of our Professional Liability Group, Chief Financial Officer, Corporate Secretary, and as the Senior Vice President of Corporate Development. Mr. Friedman joined our predecessor in 1996. Mr. Friedman is an Associate of the Casualty Actuarial Society and a member of the American Academy of Actuaries. (Age 55)
|
|
|
|
Jeffrey P. Lisenby
|
|
Mr. Lisenby was appointed as an Executive Vice President in 2014 and is also our General Counsel, Corporate Secretary and head of the corporate Legal Department. Mr. Lisenby has previously served as Senior Vice President. Prior to joining ProAssurance, Mr. Lisenby practiced law privately in Birmingham, Alabama. Mr. Lisenby is a member of the Alabama State Bar and the United States Supreme Court Bar and is a Chartered Property Casualty Underwriter. (Age 45)
|
|
|
|
Edward L. Rand, Jr.
|
|
Mr. Rand was appointed as an Executive Vice President in 2014 and is also our Chief Financial Officer. Mr. Rand previously served as our Senior Vice President of Finance upon joining ProAssurance in 2004. Prior to joining ProAssurance Mr. Rand was the Chief Accounting Officer and Head of Corporate Finance for PartnerRe Ltd. Prior to that time Mr. Rand served as the Chief Financial Officer of Atlantic American Corporation. Mr. Rand is a Certified Public Accountant. (Age 47)
|
|
|
|
Frank B. O’Neil
|
|
Mr. O’Neil was appointed as our Senior Vice President and Chief Communications Officer in 2001. Mr. O’Neil has previously served as our Senior Vice President of Corporate Communications, having joined our predecessor in 1987. (Age 60)
|
|
|
|
Michael L. Boguski
|
|
Mr. Boguski is President of our Eastern subsidiary. Prior to the acquisition of Eastern, Mr. Boguski served as President and Chief Executive Officer of Eastern, and first joined Eastern in 1997. Mr. Boguski has 26 years of insurance industry experience. (Age 51)
|
|
|
|
Mary Todd Peterson
|
|
Ms. Peterson is President of our Medmarc subsidiary. Prior to the acquisition of Medmarc, Ms. Peterson served as Medmarc's President and CEO. She previously served as Medmarc's Senior Vice President and Chief Operating Officer as well as its Senior Vice President, Chief Financial Officer and Treasurer. Ms. Peterson has 19 years of insurance industry experience and 18 years of public accounting experience. Ms. Peterson serves on the Board of Governors for the Property Casualty Insurance Association of America where she chairs the Investment Committee and serves on the Executive and Finance Committees. Ms. Peterson also serves on the Board of Directors of The Community Financial Corporation where she chairs the Audit Committee. (Age 59)
|
|
|
|
Ross E. Taubman
|
|
Dr. Taubman is President and Chief Medical Officer of our PICA subsidiary. Prior to joining PICA Dr. Taubman practiced podiatry for 26 years. During that time, Dr. Taubman served as Treasurer, Vice-President and President of the Maryland Podiatric Medical Association. Dr. Taubman is a diplomate in the American Board of Podiatric Surgery. (Age 56)
|
|
|
|
Kelly B. Brewer
|
|
Ms. Brewer was appointed as our Chief Accounting Officer in 2014 and has served as our Vice President of Finance since joining ProAssurance in 2008. Prior to joining ProAssurance Ms. Brewer was a Senior Manager for PricewaterhouseCoopers for four years. Prior to that time Ms. Brewer served financial services clients in audit and forensic accounting engagements for five years. Ms. Brewer is a Certified Public Accountant. (Age 38)
|
|
|
2013
|
|
2012
|
||||||||||||
Quarter
|
|
High
|
|
Low
|
|
High
|
|
Low
|
||||||||
First
|
|
$
|
47.92
|
|
|
$
|
43.06
|
|
|
$
|
45.00
|
|
|
$
|
39.35
|
|
Second
|
|
52.73
|
|
|
47.11
|
|
|
45.06
|
|
|
41.94
|
|
||||
Third
|
|
55.28
|
|
|
45.06
|
|
|
46.29
|
|
|
43.80
|
|
||||
Fourth
|
|
49.38
|
|
|
42.70
|
|
|
46.49
|
|
|
42.17
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
Dividends Declared
|
|
Dividends Paid
|
||||||||||||
Quarter
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||||
First
|
|
$
|
0.250
|
|
|
$
|
0.125
|
|
|
$
|
—
|
|
|
$
|
0.125
|
|
Second
|
|
0.250
|
|
|
0.125
|
|
|
0.250
|
|
|
0.125
|
|
||||
Third
|
|
0.250
|
|
|
0.125
|
|
|
0.250
|
|
|
0.125
|
|
||||
Fourth*
|
|
0.300
|
|
|
2.750
|
|
|
0.250
|
|
|
2.875
|
|
Plan Category
|
|
Number of securities to be
issued upon exercise of outstanding options, warrants and rights |
|
Weighted-average
exercise price of outstanding options, warrants and rights |
|
Number of securities
remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |
||||
|
|
(a)
|
|
(b)
|
|
(c)
|
||||
Equity compensation plans approved by security holders
|
|
828,328
|
|
|
$
|
23.00
|
|
*
|
2,960,052
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
|
—
|
|
|
—
|
|
Period
|
|
Total Number of
Shares Purchased |
|
Average
Price Paid per Share |
|
Total Number
of Shares Purchased as Part of Publicly Announced Plans or Programs |
|
Approximate Dollar
Value of Shares that May Yet Be Purchased Under the Plans or Programs * (in thousands) |
||||
October 1 - 31, 2013
|
|
—
|
|
|
—
|
|
|
—
|
|
|
127,119
|
|
November 1 - 30, 2013
|
|
—
|
|
|
—
|
|
|
—
|
|
|
127,119
|
|
December 1 - 31, 2013
|
|
507,192
|
|
|
48.26
|
|
|
507,192
|
|
|
202,629
|
|
Total
|
|
507,192
|
|
|
48.26
|
|
|
507,192
|
|
|
|
|
|
Year Ended December 31
|
||||||||||||||||||
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
|
2009
|
||||||||||
|
|
(In thousands except per share data)
|
||||||||||||||||||
Selected Financial Data
(1)
|
|
|
||||||||||||||||||
Gross premiums written
|
|
$
|
567,547
|
|
|
$
|
536,431
|
|
|
$
|
565,895
|
|
|
$
|
533,205
|
|
|
$
|
553,922
|
|
Net premiums earned
|
|
527,919
|
|
|
550,664
|
|
|
565,415
|
|
|
519,107
|
|
|
497,543
|
|
|||||
Net investment income
|
|
129,265
|
|
|
136,094
|
|
|
140,956
|
|
|
146,380
|
|
|
150,945
|
|
|||||
Equity in earnings (loss) of unconsolidated subsidiaries
|
|
7,539
|
|
|
(6,873
|
)
|
|
(9,147
|
)
|
|
1,245
|
|
|
1,438
|
|
|||||
Net realized investment gains (losses)
|
|
67,904
|
|
|
28,863
|
|
|
5,994
|
|
|
17,342
|
|
|
12,792
|
|
|||||
Other revenues
|
|
7,551
|
|
|
7,106
|
|
|
13,566
|
|
|
7,991
|
|
|
9,965
|
|
|||||
Total revenues
|
|
740,178
|
|
|
715,854
|
|
|
716,784
|
|
|
692,065
|
|
|
672,683
|
|
|||||
Net losses and loss adjustment expenses
|
|
224,761
|
|
|
179,913
|
|
|
162,287
|
|
|
221,115
|
|
|
231,068
|
|
|||||
Net income (2)
|
|
$
|
297,523
|
|
|
$
|
275,470
|
|
|
$
|
287,096
|
|
|
$
|
231,598
|
|
|
$
|
222,026
|
|
Net income per share (3):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
$
|
4.82
|
|
|
$
|
4.49
|
|
|
$
|
4.70
|
|
|
$
|
3.64
|
|
|
$
|
3.38
|
|
Diluted
|
|
$
|
4.80
|
|
|
$
|
4.46
|
|
|
$
|
4.65
|
|
|
$
|
3.60
|
|
|
$
|
3.35
|
|
Weighted average shares outstanding (3):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
61,761
|
|
|
61,342
|
|
|
61,140
|
|
|
63,576
|
|
|
65,696
|
|
|||||
Diluted
|
|
62,020
|
|
|
61,833
|
|
|
61,684
|
|
|
64,351
|
|
|
66,300
|
|
|||||
Balance Sheet Data (as of December 31)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total investments
|
|
$
|
3,941,045
|
|
|
$
|
3,926,902
|
|
|
$
|
4,090,541
|
|
|
$
|
3,990,431
|
|
|
$
|
3,838,222
|
|
Total assets
|
|
5,150,891
|
|
|
4,876,578
|
|
|
4,998,878
|
|
|
4,875,056
|
|
|
4,647,414
|
|
|||||
Reserve for losses and loss adjustment expenses
|
|
2,072,822
|
|
|
2,054,994
|
|
|
2,247,772
|
|
|
2,414,100
|
|
|
2,422,230
|
|
|||||
Long-term debt
|
|
250,000
|
|
|
125,000
|
|
|
49,687
|
|
|
51,104
|
|
|
50,203
|
|
|||||
Total liabilities
|
|
2,756,477
|
|
|
2,605,998
|
|
|
2,834,425
|
|
|
3,019,193
|
|
|
2,942,819
|
|
|||||
Total capital
|
|
$
|
2,394,414
|
|
|
$
|
2,270,580
|
|
|
$
|
2,164,453
|
|
|
$
|
1,855,863
|
|
|
$
|
1,704,595
|
|
Total capital per share of common stock outstanding (3)
|
|
$
|
39.13
|
|
|
$
|
36.85
|
|
|
$
|
35.42
|
|
|
$
|
30.17
|
|
|
$
|
26.30
|
|
Common stock outstanding, period end (3)
|
|
61,197
|
|
|
61,624
|
|
|
61,107
|
|
|
61,506
|
|
|
64,824
|
|
(1)
|
Includes acquired entities since date of acquisition only.
|
(2)
|
Includes a loss on extinguishment of debt of
$2.2 million
and
$2.8 million
for the years ended December 31, 2012 and 2009, respectively.
|
(3)
|
For all periods presented, share and per share amounts reflect the effect of the two-for-one stock split effected in the form of a stock dividend that was effective December 27, 2012.
|
•
|
Bornhuetter-Ferguson (Paid and Reported) Method
|
•
|
Paid Development Method
|
•
|
Reported Development Method
|
•
|
Average Paid Value Method
|
•
|
Average Reported Value Method
|
•
|
Backward Recursive Development Method
|
•
|
The Adjusted Reported and the Adjusted Paid Methods
|
(In thousands)
|
2013
|
|
2012
|
|
2011
|
2012
|
$4,828
|
|
N/A
|
|
N/A
|
2011
|
(11,665)
|
|
$(4,889)
|
|
N/A
|
2010
|
(27,452)
|
|
(13,612)
|
|
$(3,293)
|
2009
|
(45,065)
|
|
(24,378)
|
|
(22,090)
|
2008
|
(38,631)
|
|
(55,659)
|
|
(51,562)
|
2007
|
(34,086)
|
|
(51,047)
|
|
(61,663)
|
2006
|
(21,777)
|
|
(38,708)
|
|
(58,795)
|
2005
|
(14,232)
|
|
(24,961)
|
|
(36,100)
|
2004
|
(7,581)
|
|
(18,917)
|
|
(39,288)
|
Prior to 2004
|
(20,212)
|
|
(39,868)
|
|
(53,074)
|
($ in millions)
|
2013
|
|
2012
|
|
2011
|
Prior accident years
|
2010-2012
|
|
2009-2011
|
|
2008-2010
|
Net favorable development recognized for the specified years
|
$34.3
|
|
$42.9
|
|
$76.9
|
Development as a % of established ultimates, prior calendar year end
|
2.4%
|
|
2.9%
|
|
5.1%
|
|
Low End Point
|
|
Carried Net Reserve
|
|
High End Point
|
80% Confidence Level
|
$1.407 billion
|
|
$1.825 billion
|
|
$2.300 billion
|
60% Confidence Level
|
$1.520 billion
|
|
$1.825 billion
|
|
$2.105 billion
|
|
Distribution by GAAP Fair Value Hierarchy
|
|
December 31, 2013
|
||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
Investments |
Investments recorded at:
|
|
|
|
|
|
|
|
Fair value
|
13%
|
|
78%
|
|
3%
|
|
94%
|
Other valuations
|
|
|
|
|
|
|
6%
|
Total Investments
|
|
|
|
|
|
|
100%
|
(In millions)
|
Carrying Value
|
|
GAAP Measurement
Method |
||
Other investments:
|
|
|
|
||
Investments in LPs, at cost
|
$
|
47.3
|
|
|
Cost
|
Federal Home Loan Bank (FHLB) capital stock
|
3.4
|
|
|
Cost
|
|
Other
|
1.5
|
|
|
Amortized cost
|
|
Total other investments
|
$
|
52.2
|
|
|
|
|
|
|
|
||
Investment in unconsolidated subsidiaries:
|
|
|
|
||
Investments in tax credit partnerships
|
$
|
142.2
|
|
|
Equity
|
|
|
|
|
||
Business owned life insurance
|
$
|
54.4
|
|
|
Cash surrender value
|
|
|
|
|
||
Total investments - Other valuation methodologies
|
$
|
248.8
|
|
|
|
•
|
third party research and credit rating reports;
|
•
|
the current credit standing of the issuer, including credit rating downgrades;
|
•
|
the extent to which the decline in fair value is attributable to credit risk specifically associated with the security or its issuer;
|
•
|
our internal assessments and those of our external portfolio managers regarding specific circumstances surrounding a security, which can cause us to believe the security is more or less likely to recover its value than other securities with a similar structure;
|
•
|
for asset-backed securities, the origination date of the underlying loans, the remaining average life, the probability that credit performance of the underlying loans will deteriorate in the future, and our assessment of the quality of the collateral underlying the loan;
|
•
|
failure of the issuer of the security to make scheduled interest or principal payments;
|
•
|
any changes to the rating of the security by a rating agency;
|
•
|
recoveries or additional declines in fair value subsequent to the balance sheet date; and
|
•
|
our intent to sell and whether it is more likely than not we will be required to sell the security before the recovery of its amortized cost basis.
|
•
|
The
net loss ratio
is calculated as net losses incurred divided by net premiums earned and is a component of underwriting profitability.
|
•
|
The
underwriting expense ratio
is calculated as underwriting, policy acquisition and operating expenses incurred divided by net premiums earned and is a component of underwriting profitability.
|
•
|
The
combined ratio
is the sum of the underwriting expense ratio and the net loss ratio and measures underwriting profitability.
|
•
|
The
investment income ratio
is calculated as net investment income divided by net premiums earned and measures the contribution investment earnings provides to our overall profitability.
|
•
|
The
operating ratio
is the combined ratio, less the investment income ratio. This ratio provides the combined effect of investment income and underwriting profitability.
|
•
|
The
tax ratio
is calculated as total income tax expense divided by income (loss) before income taxes and measures our effective tax rate.
|
•
|
Return on equity (ROE)
is calculated as net income for the period divided by the average of beginning and ending shareholders’ equity. This ratio measures our overall after-tax profitability and shows how efficiently invested capital is being used.
|
•
|
Growth in book value.
Book value per share is calculated as total shareholders’ equity at the balance sheet date divided by the total number of common shares outstanding. This ratio measures the net worth of the company to shareholders on a per-share basis. Growth in book value per share is an indicator of overall profitability.
|
(In millions)
|
Operating
Cash Flow
|
||
Cash provided by operating activities for the year ended December 31, 2012
|
$
|
91
|
|
Increase (decrease) in operating cash flows:
|
|
||
Decrease in premium receipts (1)
|
(33
|
)
|
|
Decrease in payments to reinsurers (2)
|
3
|
|
|
Increase in losses paid, net of reinsurance recoveries (3)
|
(3
|
)
|
|
Decrease in cash received from investments
|
(9
|
)
|
|
Increase in Federal and state income tax payments (4)
|
(3
|
)
|
|
Net cash provided (used) by acquisitions (5)
|
(6
|
)
|
|
Cash paid for start-up expenses related to Syndicate 1729 (6)
|
(3
|
)
|
|
Other amounts not individually significant, net
|
2
|
|
|
Cash provided by operating activities for the year ended December 31, 2013
|
$
|
39
|
|
(1)
|
The reduction in premium receipts reflected lower premium volume in 2013 exclusive of acquisitions as well as the effect of the timing of premium receipts on several large policies.
|
(2)
|
Reinsurance contracts are generally for premiums written in a specific annual period, but, absent a commutation agreement, remain in effect until all claims under the contract have been resolved. Some contracts require annual settlements while others require settlement only after a number of years have elapsed, thus the amounts paid can vary widely from period to period.
|
(3)
|
The timing of our net loss payments varies from period to period because the process for resolving claims is complex and occurs at an uneven pace depending upon the circumstances of the individual claim.
|
(4)
|
The net increase in tax payments during 2013 was attributable to:
|
•
|
A
$20.6 million
protective tax payment made in 2013 related to a dispute with the Internal Revenue Service (IRS), as discussed in further detail in this section under the heading "Taxes."
|
•
|
An
$8.3 million
decrease in the final tax payments made during 2013 for the prior fiscal year.
|
•
|
A
$3.4 million
decrease in estimated tax payments during 2013 for current fiscal year.
|
•
|
GAAP requires that excess tax benefits recognized when shares are issued under stock compensation plans be reflected as a reduction to operating cash flows and as an increase to financing cash flows in the period the shares are issued. Such excess tax benefits were
$4.9 million
lower in 2013 as compared to 2012.
|
(5)
|
Net cash used by acquisitions reflected the payments of transaction costs, loss payments made by the acquired companies related to prior accident years, and normal expense payments of the acquired companies for which the timing of the payment differs from the recognition of the expense.
|
(6)
|
Cash paid for expenses related to the start-up of Syndicate 1729, which were principally professional fees.
|
(In millions)
|
Operating
Cash Flow
|
||
Cash provided by operating activities for the year ended December 31, 2011
|
$
|
159
|
|
Increase (decrease) in operating cash flows:
|
|
||
Decrease in premium receipts (1)
|
(12
|
)
|
|
Increase in payments to reinsurers (2)
|
(8
|
)
|
|
Increase in losses paid, net of reinsurance recoveries (3)
|
(35
|
)
|
|
Decrease in cash received from investments
|
(8
|
)
|
|
Decrease in cash paid for other expenses (4)
|
13
|
|
|
Increase in Federal and state income tax payments (5)
|
(18
|
)
|
|
Cash provided by operating activities for the year ended December 31, 2012
|
$
|
91
|
|
(1)
|
The reduction in premium receipts reflected lower premium volume in 2012, exclusive of a volume decline related to twenty-four month term policies and a volume increase related to tail policies. The premium from two-year term policies is included in gross written premium in the period in which the policy is written, but has little effect on timing of premium receipts since half of the written amount is billed in the second term. Tail policies are typically collected in the period written.
|
(2)
|
Reinsurance contracts are generally for premiums written in a specific annual period, but, absent a commutation agreement, remain in effect until all claims under the contract have been resolved. Some contracts require annual settlements while others require settlement only after a number of years have elapsed, thus the amounts paid can vary widely from period to period.
|
(3)
|
The timing of our net loss payments varies from period to period because the process for resolving claims is complex and occurs at an uneven pace depending upon the circumstances of the individual claim. The increase in loss payments for 2012 primarily reflected a greater number of claims resolved with large indemnity payments, a portion of which was recovered under existing reinsurance agreements. The additional loss payments were not isolated to any one state or to any specific risk groups. Loss payments made during 2012 were included in the data considered by our actuaries and by our Management in determining their best estimate of losses incurred during 2012.
|
(4)
|
The decrease in cash paid for other expenses was principally attributable to non-recurring payments of APS integration costs, primarily compensation-related, during 2011.
|
(5)
|
The net increase in tax payments during 2012 was attributable to:
|
•
|
A $7.4 million increase in the final payments for the prior fiscal year, partially offset by a $4.8 million decrease in estimated tax payments for the current year.
|
•
|
There were no Federal tax refunds in 2012. In 2011 refunds approximated $17.3 million.
|
•
|
GAAP requires that excess tax benefits recognized when shares are issued under stock compensation plans be reflected as a reduction to operating cash flows and an increase to financing cash flows in the period the shares are issued. Such excess tax benefits were $5.3 million greater in 2012 as compared to 2011.
|
•
|
The above increases to tax related outflows were offset by:
|
•
|
Payments of $5.9 million made in 2011 for the 2008 and 2007 tax years as a result of Federal tax return audits conducted by the Internal Revenue Service. The payments reduced tax liabilities recognized prior to January 1, 2011 and did not increase or decrease 2011 tax expense.
|
•
|
A reduction in state and other tax payments of $1.8 million.
|
(In millions)
|
Operating
Cash Flow
|
||
Cash provided by operating activities for the year ended December 31, 2010
|
$
|
139
|
|
Increase (decrease) in operating cash flows during 2011:
|
|
||
Decrease in premium receipts, exclusive of APS (1)
|
(22
|
)
|
|
Increase in payments to reinsurers, exclusive of APS (2)
|
(3
|
)
|
|
Decrease in losses paid, net of reinsurance recoveries, exclusive of APS (3)
|
27
|
|
|
Increase in Federal and state income tax payments (4)
|
(6
|
)
|
|
Cash flows attributable to operations acquired from APS (exclusive of tax payments or refunds)
|
25
|
|
|
Other amounts not individually significant, net
|
(1
|
)
|
|
Cash provided by operating activities for the year ended December 31, 2011
|
$
|
159
|
|
(1)
|
The decline in premium receipts is primarily attributable to reduced premium volume. Exclusive of twenty-four month term policies and the business acquired from APS, gross written premiums were lower in 2011.
|
(2)
|
Reinsurance contracts are generally for premiums written in a specific annual period, but, absent a commutation agreement, remain in effect until all claims under the contract have been resolved. Some contracts require annual settlements while others require settlement only after a number of years have elapsed, thus the amounts paid can vary widely from period to period.
|
(3)
|
The timing of our net loss payments varies from period to period because the process for resolving claims is complex and occurs at an uneven pace depending upon the circumstances of the individual claim. Net loss payments are also subject to reinsurance recoveries under existing reinsurance agreements.
|
(4)
|
The increase in tax payments primarily reflects:
|
•
|
An increase in estimated tax payments of $16.1 million during 2011 as compared to 2010.
|
•
|
Payments of $5.9 million made in 2011 for the 2008 and 2007 tax years as a result of Federal tax return audits conducted by the Internal Revenue Service. The payments reduced tax liabilities recognized prior to January 1, 2011 and did not increase or decrease 2011 tax expense.
|
•
|
The above increases to tax payments were partially offset by greater Federal tax refunds in 2011 of $15.9 million. Principally, refunds from capital loss carry backs were higher in 2011 than in 2010 and a refund associated with the APS 2010 pre-acquisition period was received in 2011.
|
•
|
The line entitled “Reserve for losses, undiscounted and net of reinsurance recoverables” reflects our reserve for losses and loss adjustment expense, less the receivables from reinsurers, each as reported in our consolidated financial statements at the end of each year (the Balance Sheet Reserves).
|
•
|
The section entitled “Cumulative net paid, as of” reflects the cumulative amounts paid as of the end of each succeeding year with respect to the previously recorded Balance Sheet Reserves.
|
•
|
The section entitled “Re-estimated net liability as of” reflects the re-estimated amount of the liability previously recorded as Balance Sheet Reserves that includes the cumulative amounts paid and an estimate of the remaining net liability based upon claims experience as of the end of each succeeding year (the Net Re-estimated Liability).
|
•
|
The line entitled “Net cumulative redundancy (deficiency)” reflects the difference between the previously recorded Balance Sheet Reserve for each applicable year and the Net Re-estimated Liability relating thereto as of the end of the most recent fiscal year.
|
Analysis of Reserve Development
|
|||||||||||||||||||||||||||||||||||||||||||
(in thousands)
|
|||||||||||||||||||||||||||||||||||||||||||
December 31,
|
|||||||||||||||||||||||||||||||||||||||||||
|
2003
|
|
2004
|
|
2005
|
|
2006
|
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
||||||||||||||||||||||
|
|
|
|
|
(1)
|
|
(2)
|
|
|
|
|
|
(3)
|
|
(4)
|
|
|
|
(5)
|
|
(6)
|
||||||||||||||||||||||
Reserve for losses, undiscounted and net of reinsurance recoverables
|
$
|
1,298,458
|
|
|
$
|
1,544,981
|
|
|
$
|
1,896,743
|
|
|
$
|
2,236,385
|
|
|
$
|
2,232,596
|
|
|
$
|
2,111,112
|
|
|
$
|
2,159,571
|
|
|
$
|
2,136,664
|
|
|
$
|
2,000,114
|
|
|
$
|
1,860,076
|
|
|
$
|
1,825,304
|
|
Cumulative net paid, as of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
One Year Later
|
200,314
|
|
|
199,617
|
|
|
242,608
|
|
|
331,295
|
|
|
312,348
|
|
|
278,655
|
|
|
291,654
|
|
|
264,597
|
|
|
300,703
|
|
|
311,835
|
|
|
|
||||||||||||
Two Years Later
|
378,036
|
|
|
384,050
|
|
|
503,271
|
|
|
600,500
|
|
|
550,042
|
|
|
468,277
|
|
|
476,682
|
|
|
491,657
|
|
|
526,903
|
|
|
|
|
|
|||||||||||||
Three Years Later
|
526,867
|
|
|
578,455
|
|
|
697,349
|
|
|
787,347
|
|
|
694,113
|
|
|
584,410
|
|
|
614,369
|
|
|
639,220
|
|
|
|
|
|
|
|
||||||||||||||
Four Years Later
|
680,470
|
|
|
728,582
|
|
|
825,139
|
|
|
897,814
|
|
|
777,114
|
|
|
666,105
|
|
|
706,091
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Five Years Later
|
794,870
|
|
|
805,270
|
|
|
901,644
|
|
|
955,728
|
|
|
833,471
|
|
|
724,377
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Six Years Later
|
852,985
|
|
|
861,512
|
|
|
937,984
|
|
|
995,921
|
|
|
874,479
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Seven Years Later
|
894,355
|
|
|
888,065
|
|
|
959,870
|
|
|
1,022,273
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Eight Years Later
|
915,964
|
|
|
901,867
|
|
|
980,665
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Nine Years Later
|
927,805
|
|
|
919,840
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Ten Years Later
|
941,991
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Re-estimated net liability as of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
End of Year
|
1,298,458
|
|
|
1,544,981
|
|
|
1,896,743
|
|
|
2,236,385
|
|
|
2,232,596
|
|
|
2,111,112
|
|
|
2,159,571
|
|
|
2,136,664
|
|
|
2,000,114
|
|
|
1,860,076
|
|
|
|
||||||||||||
One Year Later
|
1,289,744
|
|
|
1,522,000
|
|
|
1,860,451
|
|
|
2,131,400
|
|
|
2,047,344
|
|
|
1,903,812
|
|
|
1,925,581
|
|
|
1,810,799
|
|
|
1,728,076
|
|
|
1,644,203
|
|
|
|
||||||||||||
Two Years Later
|
1,282,920
|
|
|
1,479,773
|
|
|
1,764,076
|
|
|
1,955,903
|
|
|
1,829,140
|
|
|
1,665,832
|
|
|
1,615,603
|
|
|
1,543,650
|
|
|
1,498,158
|
|
|
|
|
|
|||||||||||||
Three Years Later
|
1,259,802
|
|
|
1,418,802
|
|
|
1,615,125
|
|
|
1,747,459
|
|
|
1,596,508
|
|
|
1,383,189
|
|
|
1,362,538
|
|
|
1,324,906
|
|
|
|
|
|
|
|
||||||||||||||
Four Years Later
|
1,250,110
|
|
|
1,340,061
|
|
|
1,450,275
|
|
|
1,548,605
|
|
|
1,357,126
|
|
|
1,154,552
|
|
|
1,172,091
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Five Years Later
|
1,230,105
|
|
|
1,234,223
|
|
|
1,330,039
|
|
|
1,366,793
|
|
|
1,185,051
|
|
|
1,019,407
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Six Years Later
|
1,156,614
|
|
|
1,158,590
|
|
|
1,225,114
|
|
|
1,249,234
|
|
|
1,084,422
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Seven Years Later
|
1,111,795
|
|
|
1,092,186
|
|
|
1,148,102
|
|
|
1,180,804
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Eight Years Later
|
1,079,383
|
|
|
1,040,035
|
|
|
1,104,687
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Nine Years Later
|
1,041,880
|
|
|
1,012,643
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Ten Years Later
|
1,022,413
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net cumulative redundancy (deficiency)
|
$
|
276,045
|
|
|
$
|
532,338
|
|
|
$
|
792,056
|
|
|
$
|
1,055,581
|
|
|
$
|
1,148,174
|
|
|
$
|
1,091,705
|
|
|
$
|
987,480
|
|
|
$
|
811,758
|
|
|
$
|
501,956
|
|
|
$
|
215,873
|
|
|
|
||
Original gross liability - end of year
|
$
|
1,634,749
|
|
|
$
|
1,818,635
|
|
|
$
|
2,224,436
|
|
|
$
|
2,607,148
|
|
|
$
|
2,559,707
|
|
|
$
|
2,379,468
|
|
|
$
|
2,422,230
|
|
|
$
|
2,414,100
|
|
|
$
|
2,247,772
|
|
|
$
|
2,051,428
|
|
|
|
||
Less: reinsurance recoverables
|
(336,291
|
)
|
|
(273,654
|
)
|
|
(327,693
|
)
|
|
(370,763
|
)
|
|
(327,111
|
)
|
|
(268,356
|
)
|
|
(262,659
|
)
|
|
(277,436
|
)
|
|
(247,658
|
)
|
|
(191,352
|
)
|
|
|
||||||||||||
Original net liability - end of year
|
$
|
1,298,458
|
|
|
$
|
1,544,981
|
|
|
$
|
1,896,743
|
|
|
$
|
2,236,385
|
|
|
$
|
2,232,596
|
|
|
$
|
2,111,112
|
|
|
$
|
2,159,571
|
|
|
$
|
2,136,664
|
|
|
$
|
2,000,114
|
|
|
$
|
1,860,076
|
|
|
|
||
Gross re-estimated liability - latest
|
$
|
1,317,628
|
|
|
$
|
1,301,011
|
|
|
$
|
1,443,004
|
|
|
$
|
1,562,820
|
|
|
$
|
1,352,411
|
|
|
$
|
1,199,801
|
|
|
$
|
1,328,867
|
|
|
$
|
1,494,942
|
|
|
$
|
1,679,060
|
|
|
$
|
1,811,240
|
|
|
|
||
Re-estimated reinsurance recoverables
|
(295,215
|
)
|
|
(288,368
|
)
|
|
(338,317
|
)
|
|
(382,016
|
)
|
|
(267,989
|
)
|
|
(180,394
|
)
|
|
(156,776
|
)
|
|
(170,036
|
)
|
|
(180,902
|
)
|
|
(167,037
|
)
|
|
|
||||||||||||
Net re-estimated liability - latest
|
$
|
1,022,413
|
|
|
$
|
1,012,643
|
|
|
$
|
1,104,687
|
|
|
$
|
1,180,804
|
|
|
$
|
1,084,422
|
|
|
$
|
1,019,407
|
|
|
$
|
1,172,091
|
|
|
$
|
1,324,906
|
|
|
$
|
1,498,158
|
|
|
$
|
1,644,203
|
|
|
|
||
Gross cumulative redundancy (deficiency)
|
$
|
317,121
|
|
|
$
|
517,624
|
|
|
$
|
781,432
|
|
|
$
|
1,044,328
|
|
|
$
|
1,207,296
|
|
|
$
|
1,179,667
|
|
|
$
|
1,093,363
|
|
|
$
|
919,158
|
|
|
$
|
568,712
|
|
|
$
|
240,188
|
|
|
|
(1)
|
Reserves for 2005 and thereafter include gross and net reserves acquired in 2005 business combinations of $183.2 million and $139.7 million, respectively.
|
(2)
|
Reserves for 2006 and thereafter include gross and net reserves acquired in 2006 business combinations of $228.4 million and $171.2 million, respectively.
|
(3)
|
Reserves for 2009 and thereafter include gross and net reserves acquired in 2009 business combinations of $169.4 million and $163.9 million, respectively.
|
(4)
|
Reserves for 2010 and thereafter include gross and net reserves acquired in 2010 business combinations of $88.1 million and $82.2 million, respectively.
|
(5)
|
Reserves for 2012 and thereafter include gross and net reserves acquired in 2012 business combinations of
$21.8 million
and
$19.2 million
, respectively, which considers reductions of
$3.6 million
and
$3.3 million
, respectively, recorded in 2013 due to the re-estimation of the fair value of the acquired reserves.
|
(6)
|
Reserves for 2013 include gross and net reserves acquired in 2013 business combinations of
$201.1 million
and
$126.0 million
, respectively.
|
•
|
The HCPL legal environment deteriorated in the late 1990’s and severity began to increase at a greater pace than anticipated in our rates and reserve estimates. We addressed the adverse severity trends through increased rates, stricter underwriting and modifications to claims handling procedures. The expectation of increased claim severity was also considered in establishing our initial reserves for subsequent years.
|
•
|
These adverse severity trends later moderated with that moderation becoming more pronounced beginning in 2009. We have been cautious in giving full recognition to indications that the pace of severity increase has slowed, but have given measured recognition of the improving trends in our reserve estimates, as discussed more fully under “Critical Accounting Estimates—Reserve for Losses and Loss Adjustment Expenses (reserve for losses or reserve).” The favorable development was most pronounced for years 2004 to 2008, as the initial reserves for these accident years were established prior to substantial indication that severity trends were moderating. We give stronger recognition to a lower severity trend as time elapses and the percentage of closed claims increases.
|
•
|
A general decline in claim frequency has also been a contributor to favorable loss development. A significant portion of our policies through 2003 were issued on an occurrence basis, and a smaller portion of our ongoing business results from the issuance of extended reporting endorsements which have occurrence-like exposure. As claim frequency declined, the number of reported claims related to these coverages was less than originally expected.
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
2013
|
|
2012
|
|
2011
|
||||||
Balance, beginning of year
|
$
|
2,054,994
|
|
|
$
|
2,247,772
|
|
|
$
|
2,414,100
|
|
Less reinsurance recoverables on unpaid losses and loss adjustment expenses
|
191,645
|
|
|
247,658
|
|
|
277,436
|
|
|||
Net balance, beginning of year
|
1,863,349
|
|
|
2,000,114
|
|
|
2,136,664
|
|
|||
Reserves acquired from acquisitions (1)
|
126,007
|
|
|
22,464
|
|
|
—
|
|
|||
Incurred related to:
|
|
|
|
|
|
||||||
Current year
|
447,510
|
|
|
451,951
|
|
|
488,152
|
|
|||
Favorable development of reserves established in prior years, net
|
(222,749
|
)
|
|
(272,038
|
)
|
|
(325,865
|
)
|
|||
Total incurred
|
224,761
|
|
|
179,913
|
|
|
162,287
|
|
|||
Paid related to:
|
|
|
|
|
|
||||||
Current year
|
(43,616
|
)
|
|
(38,439
|
)
|
|
(34,240
|
)
|
|||
Prior years (2)
|
(345,197
|
)
|
|
(300,703
|
)
|
|
(264,597
|
)
|
|||
Total paid
|
(388,813
|
)
|
|
(339,142
|
)
|
|
(298,837
|
)
|
|||
Net balance, end of year
|
1,825,304
|
|
|
1,863,349
|
|
|
2,000,114
|
|
|||
Plus reinsurance recoverables on unpaid losses and loss adjustment expenses
|
247,518
|
|
|
191,645
|
|
|
247,658
|
|
|||
Balance, end of year
|
$
|
2,072,822
|
|
|
$
|
2,054,994
|
|
|
$
|
2,247,772
|
|
|
|
|
Included in Carrying Value:
|
|
|
|
|
|
|
|||||||||
($ in thousands)
|
Carrying
Value
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Average
Rating
|
|
(1)
|
|
% Total
Investments |
|||||||
Fixed Maturities
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Government
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
U.S. Treasury
|
$
|
170,714
|
|
|
$
|
6,118
|
|
|
$
|
(1,519
|
)
|
|
AA+
|
|
(2)
|
|
4
|
%
|
U.S. Government-sponsored enterprise
|
32,768
|
|
|
2,251
|
|
|
(425
|
)
|
|
AA+
|
|
(2)
|
|
1
|
%
|
|||
Total government
|
203,482
|
|
|
8,369
|
|
|
(1,944
|
)
|
|
AA+
|
|
(2)
|
|
5
|
%
|
|||
State and Municipal Bonds
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Pre-refunded
|
167,631
|
|
|
6,861
|
|
|
(47
|
)
|
|
AA
|
|
|
|
4
|
%
|
|||
General obligation
|
321,532
|
|
|
14,477
|
|
|
(1,236
|
)
|
|
AA+
|
|
|
|
8
|
%
|
|||
Special revenue
|
665,503
|
|
|
25,195
|
|
|
(6,644
|
)
|
|
AA
|
|
|
|
17
|
%
|
|||
Total state and municipal bonds
|
1,154,666
|
|
|
46,533
|
|
|
(7,927
|
)
|
|
AA
|
|
|
|
29
|
%
|
|||
Corporate Debt
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Financial institutions
|
396,564
|
|
|
13,957
|
|
|
(4,030
|
)
|
|
A
|
|
|
|
10
|
%
|
|||
Consumer oriented
|
275,708
|
|
|
15,428
|
|
|
(4,796
|
)
|
|
BBB+
|
|
|
|
7
|
%
|
|||
Utilities/Energy
|
279,535
|
|
|
12,519
|
|
|
(3,193
|
)
|
|
BBB+
|
|
|
|
7
|
%
|
|||
Industrial
|
399,180
|
|
|
10,945
|
|
|
(1,668
|
)
|
|
BBB
|
|
|
|
10
|
%
|
|||
Other
|
10,166
|
|
|
210
|
|
|
(57
|
)
|
|
A
|
|
|
|
<1%
|
|
|||
Total corporate debt
|
1,361,153
|
|
|
53,059
|
|
|
(13,744
|
)
|
|
BBB+
|
|
|
|
35
|
%
|
|||
Securities backed by:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Agency mortgages
|
230,660
|
|
|
7,564
|
|
|
(2,629
|
)
|
|
AA+
|
|
(2)
|
|
6
|
%
|
|||
Non-agency mortgages
|
4,939
|
|
|
44
|
|
|
(226
|
)
|
|
AA-
|
|
|
|
<1%
|
|
|||
Alt -A mortgages
|
15
|
|
|
—
|
|
|
—
|
|
|
AA+
|
|
|
|
<1%
|
|
|||
Agency commercial mortgages
|
27,475
|
|
|
343
|
|
|
(136
|
)
|
|
AA+
|
|
(2)
|
|
1
|
%
|
|||
Subprime home equity loans
|
3,889
|
|
|
17
|
|
|
(237
|
)
|
|
BBB+
|
|
|
|
<1%
|
|
|||
Other commercial mortgages
|
61,390
|
|
|
2,491
|
|
|
(167
|
)
|
|
AAA
|
|
|
|
2
|
%
|
|||
Credit card loans
|
10,252
|
|
|
274
|
|
|
(9
|
)
|
|
AAA
|
|
|
|
<1%
|
|
|||
Automobile loans
|
41,959
|
|
|
126
|
|
|
(20
|
)
|
|
AAA
|
|
|
|
1
|
%
|
|||
Other asset loans
|
18,169
|
|
|
70
|
|
|
(58
|
)
|
|
AA
|
|
|
|
<1%
|
|
|||
Total asset-backed securities
|
398,748
|
|
|
10,929
|
|
|
(3,482
|
)
|
|
AAA
|
|
|
|
10
|
%
|
|||
Total fixed maturities
|
3,118,049
|
|
|
118,890
|
|
|
(27,097
|
)
|
|
A+
|
|
|
|
79
|
%
|
|||
Equities
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Financial
|
81,536
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
2
|
%
|
|||
Utilities/Energy
|
32,350
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
Industrial
|
57,262
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
Consumer oriented
|
66,461
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
2
|
%
|
|||
All Other
|
15,932
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
<1%
|
|
|||
Total equities
|
253,541
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
6
|
%
|
|||
Short-Term
|
248,605
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
6
|
%
|
|||
Business-owned life insurance (BOLI)
|
54,374
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
Investment in Unconsolidated Subsidiaries
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Investment in tax credit partnerships
|
142,174
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
4
|
%
|
|||
Investment in LPs, carried at NAV
|
72,062
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
2
|
%
|
|||
Total investment in unconsolidated subsidiaries
|
214,236
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
5
|
%
|
|||
Other Investments
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
FHLB capital stock
|
3,449
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
<1%
|
|
|||
Investments in LPs, carried at cost
|
47,258
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
Other
|
1,533
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
<1%
|
|
|||
Total other investments
|
52,240
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
Total Investments
|
$
|
3,941,045
|
|
|
$
|
118,890
|
|
|
$
|
(27,097
|
)
|
|
|
|
|
|
100
|
%
|
(1)
|
A weighted average rating is calculated using available ratings from Standard & Poor’s, Moody’s and Fitch. The table presents the Standard & Poor’s rating that is equivalent to the computed average.
|
(2)
|
The rating presented is the Standard & Poor’s rating rather than the average. The Moody’s rating is
Aaa
and the Fitch rating is
AAA
.
|
|
|
European Debt Exposure by Country and Industry Type
|
||||||||||||||
(in millions)
|
|
Total
Exposure |
|
Financial
Institutions |
|
Industrial &
Utilities |
|
Energy &
Communication |
||||||||
United Kingdom
|
|
$
|
57.4
|
|
|
$
|
23.5
|
|
|
$
|
21.6
|
|
|
$
|
12.3
|
|
Netherlands
|
|
20.6
|
|
|
5.0
|
|
|
6.8
|
|
|
8.8
|
|
||||
France
|
|
10.8
|
|
|
3.6
|
|
|
—
|
|
|
7.2
|
|
||||
Switzerland
|
|
10.0
|
|
|
10.0
|
|
|
—
|
|
|
—
|
|
||||
Luxembourg
|
|
9.5
|
|
|
—
|
|
|
4.3
|
|
|
5.2
|
|
||||
Sweden
|
|
3.6
|
|
|
3.6
|
|
|
—
|
|
|
—
|
|
||||
Ireland
|
|
3.3
|
|
|
0.1
|
|
|
1.2
|
|
|
2.0
|
|
||||
Norway
|
|
3.2
|
|
|
1.3
|
|
|
1.2
|
|
|
0.7
|
|
||||
Spain
|
|
2.2
|
|
|
—
|
|
|
—
|
|
|
2.2
|
|
||||
Denmark
|
|
1.8
|
|
|
1.8
|
|
|
—
|
|
|
—
|
|
||||
Austria
|
|
1.3
|
|
|
—
|
|
|
1.3
|
|
|
—
|
|
||||
Germany
|
|
1.0
|
|
|
—
|
|
|
1.0
|
|
|
—
|
|
||||
|
|
$
|
124.7
|
|
|
$
|
48.9
|
|
|
$
|
37.4
|
|
|
$
|
38.4
|
|
|
Year Ended December 31
|
|||||||
(in thousands)
|
2013
|
|
2012
|
|
2011
|
|||
Treasury shares at the beginning of the period
|
244
|
|
|
7,996
|
|
|
7,332
|
|
Shares reissued in conjunction with stock split
|
—
|
|
|
(7,729
|
)
|
|
—
|
|
Shares reacquired, at cost of $32 million, $0 million and $21 million, respectively
|
681
|
|
|
—
|
|
|
682
|
|
Shares reissued to the ProAssurance 2011 Employee Stock Ownership Plan, fair value of $1 million, $1 million and $0.7 million, respectively
|
(25
|
)
|
|
(23
|
)
|
|
(18
|
)
|
Treasury shares at the end of the period
|
900
|
|
|
244
|
|
|
7,996
|
|
|
|
Payments due by period
|
||||||||||||||||||
(In thousands)
|
|
Total
|
|
Less than
1 year
|
|
1-3 years
|
|
3-5 years
|
|
More than
5 years
|
||||||||||
Loss and loss adjustment expenses
|
|
$
|
2,072,822
|
|
|
$
|
557,769
|
|
|
$
|
688,077
|
|
|
$
|
410,891
|
|
|
$
|
416,085
|
|
Eastern acquisition
|
|
205,000
|
|
|
205,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Long-term debt obligations including interest
|
|
382,316
|
|
|
14,722
|
|
|
26,500
|
|
|
26,500
|
|
|
314,594
|
|
|||||
Revolving credit agreement fees
|
|
591
|
|
|
263
|
|
|
328
|
|
|
—
|
|
|
—
|
|
|||||
Operating lease obligations
|
|
19,911
|
|
|
3,039
|
|
|
5,303
|
|
|
4,553
|
|
|
7,016
|
|
|||||
Funding commitments primarily related to non-public investment entities
|
|
164,182
|
|
|
49,604
|
|
|
68,940
|
|
|
26,838
|
|
|
18,800
|
|
|||||
Total
|
|
$
|
2,844,822
|
|
|
$
|
830,397
|
|
|
$
|
789,148
|
|
|
$
|
468,782
|
|
|
$
|
756,495
|
|
|
Year Ended December 31
|
||||||
(In millions, except per share data)
|
2013
|
|
2012
|
||||
Net income
|
$
|
297.5
|
|
|
$
|
275.5
|
|
Operating income
|
$
|
221.1
|
|
|
$
|
257.2
|
|
|
|
|
|
||||
Net income per diluted share
|
$
|
4.80
|
|
|
$
|
4.46
|
|
Operating income per diluted share
|
$
|
3.56
|
|
|
$
|
4.16
|
|
|
Book Value Per Share
|
||
Book Value Per Share at December 31, 2012
|
$
|
36.85
|
|
Increase (decrease) to book value per share during the year ended December 31, 2013 attributable to:
|
|
||
Net income
|
4.82
|
|
|
Decline in accumulated other comprehensive income
|
(1.40
|
)
|
|
Dividends declared
|
(1.05
|
)
|
|
Other
|
(0.09
|
)
|
|
Book Value Per Share at December 31, 2013
|
$
|
39.13
|
|
|
Year Ended December 31
|
||||||
(In thousands, except per share data)
|
2013
|
|
2012
|
||||
Net income
|
$
|
297,523
|
|
|
$
|
275,470
|
|
Items excluded in the calculation of operating income:
|
|
|
|
||||
(Gain) loss on extinguishment of debt
|
—
|
|
|
2,163
|
|
||
Net realized investment (gains) losses
|
(67,904
|
)
|
|
(28,863
|
)
|
||
Guaranty fund assessments (recoupments)
|
40
|
|
|
345
|
|
||
Gain on acquisition
|
(32,314
|
)
|
|
—
|
|
||
Effect of confidential settlements, net
|
—
|
|
|
(1,694
|
)
|
||
Pre-tax effect of exclusions
|
(100,178
|
)
|
|
(28,049
|
)
|
||
|
|
|
|
||||
Tax effect, at 35%, exclusive of non-taxable gain on acquisition
|
23,752
|
|
|
9,817
|
|
||
|
|
|
|
||||
Operating income
|
$
|
221,097
|
|
|
$
|
257,238
|
|
Per diluted common share:
|
|
|
|
||||
Net income
|
$
|
4.80
|
|
|
$
|
4.46
|
|
Effect of exclusions
|
(1.24
|
)
|
|
(0.30
|
)
|
||
Operating income per diluted common share
|
$
|
3.56
|
|
|
$
|
4.16
|
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
Gross premiums written
|
$
|
567,547
|
|
|
$
|
536,431
|
|
|
$
|
31,116
|
|
|
5.8
|
%
|
Ceded premiums written
|
(42,365
|
)
|
|
(8,133
|
)
|
|
(34,232
|
)
|
|
>100%
|
|
|||
Net premiums written
|
$
|
525,182
|
|
|
$
|
528,298
|
|
|
$
|
(3,116
|
)
|
|
(0.6
|
%)
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
Professional liability
|
|
|
|
|
|
|
|
|||||||
Physicians:
|
|
|
|
|
|
|
|
|||||||
Twelve month term
|
$
|
388,583
|
|
|
$
|
403,429
|
|
|
$
|
(14,846
|
)
|
|
(3.7
|
%)
|
Twenty-four month term
|
25,584
|
|
|
13,081
|
|
|
12,503
|
|
|
95.6
|
%
|
|||
Total Physicians
|
414,167
|
|
|
416,510
|
|
|
(2,343
|
)
|
|
(0.6
|
%)
|
|||
Other healthcare providers
|
43,125
|
|
|
43,492
|
|
|
(367
|
)
|
|
(0.8
|
%)
|
|||
Healthcare facilities
|
26,202
|
|
|
28,259
|
|
|
(2,057
|
)
|
|
(7.3
|
%)
|
|||
Legal professionals
|
27,060
|
|
|
17,146
|
|
|
9,914
|
|
|
57.8
|
%
|
|||
Tail coverages
|
20,920
|
|
|
29,394
|
|
|
(8,474
|
)
|
|
(28.8
|
%)
|
|||
Total professional liability
|
531,474
|
|
|
534,801
|
|
|
(3,327
|
)
|
|
(0.6
|
%)
|
|||
Medical technology and life sciences products liability
|
34,190
|
|
|
—
|
|
|
34,190
|
|
|
nm
|
|
|||
Other
|
1,883
|
|
|
1,630
|
|
|
253
|
|
|
15.5
|
%
|
|||
Total
|
$
|
567,547
|
|
|
$
|
536,431
|
|
|
$
|
31,116
|
|
|
5.8
|
%
|
|
Year Ended December 31
|
||
($ in thousands)
|
2013
|
||
Gross premiums written:
|
|
||
Professional liability
|
|
||
Physicians, twelve month term
|
$
|
10,474
|
|
Other healthcare providers
|
280
|
|
|
Legal professionals
|
9,418
|
|
|
Total professional liability
|
20,172
|
|
|
Medical technology and life sciences products liability
|
34,190
|
|
|
Total
|
$
|
54,362
|
|
•
|
The acquisition of IND contributed approximately
$10.5 million
of physician premium to
2013
.
|
•
|
In addition to premium contributed by IND, we wrote new physician business of approximately
$18 million
in
2013
.
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
Primary reinsurance arrangements (1)
|
16,177
|
|
|
21,997
|
|
|
(5,820
|
)
|
|
(26.5
|
%)
|
|||
Secondary reinsurance arrangements (2)
|
17,279
|
|
|
9,116
|
|
|
8,163
|
|
|
89.5
|
%
|
|||
Reduction in premiums owed under reinsurance agreements, prior accident years, net (3)
|
(16,403
|
)
|
|
(34,328
|
)
|
|
17,925
|
|
|
(52.2
|
%)
|
|||
Premiums ceded associated with acquired entities
|
14,308
|
|
|
—
|
|
|
14,308
|
|
|
nm
|
|
|||
Other ceded premiums written
|
$
|
11,004
|
|
|
$
|
11,348
|
|
|
$
|
(344
|
)
|
|
(3.0
|
%)
|
Total ceded premiums written
|
$
|
42,365
|
|
|
$
|
8,133
|
|
|
$
|
34,232
|
|
|
>100%
|
|
(1)
|
As discussed previously, the premium that we cede under our reinsurance arrangements is determined, in part, by the losses ceded under these arrangements. Ceded premiums decreased due to lower premiums in 2013, and beginning with the second quarter of 2012, we projected (estimated) lower losses for our ceded coverages and reduced our estimate of the associated ceded premium for the current accident year. The year ended
December 31, 2013
reflected those lower projections for the full period in 2013 as compared to two quarters in 2012.
|
(2)
|
We have secondary arrangements with certain large healthcare groups that include quota share, fronting and other risk sharing arrangements. Growth in these arrangements increased ceded premium in
2013
as compared to
2012
. These arrangements are primarily comprised of the following:
|
•
|
We share risk of loss for policies written or renewed under the Ascension Health (Ascension) Certitude program with an Ascension affiliate under a quota share arrangement.
|
•
|
We have entered into fronting arrangements with certain large healthcare groups. Under the arrangements we provide specified underwriting, claims and risk management services but cede a large portion of the risk of the coverages provided back to the group or affiliates of the group. Volume under such arrangements can vary between periods.
|
•
|
During 2013, we entered into quota share arrangements under which we share the risk of loss with captive insurers affiliated with one of our agents.
|
(3)
|
Given the length of time that it takes to resolve our claims, many years may elapse before all losses recoverable under a reinsurance agreement are known. As a part of the process of estimating our loss reserves we also make estimates regarding the amounts recoverable under our reinsurance agreements. As previously discussed, the amounts ultimately owed under our reinsurance agreements are subject to the losses ceded under the agreements. In both
2013
and
2012
, on a net basis, we reduced our estimate of expected losses and associated recoveries for prior year ceded losses, as well as our estimate of ceded premiums owed to reinsurers. The reductions were substantially less in 2013 than in 2012. The net reduction for 2013 includes an offsetting increase of $1.6 million that was attributable to loss reserves acquired in business combinations. In
2012
we also revised the expected amount receivable under certain older reinsurance agreements for which there were limited remaining open items. Changes to estimates of premiums ceded related to prior accident years are fully earned in the period the change in estimates occur.
|
|
Year Ended December 31
|
||||||
|
2013
|
|
2012
|
|
Change
|
||
Ceded premiums ratio, as reported
|
7.5
|
%
|
|
1.5
|
%
|
|
6.0
|
Less the effect of reduction in premiums owed under reinsurance agreements, prior accident years (as previously discussed)*
|
(2.9
|
%)
|
|
(6.4
|
%)
|
|
3.5
|
Ratio, current accident year
|
10.4
|
%
|
|
7.9
|
%
|
|
2.5
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
Gross premiums earned
|
$
|
569,433
|
|
|
$
|
558,316
|
|
|
$
|
11,117
|
|
|
2.0
|
%
|
Premiums ceded
|
(41,514
|
)
|
|
(7,652
|
)
|
|
(33,862
|
)
|
|
>100%
|
|
|||
Net premiums earned
|
$
|
527,919
|
|
|
$
|
550,664
|
|
|
$
|
(22,745
|
)
|
|
(4.1
|
%)
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
Fixed maturities
|
$
|
122,065
|
|
|
$
|
133,088
|
|
|
$
|
(11,023
|
)
|
|
(8.3
|
%)
|
Equities
|
9,454
|
|
|
6,947
|
|
|
2,507
|
|
|
36.1
|
%
|
|||
Short-term investments and Other invested assets
|
2,584
|
|
|
660
|
|
|
1,924
|
|
|
>100%
|
|
|||
Business owned life insurance
|
1,960
|
|
|
2,008
|
|
|
(48
|
)
|
|
(2.4
|
%)
|
|||
Investment fees and expenses
|
(6,798
|
)
|
|
(6,609
|
)
|
|
(189
|
)
|
|
2.9
|
%
|
|||
Net investment income
|
$
|
129,265
|
|
|
$
|
136,094
|
|
|
$
|
(6,829
|
)
|
|
(5.0
|
%)
|
|
Year Ended December 31
|
||
|
2013
|
|
2012
|
Average income yield
|
3.7%
|
|
3.9%
|
Average tax equivalent income yield
|
4.3%
|
|
4.5%
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
2013
|
|
2012
|
|
Change
|
||||||
Investment LPs
|
$
|
17,673
|
|
|
$
|
278
|
|
|
$
|
17,395
|
|
Business LLC interest
|
—
|
|
|
(728
|
)
|
|
728
|
|
|||
Tax credit partnerships
|
(10,134
|
)
|
|
(6,423
|
)
|
|
(3,711
|
)
|
|||
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
7,539
|
|
|
$
|
(6,873
|
)
|
|
$
|
14,412
|
|
|
Year Ended December 31
|
||||||
(In thousands)
|
2013
|
|
2012
|
||||
Tax credits recognized during the period
|
$
|
17,888
|
|
|
$
|
10,005
|
|
Deferred tax benefit of amortization
|
$
|
3,547
|
|
|
$
|
2,248
|
|
|
Year Ended December 31
|
||||||
(In thousands)
|
2013
|
|
2012
|
||||
GAAP net investment result:
|
|
|
|
||||
Net investment income
|
$
|
129,265
|
|
|
$
|
136,094
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
7,539
|
|
|
(6,873
|
)
|
||
GAAP net investment result
|
$
|
136,804
|
|
|
$
|
129,221
|
|
|
|
|
|
||||
Pro forma tax-equivalent investment results
|
$
|
184,628
|
|
|
$
|
165,632
|
|
|
|
|
|
||||
Reconciliation of pro forma and GAAP tax-equivalent investment results:
|
|
|
|
||||
Pro forma tax-equivalent investment results
|
$
|
184,628
|
|
|
$
|
165,632
|
|
Taxable equivalent adjustments, calculated using the 35% federal statutory tax rate:
|
|
|
|
||||
State and municipal bonds
|
(17,590
|
)
|
|
(18,482
|
)
|
||
BOLI
|
(1,056
|
)
|
|
(1,081
|
)
|
||
Dividends received
|
(1,674
|
)
|
|
(1,456
|
)
|
||
Tax credit partnerships
|
(27,504
|
)
|
|
(15,392
|
)
|
||
GAAP net investment result
|
$
|
136,804
|
|
|
$
|
129,221
|
|
|
Year Ended December 31
|
||||||
(In thousands)
|
2013
|
|
2012
|
||||
Other-than-temporary impairment losses, total:
|
|
|
|
||||
State and municipal bonds
|
$
|
(71
|
)
|
|
$
|
—
|
|
Residential mortgage-backed securities
|
—
|
|
|
(557
|
)
|
||
Corporate debt
|
—
|
|
|
(878
|
)
|
||
Other investments
|
—
|
|
|
(131
|
)
|
||
Portion recognized in (reclassified from) Other Comprehensive Income:
|
|
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
(201
|
)
|
||
Net impairment losses recognized in earnings
|
(71
|
)
|
|
(1,767
|
)
|
||
Gross realized gains, available-for-sale securities
|
18,130
|
|
|
18,645
|
|
||
Gross realized (losses), available-for-sale securities
|
(7,031
|
)
|
|
(2,076
|
)
|
||
Net realized gains (losses), trading securities
|
20,444
|
|
|
1,485
|
|
||
Change in unrealized holding gains (losses), trading securities
|
35,507
|
|
|
12,673
|
|
||
Decrease (increase) in the fair value of liabilities carried at fair value
|
—
|
|
|
(1,245
|
)
|
||
Other
|
925
|
|
|
1,148
|
|
||
Net realized investment gains (losses)
|
$
|
67,904
|
|
|
$
|
28,863
|
|
|
Net Loss Ratios (1)
|
||||||
|
Year Ended December 31
|
||||||
|
2013
|
|
2012
|
|
Change
|
||
Calendar year net loss ratio
|
42.6
|
%
|
|
32.7
|
%
|
|
9.9
|
Less prior accident year net loss ratio
|
(42.2
|
%)
|
|
(49.4
|
%)
|
|
7.2
|
Current accident year net loss ratio, as reported
|
84.8
|
%
|
|
82.1
|
%
|
|
2.7
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
||
Ceded premium reductions, prior accident years, net (2)
|
(2.7
|
%)
|
|
(5.4
|
%)
|
|
2.7
|
Current accident year net loss ratio, less ceded premium effect above (3)
|
87.5
|
%
|
|
87.5
|
%
|
|
—
|
(1)
|
Net losses as specified divided by net premiums earned.
|
(2)
|
Reductions to premiums owed under reinsurance agreements for prior accident years increased net earned premiums (the denominator of the current accident year ratio) in both 2013 and 2012. The net increase to the ratio in 2013 reflects an offset of 0.3 percentage points that is attributable to loss reserves acquired in business combinations. See the discussion under the heading “Ceded Premiums Written” for additional information.
|
(3)
|
In addition to the effect of ceded premiums associated with prior accident years, the loss ratio for the current period reflects an increase due to higher unallocated loss adjustment expenses in 2013, the effect of which was offset by decreases to the ratio attributable to a lower amount of tail premium in 2013, a greater benefit from current accident year reinsurance in 2013, and lower average loss ratios for the business acquired from Medmarc and IND. The amount of tail premium affects the average ratio because we generally expect higher losses from tail coverages.
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
Underwriting, policy acquisition and operating expenses
|
$
|
147,817
|
|
|
$
|
135,631
|
|
|
$
|
12,186
|
|
|
9.0
|
%
|
(In millions)
|
Expense Increase (Decrease)
2013 versus 2012 |
||
Expenses of operations from acquired entities (1)
|
$
|
12.8
|
|
Higher compensation costs during 2013, principally attributable to incentive compensation
|
3.1
|
|
|
Increase in compensation costs allocated to ULAE or capitalized as deferred policy acquisition costs during 2013
|
(9.1
|
)
|
|
Amortization of deferred policy acquisition costs reflects a reduction in 2013 attributable to lower premium volume and a reduction attributable to the adoption of new accounting guidance at the beginning of 2012. The effect of lower premium volume was somewhat offset in 2013 by underwriting compensation costs which were higher in 2013 than in 2012.
|
(2.6
|
)
|
|
|
|
||
Variances attributable to discrete events of 2013 or 2012:
|
|
||
Eastern transaction-related costs, principally professional fees (2)
|
0.9
|
|
|
Syndicate 1729 start-up costs, principally professional fees (3)
|
3.0
|
|
|
Medmarc and IND transaction-related costs, principally professional fees and one time compensation costs
|
3.1
|
|
|
Compensation costs associated with employee relocation and severance, principally related to the enhancement of our customer service capabilities in 2012
|
(0.7
|
)
|
|
Recoveries received in 2012 related to the settlement of litigation
|
1.7
|
|
|
Net change in expenses
|
$
|
12.2
|
|
(1)
|
The impact of purchase accounting related to deferred policy acquisition costs reduced the reported expenses by approximately
$4.4 million
in
2013
.
|
(2)
|
As discussed previously in ProAssurance Overview, we acquired Eastern Insurance Holding, Inc. effective January 1, 2014. We anticipate additional expenses directly related to our merger with Eastern of approximately
$3.3 million
, of which
$1.3 million
is expected to be incurred during the first six months of 2014. The remainder consists of retention and severance costs that we expect to incur fairly evenly over the next three years.
|
(3)
|
Also, as discussed in ProAssurance Overview, we completed the process of becoming a corporate member of Lloyd's of London late in 2013. We do not expect to incur significant expenses in 2014 related to the start-up of Syndicate 1729; additional costs will primarily be incurred by Syndicate 1729.
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
2013
|
|
2012
|
|
Change
|
||||||
Senior notes due 2023
|
$
|
1,502
|
|
|
$
|
—
|
|
|
$
|
1,502
|
|
Revolving credit agreement (including fees and amortization)
|
1,187
|
|
|
630
|
|
|
557
|
|
|||
Letter of credit fees
|
58
|
|
|
—
|
|
|
58
|
|
|||
Other debt instruments, principally long-term debt repaid in 2012
|
8
|
|
|
1,551
|
|
|
(1,543
|
)
|
|||
|
$
|
2,755
|
|
|
$
|
2,181
|
|
|
$
|
574
|
|
|
Year Ended December 31
|
||||
|
2013
|
|
2012
|
||
Statutory rate
|
35.0
|
%
|
|
35.0
|
%
|
Tax-exempt income
|
(3.7
|
%)
|
|
(3.7
|
%)
|
Tax credits
|
(4.5
|
%)
|
|
(2.5
|
%)
|
Non-taxable gain on acquisition
|
(2.8
|
%)
|
|
—
|
%
|
Other
|
1.1
|
%
|
|
1.6
|
%
|
Effective tax rate
|
25.1
|
%
|
|
30.4
|
%
|
|
Year Ended
December 31
|
||||||
(In millions, except per share data)
|
2012
|
|
2011
|
||||
Net income
|
$
|
275.5
|
|
|
$
|
287.1
|
|
Operating income
|
$
|
257.2
|
|
|
$
|
278.5
|
|
Net income per diluted share
|
$
|
4.46
|
|
|
$
|
4.65
|
|
Operating income per diluted share
|
$
|
4.16
|
|
|
$
|
4.52
|
|
|
Year Ended December 31
|
||||||
(In thousands, except per share data)
|
2012
|
|
2011
|
||||
Net income
|
$
|
275,470
|
|
|
$
|
287,096
|
|
Items excluded in the calculation of operating income:
|
|
|
|
||||
(Gain) loss on extinguishment of debt
|
2,163
|
|
|
—
|
|
||
Net realized investment (gains) losses
|
(28,863
|
)
|
|
(5,994
|
)
|
||
Guaranty fund assessments (recoupments)
|
345
|
|
|
(66
|
)
|
||
Effect of confidential settlements, net
|
(1,694
|
)
|
|
(7,143
|
)
|
||
Pre-tax effect of exclusions
|
(28,049
|
)
|
|
(13,203
|
)
|
||
|
|
|
|
||||
Tax effect, at 35%
|
9,817
|
|
|
4,621
|
|
||
|
|
|
|
||||
Operating income
|
$
|
257,238
|
|
|
$
|
278,514
|
|
Per diluted common share:
|
|
|
|
||||
Net income
|
$
|
4.46
|
|
|
$
|
4.65
|
|
Effect of exclusions
|
(0.30
|
)
|
|
(0.13
|
)
|
||
Operating income per diluted common share
|
$
|
4.16
|
|
|
$
|
4.52
|
|
|
Year Ended December 31
|
||||||||||
($ in thousands, except share data)
|
2012
|
|
2011
|
|
Change
|
||||||
Revenues:
|
|
|
|
|
|
||||||
Net premiums earned
|
$
|
550,664
|
|
|
$
|
565,415
|
|
|
$
|
(14,751
|
)
|
Net investment income
|
136,094
|
|
|
140,956
|
|
|
(4,862
|
)
|
|||
Equity in earnings (loss) of unconsolidated subsidiaries
|
(6,873
|
)
|
|
(9,147
|
)
|
|
2,274
|
|
|||
Net investment result
|
129,221
|
|
|
131,809
|
|
|
(2,588
|
)
|
|||
Net realized investment gains (losses)
|
28,863
|
|
|
5,994
|
|
|
22,869
|
|
|||
Other income
|
7,106
|
|
|
13,566
|
|
|
(6,460
|
)
|
|||
Total revenues
|
715,854
|
|
|
716,784
|
|
|
(930
|
)
|
|||
|
|
|
|
|
|
||||||
Expenses:
|
|
|
|
|
|
||||||
Losses and loss adjustment expenses
|
161,726
|
|
|
151,270
|
|
|
10,456
|
|
|||
Reinsurance recoveries
|
18,187
|
|
|
11,017
|
|
|
7,170
|
|
|||
Net losses and loss adjustment expenses
|
179,913
|
|
|
162,287
|
|
|
17,626
|
|
|||
Underwriting, policy acquisition and operating expenses
|
135,631
|
|
|
136,421
|
|
|
(790
|
)
|
|||
Interest expense
|
2,181
|
|
|
3,478
|
|
|
(1,297
|
)
|
|||
Loss on extinguishment of debt
|
2,163
|
|
|
—
|
|
|
2,163
|
|
|||
Total expenses
|
319,888
|
|
|
302,186
|
|
|
17,702
|
|
|||
|
|
|
|
|
|
||||||
Income before income taxes
|
395,966
|
|
|
414,598
|
|
|
(18,632
|
)
|
|||
|
|
|
|
|
|
||||||
Income taxes
|
120,496
|
|
|
127,502
|
|
|
(7,006
|
)
|
|||
|
|
|
|
|
|
||||||
Net income
|
$
|
275,470
|
|
|
$
|
287,096
|
|
|
$
|
(11,626
|
)
|
|
|
|
|
|
|
||||||
Earnings per share:
|
|
|
|
|
|
||||||
Basic
|
$
|
4.49
|
|
|
$
|
4.70
|
|
|
$
|
(0.21
|
)
|
Diluted
|
$
|
4.46
|
|
|
$
|
4.65
|
|
|
$
|
(0.19
|
)
|
|
|
|
|
|
|
||||||
Net loss ratio
|
32.7
|
%
|
|
28.7
|
%
|
|
4.0
|
|
|||
Underwriting expense ratio
|
24.4
|
%
|
|
23.8
|
%
|
|
0.6
|
|
|||
Combined ratio
|
57.1
|
%
|
|
52.5
|
%
|
|
4.6
|
|
|||
Operating ratio
|
32.4
|
%
|
|
27.6
|
%
|
|
4.8
|
|
|||
Tax ratio
|
30.4
|
%
|
|
30.8
|
%
|
|
(0.4
|
)
|
|||
Return on equity
|
12.4
|
%
|
|
14.3
|
%
|
|
(1.9
|
)
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2012
|
|
2011
|
|
Change
|
|||||||||
Gross premiums written
|
$
|
536,431
|
|
|
$
|
565,895
|
|
|
$
|
(29,464
|
)
|
|
(5.2
|
%)
|
Ceded premiums written
|
(8,133
|
)
|
|
(7,388
|
)
|
|
(745
|
)
|
|
10.1
|
%
|
|||
Net premiums written
|
$
|
528,298
|
|
|
$
|
558,507
|
|
|
$
|
(30,209
|
)
|
|
(5.4
|
%)
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2012
|
|
2011
|
|
Change
|
|||||||||
Gross premiums written:
|
|
|
|
|
|
|
|
|||||||
Physician, traditional term policies
|
$
|
403,429
|
|
|
$
|
428,928
|
|
|
$
|
(25,499
|
)
|
|
(5.9
|
%)
|
Physician, two-year term policies *
|
13,081
|
|
|
22,253
|
|
|
(9,172
|
)
|
|
(41.2
|
%)
|
|||
Total Physician
|
416,510
|
|
|
451,181
|
|
|
(34,671
|
)
|
|
(7.7
|
%)
|
|||
Non-physician healthcare providers
|
42,864
|
|
|
45,641
|
|
|
(2,777
|
)
|
|
(6.1
|
%)
|
|||
Hospital and facility
|
28,259
|
|
|
28,088
|
|
|
171
|
|
|
0.6
|
%
|
|||
Other
|
18,778
|
|
|
17,961
|
|
|
817
|
|
|
4.5
|
%
|
|||
Non-continuing
|
626
|
|
|
2,078
|
|
|
(1,452
|
)
|
|
(69.9
|
%)
|
|||
Tail coverage premiums, all policy types
|
29,394
|
|
|
20,946
|
|
|
8,448
|
|
|
40.3
|
%
|
|||
Total
|
$
|
536,431
|
|
|
$
|
565,895
|
|
|
$
|
(29,464
|
)
|
|
(5.2
|
%)
|
* We offer two- year term policies to our physician insureds in one selected jurisdiction. The premium associated with both years is included in written premium in the period the policy is written; comparison of gross written premium between successive years reflect volume differences that have no effect on earned premium. A comparison to 2010 is more meaningful; gross written premium for two-year term policies in 2010 was $10.9 million.
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2012
|
|
2011
|
|
Change
|
|||||||||
Primary reinsurance agreement, current accident year
|
$
|
23,213
|
|
|
$
|
25,479
|
|
|
$
|
(2,266
|
)
|
|
(8.9
|
%)
|
Reduction in premiums owed under reinsurance agreements
|
(34,328
|
)
|
|
(30,584
|
)
|
|
(3,744
|
)
|
|
12.2
|
%
|
|||
Ascension Health Certitude program
|
7,308
|
|
|
5,027
|
|
|
2,281
|
|
|
45.4
|
%
|
|||
Commutation
|
—
|
|
|
(5,634
|
)
|
|
5,634
|
|
|
nm
|
|
|||
Other premiums ceded
|
11,940
|
|
|
13,100
|
|
|
(1,160
|
)
|
|
(8.9
|
%)
|
|||
Total ceded premiums written
|
$
|
8,133
|
|
|
$
|
7,388
|
|
|
$
|
745
|
|
|
10.1
|
%
|
|
Year Ended December 31
|
|||||||
|
2012
|
|
2011
|
|
Change
|
|||
Ceded premiums ratio, as reported
|
1.5
|
%
|
|
1.3
|
%
|
|
0.2
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|||
Reduction in premiums owed under reinsurance agreements
|
(6.6
|
%)
|
|
(6.1
|
%)
|
|
(0.5
|
)
|
Ascension Certitude program
|
1.4
|
%
|
|
1.0
|
%
|
|
0.4
|
|
Commutation
|
—
|
%
|
|
(1.1
|
%)
|
|
1.1
|
|
Ceded premiums ratio, excluding other listed factors
|
6.7
|
%
|
|
7.5
|
%
|
|
(1.0
|
)
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2012
|
|
2011
|
|
Change
|
|||||||||
Premiums earned
|
$
|
558,316
|
|
|
$
|
571,045
|
|
|
$
|
(12,729
|
)
|
|
(2.2
|
%)
|
Premiums ceded
|
(7,652
|
)
|
|
(5,630
|
)
|
|
(2,022
|
)
|
|
35.9
|
%
|
|||
Net premiums earned
|
$
|
550,664
|
|
|
$
|
565,415
|
|
|
$
|
(14,751
|
)
|
|
(2.6
|
%)
|
|
Ceded Premiums Earned
Increase (Decrease) 2012 versus 2011 |
||
($ in thousands)
|
Year Ended
December 31 |
||
Primary reinsurance agreement, current accident year*
|
$
|
(2,576
|
)
|
Reduction in premiums owed under reinsurance agreements*
|
(3,744
|
)
|
|
Ascension Health Certitude program*
|
3,063
|
|
|
Commutation*
|
5,634
|
|
|
All other factors
|
(355
|
)
|
|
Net increase (decrease)
|
$
|
2,022
|
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2012
|
|
2011
|
|
Change
|
|||||||||
Fixed maturities
|
$
|
133,088
|
|
|
$
|
140,897
|
|
|
$
|
(7,809
|
)
|
|
(5.5
|
%)
|
Equities
|
6,947
|
|
|
1,808
|
|
|
5,139
|
|
|
>100%
|
|
|||
Short-term investments
|
132
|
|
|
100
|
|
|
32
|
|
|
32.0
|
%
|
|||
Other invested assets
|
528
|
|
|
2,712
|
|
|
(2,184
|
)
|
|
(80.5
|
%)
|
|||
Business owned life insurance
|
2,008
|
|
|
2,017
|
|
|
(9
|
)
|
|
(0.4
|
%)
|
|||
Investment fees and expenses
|
(6,609
|
)
|
|
(6,578
|
)
|
|
(31
|
)
|
|
0.5
|
%
|
|||
Net investment income
|
$
|
136,094
|
|
|
$
|
140,956
|
|
|
$
|
(4,862
|
)
|
|
(3.4
|
%)
|
|
Year Ended December 31
|
||
|
2012
|
|
2011
|
Average income yield
|
3.9%
|
|
4.0%
|
Average tax equivalent income yield
|
4.5%
|
|
4.6%
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
2012
|
|
2011
|
|
Change
|
||||||
Investment LPs
|
$
|
278
|
|
|
$
|
(1,077
|
)
|
|
$
|
1,355
|
|
Business LLC interest
|
(728
|
)
|
|
(2,479
|
)
|
|
1,751
|
|
|||
Tax credit partnerships
|
(6,423
|
)
|
|
(5,591
|
)
|
|
(832
|
)
|
|||
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
(6,873
|
)
|
|
$
|
(9,147
|
)
|
|
$
|
2,274
|
|
|
Year Ended December 31
|
||||||
(In thousands)
|
2012
|
|
2011
|
||||
Net investment income, as reported for GAAP
|
$
|
136,094
|
|
|
$
|
140,956
|
|
Taxable equivalent adjustments, calculated using the 35% federal statutory tax rate:
|
|
|
|
||||
State and municipal bonds
|
18,482
|
|
|
19,949
|
|
||
BOLI
|
1,081
|
|
|
1,086
|
|
||
Dividends received
|
1,456
|
|
|
579
|
|
||
Pro forma tax-equivalent net investment income
|
157,113
|
|
|
162,570
|
|
||
|
|
|
|
||||
Equity in earnings (loss) of unconsolidated subsidiaries, as reported for GAAP
|
(6,873
|
)
|
|
(9,147
|
)
|
||
Taxable equivalent adjustment, calculated using the 35% federal statutory tax rate:
|
|
|
|
||||
Tax credit partnerships
|
15,392
|
|
|
8,698
|
|
||
Pro forma tax-equivalent equity in earnings (loss) of unconsolidated subsidiaries
|
8,519
|
|
|
(449
|
)
|
||
Pro forma tax-equivalent investment results
|
$
|
165,632
|
|
|
$
|
162,121
|
|
|
Year Ended December 31
|
||||||
(In thousands)
|
2012
|
|
2011
|
||||
Other-than-temporary impairment losses, total:
|
|
|
|
||||
Residential mortgage-backed securities
|
$
|
(557
|
)
|
|
$
|
(782
|
)
|
Corporate debt
|
(878
|
)
|
|
(505
|
)
|
||
Other investments
|
(131
|
)
|
|
(3,827
|
)
|
||
High yield asset-backed securities
|
—
|
|
|
(75
|
)
|
||
Portion recognized in (reclassified from) Other Comprehensive Income:
|
|
|
|
||||
Residential mortgage-backed securities
|
(201
|
)
|
|
(823
|
)
|
||
Net impairment losses recognized in earnings
|
(1,767
|
)
|
|
(6,012
|
)
|
||
Gross realized gains, available-for-sale securities
|
18,645
|
|
|
14,625
|
|
||
Gross realized (losses), available-for-sale securities
|
(2,076
|
)
|
|
(1,754
|
)
|
||
Net realized gains (losses), trading securities
|
1,485
|
|
|
2,212
|
|
||
Change in unrealized holding gains (losses), trading securities
|
12,673
|
|
|
(3,188
|
)
|
||
Decrease (increase) in the fair value of liabilities carried at fair value
|
(1,245
|
)
|
|
111
|
|
||
Other
|
1,148
|
|
|
—
|
|
||
Net realized investment gains (losses)
|
$
|
28,863
|
|
|
$
|
5,994
|
|
|
Net Losses
|
|
Net Loss Ratios*
|
|||||||||||||||||
|
Year Ended December 31
|
|
Year Ended December 31
|
|||||||||||||||||
($ in millions)
|
2012
|
|
2011
|
|
Change
|
|
2012
|
|
2011
|
|
Change
|
|||||||||
Current accident year
|
$
|
452.0
|
|
|
$
|
488.2
|
|
|
$
|
(36.2
|
)
|
|
82.1
|
%
|
|
86.3
|
%
|
|
(4.2
|
)
|
Prior accident years
|
(272.0
|
)
|
|
(325.9
|
)
|
|
53.9
|
|
|
(49.4
|
%)
|
|
(57.6
|
%)
|
|
8.2
|
|
|||
Calendar year
|
$
|
180.0
|
|
|
$
|
162.3
|
|
|
$
|
17.7
|
|
|
32.7
|
%
|
|
28.7
|
%
|
|
4.0
|
|
|
Year Ended December 31
|
|||||||
|
2012
|
|
2011
|
|
Change
|
|||
Current accident year net loss ratio, as reported
|
82.1
|
%
|
|
86.3
|
%
|
|
(4.2
|
)
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|||
Change in our estimate of the reserve for death, disability and retirement
|
(0.3
|
%)
|
|
3.7
|
%
|
|
(4.0
|
)
|
Reduction in premiums owed under reinsurance agreements
|
(5.6
|
%)
|
|
(4.9
|
%)
|
|
(0.7
|
)
|
Commutation
|
—%
|
|
|
(0.1
|
%)
|
|
0.1
|
|
Tail coverages
|
1.9
|
%
|
|
1.7
|
%
|
|
0.2
|
|
Current accident year net loss ratio, excluding other listed factors
|
86.1
|
%
|
|
85.9
|
%
|
|
0.2
|
|
•
|
In 2012 we decreased our loss reserves related to death, disability and retirement (DDR) coverage endorsements provided to our insureds while in 2011 we increased loss reserves for this coverage. The reserve for DDR is actuarially estimated and is affected by changes in the number of insureds expected to benefit from the coverage endorsement.
|
•
|
Net earned premium in both 2012 and 2011 was increased by reductions to amounts owed under reinsurance agreements (see "Net Premiums Earned"). The reductions had a greater effect on the net loss ratio in 2012.
|
•
|
A commutation recorded in 2011 increased the 2011 net loss ratio; no commutation was recorded in 2012.
|
•
|
More of our net earned premium was from tail coverages in 2012. This increases our average net loss ratio because we expect higher losses for tail coverages than for our other professional liability coverages.
|
|
Year Ended December 31
|
|||||||||||||
($ in thousands)
|
2012
|
|
2011
|
|
Change
|
|||||||||
Insurance operation expenses
|
$
|
134,393
|
|
|
$
|
134,342
|
|
|
$
|
51
|
|
|
nm
|
|
Agency expenses
|
1,238
|
|
|
2,079
|
|
|
(841
|
)
|
|
(40.5
|
%)
|
|||
|
$
|
135,631
|
|
|
$
|
136,421
|
|
|
$
|
(790
|
)
|
|
(0.6
|
%)
|
•
|
We incurred expenses related to the mergers of IND and Medmarc of approximately $1.5 million in 2012.
|
•
|
As discussed in Notes 1 and 7 of the Notes to Consolidated Financial Statements, we adopted, on a prospective basis, new FASB guidance related to the deferral of policy acquisition costs. The new guidance affects the timing, but not the amount of acquisition costs ultimately expensed, as the decrease in the expense deferral reduces amortization of policy acquisition costs by the same amount, recognized over the term of the associated successful policies. Our 2012 expenses reflect a net increase of approximately $1.9 million in 2012 due to adoption of the new guidance, as we expensed approximately $4.2 million of policy acquisition costs that under prior guidance would have been deferred to later periods but also recognized amortization expense that was approximately $2.3 million lower than would have been recognized under previous guidance.
|
•
|
Exclusive of the effect of the new FASB guidance, amortization of deferred policy acquisition costs was $0.3 million lower in 2012 than in 2011. While amortization was lower in 2012 consistent with the decline in net premiums earned, amortization in 2011 was reduced by approximately $1.5 million related to the acquisition of APS in November 2010. Due to the application of GAAP purchase accounting rules, no asset for deferred policy acquisition costs was recognized as a part of the purchase price allocation of APS; consequently, amortization of deferred policy acquisition costs in 2011 was reduced.
|
•
|
On a sporadic basis our expenses are reduced by recoveries related to the settlement of litigation. Recoveries in 2012 were approximately $0.5 million lower (and thus expenses on a net basis were higher) than in 2011.
|
•
|
Costs associated with the operations acquired from APS, primarily compensation costs, were approximately $3.7 million lower in 2012 as compared to 2011.
|
•
|
Higher stock compensation and bonus costs in 2012 as compared to 2011 as well as additional costs incurred related to the enhancement of our customer service capabilities increased our 2012 expenses by approximately $5.0 million. We relocated a number of positions in order to create centralized customer service centers. Relocation benefits were provided to affected employees as well as termination benefits for employees unable to relocate. Expenses of $1.6 million related to a deferred compensation agreement with a former senior executive increased our expenses in 2011; there were no comparable expenses in 2012.
|
•
|
Various other operating costs were collectively lower by approximately $3.2 million in 2012.
|
|
|
Underwriting Expense Ratio *
|
|||||||
|
|
Year Ended December 31
|
|||||||
|
|
2012
|
|
2011
|
|
Change
|
|||
Underwriting expense ratio, as reported
|
|
24.4
|
%
|
|
23.8
|
%
|
|
0.6
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|
|||
Reduction in premiums owed under reinsurance agreements
|
|
(1.5
|
%)
|
|
(1.4
|
%)
|
|
(0.1
|
)
|
Commutation
|
|
—
|
%
|
|
(0.2
|
%)
|
|
0.2
|
|
Underwriting expense ratio, excluding listed factors
|
|
25.9
|
%
|
|
25.4
|
%
|
|
0.5
|
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
2012
|
|
2011
|
|
Change
|
||||||
Trust preferred securities due 2034
|
$
|
635
|
|
|
$
|
970
|
|
|
$
|
(335
|
)
|
Surplus notes due May 2034
|
342
|
|
|
509
|
|
|
(167
|
)
|
|||
2019 note payable
|
571
|
|
|
1,157
|
|
|
(586
|
)
|
|||
Credit facility fees and amortization
|
630
|
|
|
442
|
|
|
188
|
|
|||
Other
|
3
|
|
|
400
|
|
|
(397
|
)
|
|||
|
$
|
2,181
|
|
|
$
|
3,478
|
|
|
$
|
(1,297
|
)
|
|
Year Ended December 31
|
||||
|
2012
|
|
2011
|
||
Statutory rate
|
35.0
|
%
|
|
35.0
|
%
|
Tax-exempt income
|
(3.4
|
%)
|
|
(3.2
|
%)
|
Tax credits
|
(2.5
|
%)
|
|
(1.4
|
%)
|
Other
|
1.3
|
%
|
|
0.4
|
%
|
Effective tax rate
|
30.4
|
%
|
|
30.8
|
%
|
|
Interest Rate Shift in Basis Points
|
||||||||||||||||||
|
December 31, 2013
|
||||||||||||||||||
|
(200)
|
|
(100)
|
|
Current
|
|
100
|
|
200
|
||||||||||
Fair Value (in millions):
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
$
|
176
|
|
|
$
|
174
|
|
|
$
|
171
|
|
|
$
|
168
|
|
|
$
|
165
|
|
U.S. Government-sponsored enterprise obligations
|
34
|
|
|
34
|
|
|
33
|
|
|
32
|
|
|
30
|
|
|||||
State and municipal bonds
|
1,220
|
|
|
1,195
|
|
|
1,155
|
|
|
1,107
|
|
|
1,061
|
|
|||||
Corporate debt
|
1,453
|
|
|
1,413
|
|
|
1,361
|
|
|
1,308
|
|
|
1,257
|
|
|||||
Asset-backed securities
|
410
|
|
|
406
|
|
|
398
|
|
|
385
|
|
|
371
|
|
|||||
All fixed maturity securities
|
$
|
3,293
|
|
|
$
|
3,222
|
|
|
$
|
3,118
|
|
|
$
|
3,000
|
|
|
$
|
2,884
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
3.85
|
|
|
3.81
|
|
|
3.77
|
|
|
3.72
|
|
|
3.68
|
|
|||||
U.S. Government-sponsored enterprise obligations
|
2.82
|
|
|
3.07
|
|
|
3.15
|
|
|
3.12
|
|
|
3.07
|
|
|||||
State and municipal bonds
|
3.61
|
|
|
3.84
|
|
|
4.07
|
|
|
4.20
|
|
|
4.25
|
|
|||||
Corporate debt
|
4.10
|
|
|
4.13
|
|
|
4.09
|
|
|
4.03
|
|
|
3.96
|
|
|||||
Asset-backed securities
|
2.08
|
|
|
2.55
|
|
|
3.12
|
|
|
3.57
|
|
|
3.80
|
|
|||||
All fixed maturity securities
|
3.60
|
|
|
3.80
|
|
|
3.90
|
|
|
4.00
|
|
|
4.00
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
December 31, 2012
|
||||||||||||||||||
Fair Value (in millions):
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
$
|
210
|
|
|
$
|
209
|
|
|
$
|
206
|
|
|
$
|
202
|
|
|
$
|
197
|
|
U.S. Government-sponsored enterprise obligations
|
58
|
|
|
58
|
|
|
57
|
|
|
55
|
|
|
53
|
|
|||||
State and municipal bonds
|
1,269
|
|
|
1,258
|
|
|
1,220
|
|
|
1,170
|
|
|
1,122
|
|
|||||
Corporate debt
|
1,533
|
|
|
1,521
|
|
|
1,471
|
|
|
1,409
|
|
|
1,350
|
|
|||||
Asset-backed securities
|
498
|
|
|
499
|
|
|
494
|
|
|
481
|
|
|
466
|
|
|||||
All fixed maturity securities
|
$
|
3,568
|
|
|
$
|
3,545
|
|
|
$
|
3,448
|
|
|
$
|
3,317
|
|
|
$
|
3,188
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury obligations
|
2.92
|
|
|
2.89
|
|
|
2.84
|
|
|
2.77
|
|
|
2.70
|
|
|||||
U.S. Government-sponsored enterprise obligations
|
2.89
|
|
|
2.90
|
|
|
2.98
|
|
|
3.08
|
|
|
3.08
|
|
|||||
State and municipal bonds
|
3.78
|
|
|
3.91
|
|
|
4.06
|
|
|
4.17
|
|
|
4.26
|
|
|||||
Corporate debt
|
4.26
|
|
|
4.27
|
|
|
4.27
|
|
|
4.22
|
|
|
4.15
|
|
|||||
Asset-backed securities
|
1.81
|
|
|
1.82
|
|
|
2.35
|
|
|
3.06
|
|
|
3.66
|
|
|||||
All fixed maturity securities
|
3.65
|
|
|
3.70
|
|
|
3.81
|
|
|
3.93
|
|
|
4.01
|
|
Index to Consolidated Financial Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
Financial Statements
. The following consolidated financial statements of ProAssurance Corporation and subsidiaries are included herein in accordance with Item 8 of Part II of this report.
|
(b)
|
The exhibits required to be filed by Item 15(b) are listed herein in the Exhibit Index.
|
PROASSURANCE CORPORATION
|
|
|
|
By:
|
/
S
/ W. S
TANCIL
S
TARNES
|
|
W. Stancil Starnes
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
||
|
/
S
/ W. S
TANCIL
S
TARNES
, J.D.
|
|
Chairman of the Board, Chief Executive Officer
|
|
February 20, 2014
|
|
W. Stancil Starnes, J.D.
|
|
(Principal Executive Officer) and President
|
|
|
|
|
|
|
||
|
/
S
/ E
DWARD
L. R
AND
, J
R
.
|
|
Chief Financial Officer
|
|
February 20, 2014
|
|
Edward L. Rand, Jr.
|
|
|
|
|
|
|
|
|
||
|
/
S
/ K
ELLY
B. B
REWER
|
|
Chief Accounting Officer
|
|
February 20, 2014
|
|
Kelly B. Brewer
|
|
|
|
|
|
|
|
|
||
|
/
S
/ L
UCIAN
F. B
LOODWORTH
|
|
Director
|
|
February 20, 2014
|
|
Lucian F. Bloodworth
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ S
AMUEL
A. D
I
P
IAZZA,
J
R.
|
|
Director
|
|
February 20, 2014
|
|
Samuel A. Di Piazza, Jr.
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ R
OBERT
E. F
LOWERS,
M.D
.
|
|
Director
|
|
February 20, 2014
|
|
Robert E. Flowers, M.D.
|
|
|
|
|
|
|
|
|
||
|
/
S
/ M. J
AMES
G
ORRIE
|
|
Director
|
|
February 20, 2014
|
|
M. James Gorrie
|
|
|
|
|
|
|
|
|
||
|
/
S
/ W
ILLIAM
J. L
ISTWAN
, M.D.
|
|
Director
|
|
February 20, 2014
|
|
William J. Listwan, M.D.
|
|
|
|
|
|
|
|
|
||
|
/
S
/ J
OHN
J. M
C
M
AHON
|
|
Director
|
|
February 20, 2014
|
|
John J. McMahon
|
|
|
|
|
|
|
|
|
||
|
/
S
/ D
RAYTON
N
ABERS
, J
R
., J.D.
|
|
Director
|
|
February 20, 2014
|
|
Drayton Nabers, Jr., J.D.
|
|
|
|
|
|
|
|
|
||
|
/
S
/ A
NN
F. P
UTALLAZ
, P
H
.D.
|
|
Director
|
|
February 20, 2014
|
|
Ann F. Putallaz, Ph.D.
|
|
|
|
|
|
|
|
|
||
|
/
S
/ F
RANK
A. S
PINOSA
, D.P.M.
|
|
Director
|
|
February 20, 2014
|
|
Frank A. Spinosa, D.P.M.
|
|
|
|
|
|
|
|
|
||
|
/
S
/ A
NTHONY
R. T
ERSIGNI
, E
D
.D., FACHE
|
|
Director
|
|
February 20, 2014
|
|
Anthony R. Tersigni, Ed.D., FACHE
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ T
HOMAS
A. S. W
ILSON
, J
R
., M.D.
|
|
Director
|
|
February 20, 2014
|
|
Thomas A. S. Wilson, Jr., M.D.
|
|
|
|
|
|
December 31,
2013 |
|
December 31,
2012 |
||||
Assets
|
|
|
|
||||
Investments
|
|
|
|
||||
Fixed maturities, available for sale, at fair value; amortized cost, $3,026,256 and $3,224,332, respectively
|
$
|
3,118,049
|
|
|
$
|
3,447,999
|
|
Equity securities, trading, at fair value; cost, $203,308 and $187,891, respectively
|
253,541
|
|
|
202,618
|
|
||
Short-term investments
|
248,605
|
|
|
71,737
|
|
||
Business owned life insurance
|
54,374
|
|
|
52,414
|
|
||
Investment in unconsolidated subsidiaries
|
214,236
|
|
|
121,049
|
|
||
Other investments
|
52,240
|
|
|
31,085
|
|
||
Total Investments
|
3,941,045
|
|
|
3,926,902
|
|
||
Cash and cash equivalents
|
129,383
|
|
|
118,551
|
|
||
Restricted Cash
|
78,000
|
|
|
—
|
|
||
Premiums receivable
|
115,403
|
|
|
106,312
|
|
||
Receivable from reinsurers on paid losses and loss adjustment expenses
|
3,231
|
|
|
4,517
|
|
||
Receivable from reinsurers on unpaid losses and loss adjustment expenses
|
247,518
|
|
|
191,645
|
|
||
Prepaid reinsurance premiums
|
21,449
|
|
|
13,404
|
|
||
Deferred policy acquisition costs
|
28,999
|
|
|
23,179
|
|
||
Deferred tax asset
|
1,757
|
|
|
—
|
|
||
Real estate, net
|
41,010
|
|
|
41,502
|
|
||
Intangible assets
|
52,002
|
|
|
53,225
|
|
||
Goodwill
|
161,115
|
|
|
163,055
|
|
||
Other assets
|
329,979
|
|
|
234,286
|
|
||
Total Assets
|
$
|
5,150,891
|
|
|
$
|
4,876,578
|
|
|
|
|
|
||||
Liabilities and Shareholders’ Equity
|
|
|
|
||||
Liabilities
|
|
|
|
||||
Policy liabilities and accruals
|
|
|
|
||||
Reserve for losses and loss adjustment expenses
|
$
|
2,072,822
|
|
|
$
|
2,054,994
|
|
Unearned premiums
|
256,255
|
|
|
233,861
|
|
||
Reinsurance premiums payable
|
34,321
|
|
|
45,591
|
|
||
Total Policy Liabilities
|
2,363,398
|
|
|
2,334,446
|
|
||
Deferred tax liability
|
—
|
|
|
14,585
|
|
||
Other liabilities
|
143,079
|
|
|
131,967
|
|
||
Long-term debt, at amortized cost
|
250,000
|
|
|
125,000
|
|
||
Total Liabilities
|
2,756,477
|
|
|
2,605,998
|
|
||
Shareholders’ Equity
|
|
|
|
||||
Common shares, par value $0.01 per share, 100,000,000 shares authorized, 62,096,787 and 61,867,034 shares issued, respectively
|
621
|
|
|
619
|
|
||
Additional paid-in capital
|
349,894
|
|
|
341,780
|
|
||
Accumulated other comprehensive income (loss), net of deferred tax expense (benefit) of $32,127 and $78,284, respectively
|
59,661
|
|
|
145,380
|
|
||
Retained earnings
|
2,015,603
|
|
|
1,782,857
|
|
||
|
2,425,779
|
|
|
2,270,636
|
|
||
Treasury shares, at cost, 900,281 shares and 243,530 shares, respectively
|
(31,365
|
)
|
|
(56
|
)
|
||
Total Shareholders’ Equity
|
2,394,414
|
|
|
2,270,580
|
|
||
Total Liabilities and Shareholders’ Equity
|
$
|
5,150,891
|
|
|
$
|
4,876,578
|
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Retained Earnings
|
|
Treasury Stock
|
|
Total
|
||||||||||||
Balance at January 1, 2011
|
$
|
344
|
|
|
$
|
532,213
|
|
|
$
|
79,124
|
|
|
$
|
1,428,026
|
|
|
$
|
(183,844
|
)
|
|
$
|
1,855,863
|
|
Common shares reacquired
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(21,005
|
)
|
|
(21,005
|
)
|
||||||
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
—
|
|
|
2,433
|
|
|
—
|
|
|
—
|
|
|
441
|
|
|
2,874
|
|
||||||
Share-based compensation
|
—
|
|
|
7,119
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,119
|
|
||||||
Net effect of restricted and performance shares issued and stock options exercised
|
2
|
|
|
(3,140
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,138
|
)
|
||||||
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(15,269
|
)
|
|
—
|
|
|
(15,269
|
)
|
||||||
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
50,913
|
|
|
—
|
|
|
—
|
|
|
50,913
|
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
287,096
|
|
|
—
|
|
|
287,096
|
|
||||||
Balance at December 31, 2011
|
346
|
|
|
538,625
|
|
|
130,037
|
|
|
1,699,853
|
|
|
(204,408
|
)
|
|
2,164,453
|
|
||||||
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
—
|
|
|
3,041
|
|
|
—
|
|
|
—
|
|
|
553
|
|
|
3,594
|
|
||||||
Share-based compensation
|
—
|
|
|
8,639
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,639
|
|
||||||
Net effect of restricted and performance shares issued and stock options exercised
|
2
|
|
|
(4,455
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,453
|
)
|
||||||
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(192,466
|
)
|
|
—
|
|
|
(192,466
|
)
|
||||||
Two-for-one stock split effected in the form of a stock dividend
|
271
|
|
|
(204,070
|
)
|
|
—
|
|
|
—
|
|
|
203,799
|
|
|
—
|
|
||||||
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
15,343
|
|
|
—
|
|
|
—
|
|
|
15,343
|
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
275,470
|
|
|
—
|
|
|
275,470
|
|
||||||
Balance at December 31, 2012
|
619
|
|
|
341,780
|
|
|
145,380
|
|
|
1,782,857
|
|
|
(56
|
)
|
|
2,270,580
|
|
||||||
Common shares reacquired
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(32,454
|
)
|
|
(32,454
|
)
|
||||||
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
—
|
|
|
2,940
|
|
|
—
|
|
|
—
|
|
|
1,145
|
|
|
4,085
|
|
||||||
Share-based compensation
|
—
|
|
|
9,242
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,242
|
|
||||||
Net effect of restricted and performance shares issued and stock options exercised
|
2
|
|
|
(4,068
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,066
|
)
|
||||||
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(64,777
|
)
|
|
—
|
|
|
(64,777
|
)
|
||||||
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
(85,719
|
)
|
|
—
|
|
|
—
|
|
|
(85,719
|
)
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
297,523
|
|
|
—
|
|
|
297,523
|
|
||||||
Balance at December 31, 2013
|
$
|
621
|
|
|
$
|
349,894
|
|
|
$
|
59,661
|
|
|
$
|
2,015,603
|
|
|
$
|
(31,365
|
)
|
|
$
|
2,394,414
|
|
|
Year Ended December 31
|
||||||||||
|
2013
|
|
2012
|
|
2011
|
||||||
Revenues
|
|
|
|
|
|
||||||
Net premiums earned
|
$
|
527,919
|
|
|
$
|
550,664
|
|
|
$
|
565,415
|
|
Net investment income
|
129,265
|
|
|
136,094
|
|
|
140,956
|
|
|||
Equity in earnings (loss) of unconsolidated subsidiaries
|
7,539
|
|
|
(6,873
|
)
|
|
(9,147
|
)
|
|||
Net realized investment gains (losses):
|
|
|
|
|
|
||||||
Other-than-temporary impairment (OTTI) losses
|
(71
|
)
|
|
(1,566
|
)
|
|
(5,189
|
)
|
|||
Portion of OTTI losses recognized in (reclassified from) other comprehensive income before taxes
|
—
|
|
|
(201
|
)
|
|
(823
|
)
|
|||
Net impairment losses recognized in earnings
|
(71
|
)
|
|
(1,767
|
)
|
|
(6,012
|
)
|
|||
Other net realized investment gains (losses)
|
67,975
|
|
|
30,630
|
|
|
12,006
|
|
|||
Total net realized investment gains (losses)
|
67,904
|
|
|
28,863
|
|
|
5,994
|
|
|||
Other income
|
7,551
|
|
|
7,106
|
|
|
13,566
|
|
|||
|
|
|
|
|
|
||||||
Total revenues
|
740,178
|
|
|
715,854
|
|
|
716,784
|
|
|||
|
|
|
|
|
|
||||||
Expenses
|
|
|
|
|
|
||||||
Losses and loss adjustment expenses
|
243,015
|
|
|
161,726
|
|
|
151,270
|
|
|||
Reinsurance recoveries
|
(18,254
|
)
|
|
18,187
|
|
|
11,017
|
|
|||
Net losses and loss adjustment expenses
|
224,761
|
|
|
179,913
|
|
|
162,287
|
|
|||
Underwriting, policy acquisition and operating expenses
|
147,817
|
|
|
135,631
|
|
|
136,421
|
|
|||
Interest expense
|
2,755
|
|
|
2,181
|
|
|
3,478
|
|
|||
Loss on extinguishment of debt
|
—
|
|
|
2,163
|
|
|
—
|
|
|||
|
|
|
|
|
|
||||||
Total expenses
|
375,333
|
|
|
319,888
|
|
|
302,186
|
|
|||
|
|
|
|
|
|
||||||
Gain on acquisition
|
32,314
|
|
|
—
|
|
|
—
|
|
|||
|
|
|
|
|
|
||||||
Income before income taxes
|
397,159
|
|
|
395,966
|
|
|
414,598
|
|
|||
|
|
|
|
|
|
||||||
Provision for income taxes
|
|
|
|
|
|
||||||
Current expense (benefit)
|
74,977
|
|
|
82,752
|
|
|
128,553
|
|
|||
Deferred expense (benefit)
|
24,659
|
|
|
37,744
|
|
|
(1,051
|
)
|
|||
Total income tax expense (benefit)
|
99,636
|
|
|
120,496
|
|
|
127,502
|
|
|||
|
|
|
|
|
|
||||||
Net income
|
297,523
|
|
|
275,470
|
|
|
287,096
|
|
|||
|
|
|
|
|
|
||||||
Other comprehensive income (loss), after tax, net of reclassification adjustments
|
(85,719
|
)
|
|
15,343
|
|
|
50,913
|
|
|||
|
|
|
|
|
|
||||||
Comprehensive income
|
$
|
211,804
|
|
|
$
|
290,813
|
|
|
$
|
338,009
|
|
|
|
|
|
|
|
||||||
Earnings per share:
|
|
|
|
|
|
||||||
Basic
|
$
|
4.82
|
|
|
$
|
4.49
|
|
|
$
|
4.70
|
|
Diluted
|
$
|
4.80
|
|
|
$
|
4.46
|
|
|
$
|
4.65
|
|
|
|
|
|
|
|
||||||
Weighted average number of common shares outstanding:
|
|
|
|
|
|
||||||
Basic
|
61,761
|
|
|
61,342
|
|
|
61,140
|
|
|||
Diluted
|
62,020
|
|
|
61,833
|
|
|
61,684
|
|
|||
|
|
|
|
|
|
||||||
Cash dividends declared per common share
|
$
|
1.05
|
|
|
$
|
3.13
|
|
|
$
|
0.25
|
|
|
Year Ended December 31
|
||||||||||
|
2013
|
|
2012
|
|
2011
|
||||||
Operating Activities
|
|
|
|
|
|
||||||
Net income
|
$
|
297,523
|
|
|
$
|
275,470
|
|
|
$
|
287,096
|
|
Adjustments to reconcile income to net cash provided by operating activities:
|
|
|
|
|
|
||||||
Amortization, net of accretion
|
41,429
|
|
|
32,832
|
|
|
30,740
|
|
|||
Depreciation
|
4,538
|
|
|
4,741
|
|
|
4,949
|
|
|||
Loss (gain) on extinguishment of debt
|
—
|
|
|
2,163
|
|
|
—
|
|
|||
Gain on acquisition
|
(32,314
|
)
|
|
—
|
|
|
—
|
|
|||
(Increase) decrease in cash surrender value of business owned life insurance
|
(1,960
|
)
|
|
(2,008
|
)
|
|
(2,070
|
)
|
|||
Net realized investment gains
|
(67,904
|
)
|
|
(28,863
|
)
|
|
(5,994
|
)
|
|||
Share-based compensation
|
9,242
|
|
|
8,639
|
|
|
7,119
|
|
|||
Deferred income taxes
|
24,659
|
|
|
37,744
|
|
|
(1,051
|
)
|
|||
Policy acquisition costs, net amortization (net deferral)
|
(5,820
|
)
|
|
3,448
|
|
|
655
|
|
|||
Equity in earnings of unconsolidated subsidiaries, excluding distributions received and tax credit partnership amortization
|
(17,376
|
)
|
|
450
|
|
|
3,757
|
|
|||
Other
|
(3,014
|
)
|
|
(2,957
|
)
|
|
(866
|
)
|
|||
Other changes in assets and liabilities, excluding effect of business combinations:
|
|
|
|
|
|
||||||
Premiums receivable
|
(6,105
|
)
|
|
16,494
|
|
|
730
|
|
|||
Receivable from reinsurers on paid losses and loss adjustment expenses
|
2,601
|
|
|
(342
|
)
|
|
407
|
|
|||
Receivable from reinsurers on unpaid losses and loss adjustment expenses
|
15,625
|
|
|
58,870
|
|
|
29,778
|
|
|||
Prepaid reinsurance premiums
|
(849
|
)
|
|
(482
|
)
|
|
(1,545
|
)
|
|||
Other assets
|
9,582
|
|
|
(11,231
|
)
|
|
613
|
|
|||
Reserve for losses and loss adjustment expenses
|
(179,677
|
)
|
|
(218,100
|
)
|
|
(166,328
|
)
|
|||
Unearned premiums
|
(1,740
|
)
|
|
(21,919
|
)
|
|
(4,895
|
)
|
|||
Reinsurance premiums payable
|
(13,269
|
)
|
|
(36,583
|
)
|
|
(29,642
|
)
|
|||
Other liabilities
|
(36,569
|
)
|
|
(27,116
|
)
|
|
5,911
|
|
|||
Net cash provided (used) by operating activities
|
$
|
38,602
|
|
|
$
|
91,250
|
|
|
$
|
159,364
|
|
Continued on following page.
|
|
|
|
|
|
|
Year Ended December 31
|
||||||||||
|
2013
|
|
2012
|
|
2011
|
||||||
Investing Activities
|
|
|
|
|
|
||||||
Purchases of:
|
|
|
|
|
|
||||||
Fixed maturities, available for sale
|
$
|
(519,161
|
)
|
|
$
|
(646,198
|
)
|
|
$
|
(782,555
|
)
|
Equity securities, trading
|
(87,604
|
)
|
|
(120,555
|
)
|
|
(117,208
|
)
|
|||
Other investments
|
(34,699
|
)
|
|
(9,977
|
)
|
|
(4,671
|
)
|
|||
Funding of tax credit limited partnerships
|
(63,489
|
)
|
|
(35,745
|
)
|
|
(29,213
|
)
|
|||
(Investment in) distributions from unconsolidated subsidiaries, net
|
(3,261
|
)
|
|
(9,621
|
)
|
|
—
|
|
|||
Proceeds from sales or maturities of:
|
|
|
|
|
|
||||||
Fixed maturities, available for sale
|
970,708
|
|
|
926,221
|
|
|
789,709
|
|
|||
Equity securities, available for sale
|
—
|
|
|
—
|
|
|
3,921
|
|
|||
Equity securities, trading
|
123,645
|
|
|
54,670
|
|
|
50,386
|
|
|||
Other investments
|
2,352
|
|
|
1,180
|
|
|
773
|
|
|||
Net sales or maturities (purchases) of short-term investments
|
(176,092
|
)
|
|
48,565
|
|
|
49,011
|
|
|||
Cash received from (paid for) acquisitions
|
22,780
|
|
|
(28,439
|
)
|
|
—
|
|
|||
Deposit made for future acquisition
|
(205,244
|
)
|
|
(153,700
|
)
|
|
—
|
|
|||
Unsettled security transactions, net
|
205
|
|
|
4,852
|
|
|
7
|
|
|||
Funding for Syndicate 1729
|
(8,699
|
)
|
|
—
|
|
|
—
|
|
|||
Cash received (paid) for other assets
|
(11,244
|
)
|
|
(4,410
|
)
|
|
(9,771
|
)
|
|||
(Increase) decrease in restricted cash
|
(78,000
|
)
|
|
—
|
|
|
—
|
|
|||
Net cash provided (used) by investing activities
|
(67,803
|
)
|
|
26,843
|
|
|
(49,611
|
)
|
|||
Financing Activities
|
|
|
|
|
|
||||||
Proceeds from long-term debt
|
250,000
|
|
|
125,000
|
|
|
—
|
|
|||
Repayment of long-term debt
|
(127,183
|
)
|
|
(57,660
|
)
|
|
(325
|
)
|
|||
Repurchase of common stock
|
(29,089
|
)
|
|
—
|
|
|
(21,005
|
)
|
|||
Excess tax benefit from share-based payment arrangements
|
2,128
|
|
|
7,022
|
|
|
1,711
|
|
|||
Dividends to shareholders
|
(46,375
|
)
|
|
(200,118
|
)
|
|
(7,617
|
)
|
|||
Other
|
(9,448
|
)
|
|
(4,186
|
)
|
|
(2,968
|
)
|
|||
Net cash provided (used) by financing activities
|
40,033
|
|
|
(129,942
|
)
|
|
(30,204
|
)
|
|||
Increase (decrease) in cash and cash equivalents
|
10,832
|
|
|
(11,849
|
)
|
|
79,549
|
|
|||
Cash and cash equivalents at beginning of period
|
118,551
|
|
|
130,400
|
|
|
50,851
|
|
|||
Cash and cash equivalents at end of period
|
$
|
129,383
|
|
|
$
|
118,551
|
|
|
$
|
130,400
|
|
|
|
|
|
|
|
||||||
Supplemental Disclosure of Cash Flow Information
|
|
|
|
|
|
||||||
Net cash paid during the year for income taxes
|
$
|
117,107
|
|
|
$
|
110,278
|
|
|
$
|
98,141
|
|
Cash paid during the year for interest
|
$
|
913
|
|
|
$
|
2,342
|
|
|
$
|
3,182
|
|
|
|
|
|
|
|
||||||
Significant non-cash transactions
|
|
|
|
|
|
||||||
Deposit transferred as consideration for acquisition
|
$
|
153,700
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Other investment interest converted to equity securities
|
$
|
—
|
|
|
$
|
15,742
|
|
|
$
|
—
|
|
(in thousands)
|
|
Premium
Receivables |
|
Agency
Receivables |
||||
Allowance for credit losses:
|
|
|
|
|
||||
Balance at December 31, 2011
|
|
$
|
990
|
|
|
$
|
332
|
|
Estimated credit losses
|
|
157
|
|
|
—
|
|
||
Account write offs, net of recoveries
|
|
(147
|
)
|
|
(46
|
)
|
||
Balance at December 31, 2012
|
|
1,000
|
|
|
286
|
|
||
Estimated credit losses
|
|
236
|
|
|
—
|
|
||
Account write offs, net of recoveries
|
|
(246
|
)
|
|
(236
|
)
|
||
Balance at December 31, 2013
|
|
$
|
990
|
|
|
$
|
50
|
|
•
|
the length of time for which the fair value of the investment has been less than its recorded basis;
|
•
|
the financial condition and near-term prospects of the issuer underlying the investment, taking into consideration the economic prospects of the issuer’s industry and geographical region, to the extent that information is publicly available;
|
•
|
the historical and implied volatility of the fair value of the security;
|
•
|
For non-structured fixed maturities (U.S. Treasury securities, obligations of U.S. Government and government agencies and authorities, obligations of states, municipalities and political subdivisions, and corporate debt) the estimate of expected cash flows is determined by projecting a recovery value and a recovery time frame and assessing whether further principal and interest will be received. ProAssurance considers the following in projecting recovery values and recovery time frames:
|
•
|
third party research and credit rating reports;
|
•
|
the current credit standing of the issuer, including credit rating downgrades, whether before or after the balance sheet date;
|
•
|
internal assessments and the assessments of external portfolio managers regarding specific circumstances surrounding an investment, which indicate the investment is more or less likely to recover its amortized cost than other investments with a similar structure;
|
•
|
failure of the issuer of the security to make scheduled interest or principal payments;
|
•
|
For structured securities (primarily asset-backed securities), ProAssurance estimates the present value of the security’s cash flows using the effective yield of the security at the date of acquisition (or the most recent implied rate used to accrete the security if the implied rate has changed as a result of a previous impairment or changes in expected cash flows). ProAssurance considers the most recently available six month averages of the levels of delinquencies, defaults, severities, and prepayments for the collateral (loans) underlying the securitization or, if historical data is not available, sector based assumptions, to estimate expected future cash flows of these securities.
|
•
|
For the year ended
December 31, 2012
, the ProAssurance
2012
Actual Consolidated Results did not include Medmarc, and have been adjusted to include Medmarc's 2012 operating results. ProAssurance Actual Consolidated Results for the year ended
December 31, 2013
included Medmarc operating results (Revenue of
$46.5 million
and Net Income of
$15.7 million
).
|
•
|
Certain costs included in ProAssurance Actual Consolidated Results for the year ended
December 31, 2013
have been reported in the Pro Forma Consolidated Results as if the costs had been incurred for the year ended
December 31, 2012
. Such costs include direct transaction costs and certain compensation costs directly related to the integration of Medmarc operations.
|
•
|
Prior to the acquisition date, Medmarc reported on a statutory basis and expensed policy acquisition costs associated with successful contracts as incurred. After the acquisition date, in accordance with GAAP, Medmarc policy acquisition costs associated with successful contracts were capitalized and amortized to expense as the related premium revenues were earned, but no amortization was recognized for Medmarc policies written prior to the acquisition date. The Pro Forma Consolidated Results for both
2013
and
2012
have been adjusted to reflect policy acquisition costs as if Medmarc had followed GAAP guidance for these costs in pre-acquisition periods.
|
•
|
Earnings for the year ended
December 31, 2012
were reduced to reflect amortization of intangible assets and debt security premiums and discounts recorded as a part of the Medmarc purchase price allocation.
|
•
|
The non-taxable gain on the acquisition of
$32.3 million
that was included in ProAssurance Actual Consolidated Results for the year ended
December 31, 2013
has been reported in the Pro Forma Consolidated Results as being recognized during the year ended
December 31, 2012
.
|
|
Year Ended December 31, 2013
|
|
Year Ended December 31, 2012
|
||||
(In thousands)
|
ProAssurance
Pro Forma Consolidated Results |
|
ProAssurance
Actual Consolidated Results |
|
ProAssurance
Pro Forma Consolidated Results |
|
ProAssurance
Actual Consolidated Results |
Revenue
|
$740,178
|
|
$740,178
|
|
$757,240
|
|
$715,854
|
Net Income
|
$263,820
|
|
$297,523
|
|
$317,097
|
|
$275,470
|
|
Level 1:
|
quoted (unadjusted) market prices in active markets for identical assets and liabilities. For ProAssurance, Level 1 inputs are generally quotes for debt or equity securities actively traded in exchange or over-the-counter markets.
|
|
Level 2:
|
market data obtained from sources independent of the reporting entity (observable inputs). For ProAssurance, Level 2 inputs generally include quoted prices in markets that are not active, quoted prices for similar assets or liabilities, and results from pricing models that use observable inputs such as interest rates and yield curves that are generally available at commonly quoted intervals.
|
|
Level 3:
|
the reporting entity’s own assumptions about market participant assumptions based on the best information available in the circumstances (non-observable inputs). For ProAssurance, Level 3 inputs are used in situations where little or no Level 1 or 2 inputs are available or are inappropriate given the particular circumstances. Level 3 inputs include results from pricing models for which some or all of the inputs are not observable, discounted cash flow methodologies, single non-binding broker quotes and adjustments to externally quoted prices that are based on management judgment or estimation.
|
|
December 31, 2013
|
||||||||||||||
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
170,714
|
|
|
$
|
—
|
|
|
$
|
170,714
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
32,768
|
|
|
—
|
|
|
32,768
|
|
||||
State and municipal bonds
|
—
|
|
|
1,147,328
|
|
|
7,338
|
|
|
1,154,666
|
|
||||
Corporate debt, multiple observable inputs
|
—
|
|
|
1,346,977
|
|
|
—
|
|
|
1,346,977
|
|
||||
Corporate debt, limited observable inputs:
|
|
|
|
|
|
|
|
||||||||
Other corporate debt, NRSRO ratings available
|
—
|
|
|
—
|
|
|
11,449
|
|
|
11,449
|
|
||||
Other corporate debt, NRSRO ratings not available
|
—
|
|
|
—
|
|
|
2,727
|
|
|
2,727
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
235,614
|
|
|
—
|
|
|
235,614
|
|
||||
Agency commercial mortgage-backed securities
|
—
|
|
|
27,475
|
|
|
—
|
|
|
27,475
|
|
||||
Other commercial mortgage-backed securities
|
—
|
|
|
61,390
|
|
|
—
|
|
|
61,390
|
|
||||
Other asset-backed securities
|
—
|
|
|
67,455
|
|
|
6,814
|
|
|
74,269
|
|
||||
Equity securities
|
|
|
|
|
|
|
|
||||||||
Financial
|
81,536
|
|
|
—
|
|
|
—
|
|
|
81,536
|
|
||||
Utilities/Energy
|
32,350
|
|
|
—
|
|
|
—
|
|
|
32,350
|
|
||||
Consumer oriented
|
66,461
|
|
|
—
|
|
|
—
|
|
|
66,461
|
|
||||
Industrial
|
57,262
|
|
|
—
|
|
|
—
|
|
|
57,262
|
|
||||
All other
|
15,932
|
|
|
—
|
|
|
—
|
|
|
15,932
|
|
||||
Short-term investments
|
248,605
|
|
|
—
|
|
|
—
|
|
|
248,605
|
|
||||
Financial instruments carried at fair value, classified as a part of:
|
|
|
|
|
|
|
|
||||||||
Investment in unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
72,062
|
|
|
72,062
|
|
||||
Total assets
|
$
|
502,146
|
|
|
$
|
3,089,721
|
|
|
$
|
100,390
|
|
|
$
|
3,692,257
|
|
|
December 31, 2012
|
||||||||||||||
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
205,857
|
|
|
$
|
—
|
|
|
$
|
205,857
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
56,947
|
|
|
—
|
|
|
56,947
|
|
||||
State and municipal bonds
|
—
|
|
|
1,212,804
|
|
|
7,175
|
|
|
1,219,979
|
|
||||
Corporate debt, multiple observable inputs
|
—
|
|
|
1,455,333
|
|
|
—
|
|
|
1,455,333
|
|
||||
Corporate debt, limited observable inputs:
|
|
|
|
|
|
|
|
||||||||
Private placement senior notes
|
—
|
|
|
—
|
|
|
346
|
|
|
346
|
|
||||
Other corporate debt, NRSRO ratings available
|
—
|
|
|
—
|
|
|
13,835
|
|
|
13,835
|
|
||||
Other corporate debt, NRSRO ratings not available
|
—
|
|
|
—
|
|
|
1,010
|
|
|
1,010
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
289,850
|
|
|
—
|
|
|
289,850
|
|
||||
Agency commercial mortgage-backed securities
|
—
|
|
|
59,464
|
|
|
—
|
|
|
59,464
|
|
||||
Other commercial mortgage-backed securities
|
—
|
|
|
74,106
|
|
|
—
|
|
|
74,106
|
|
||||
Other asset-backed securities
|
—
|
|
|
67,237
|
|
|
4,035
|
|
|
71,272
|
|
||||
Equity securities
|
|
|
|
|
|
|
|
||||||||
Financial
|
70,900
|
|
|
—
|
|
|
—
|
|
|
70,900
|
|
||||
Utilities/Energy
|
31,383
|
|
|
—
|
|
|
—
|
|
|
31,383
|
|
||||
Consumer oriented
|
51,100
|
|
|
—
|
|
|
—
|
|
|
51,100
|
|
||||
Industrial
|
29,695
|
|
|
—
|
|
|
—
|
|
|
29,695
|
|
||||
All other
|
19,540
|
|
|
—
|
|
|
—
|
|
|
19,540
|
|
||||
Short-term investments
|
59,761
|
|
|
11,976
|
|
|
—
|
|
|
71,737
|
|
||||
Financial instruments carried at fair value, classified as a part of:
|
|
|
|
|
|
|
|
||||||||
Investment in unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
33,739
|
|
|
33,739
|
|
||||
Total assets
|
$
|
262,379
|
|
|
$
|
3,433,574
|
|
|
$
|
60,140
|
|
|
$
|
3,756,093
|
|
•
|
Level 3 securities are priced by the Vice President of Investments for our subsidiaries, who reports to the Chief Financial Officer.
|
•
|
Level 3 valuations are computed quarterly. Prices are evaluated quarterly against prior period prices and the expected change in price.
|
•
|
Exclusive of Investments in unconsolidated subsidiaries, which are valued at net asset value (NAV), the securities noted in the disclosure are primarily NRSRO rated corporate debt instruments for which comparable market inputs are commonly available for evaluating the securities in question. Valuation of these corporate debt instruments is not overly sensitive to changes in the unobservable inputs used.
|
|
Unfunded
Commitments |
Fair Value
|
||||||
(In thousands)
|
December 31,
2013 |
December 31,
2013 |
|
December 31,
2012 |
||||
Investments in LPs/LLCs:
|
|
|
|
|
||||
Secured debt fund (1)
|
$27,000
|
$
|
13,233
|
|
|
$
|
—
|
|
Long equity fund (2)
|
None
|
6,574
|
|
|
—
|
|
||
Long/Short equity funds (3)
|
None
|
28,385
|
|
|
17,115
|
|
||
Non-public equity funds (4)
|
87,603
|
23,870
|
|
|
16,624
|
|
||
|
|
$
|
72,062
|
|
|
$
|
33,739
|
|
(1)
|
The LP is structured to provide income and capital appreciation primarily through investments in senior secured debt. Redemptions are not allowed. Income and capital are to be periodically distributed at the discretion of the LP over an anticipated time frame that spans from
7
to
9
years.
|
(2)
|
The LP holds long equities of public international companies. Redemptions are allowed at the end of any calendar month with a prior notice requirement of
15 days
and are paid within
10 days
of the end of the calendar month of the redemption request.
|
(3)
|
Comprised of interests in two unrelated LP funds, each holds primarily long and short U.S. and North American equities, and targets absolute returns using a strategy designed to take advantage of event-driven market opportunities. One LP allows redemption with a notice requirement of up to
45 days
with the redemption payable within
30 days
of the redemption date, unless the redemption request is for
90%
or more of the requestor’s capital balance. Redemptions at the
90%
and above level will be paid at
90%
, with the remainder paid after the LP’s annual audit. The other LP generally allows redemption of substantially all the capital semi-annually with
30 days
notice.
|
(4)
|
Comprised of interests in three unrelated LP funds, each structured to provide capital appreciation through diversified investments in private equity, which can include investments in buyout, venture capital, mezzanine debt, distressed debt and other private equity-oriented LPs. One LP allows redemption by special consent; the others do not permit redemption. Income and capital are to be periodically distributed at the discretion of the LP over time frames that are anticipated to span from
4
to
12
years.
|
Quantitative Information about Level 3 Fair Value Measurements
|
||||||||||
|
|
Fair Value at
|
|
|
|
|
|
|
||
(In millions)
|
|
December 31, 2013
|
|
December 31, 2012
|
|
Valuation Technique
|
|
Unobservable Input
|
|
Range
(Weighted Average) |
Assets:
|
|
|
|
|
|
|
|
|
|
|
State and municipal bonds
|
|
$7.3
|
|
$7.2
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 10% (5%)
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 10% (5%)
|
Corporate debt with limited observable inputs
|
|
$14.2
|
|
$15.2
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
Other asset-backed securities
|
|
$6.8
|
|
$4.0
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
December 31, 2013
|
||||||||||||||||||||||
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||||||||||
(In thousands)
|
State and Municipal Bonds
|
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Investment in Unconsolidated Subsidiaries
|
|
Other Investments
|
|
Total
|
||||||||||||
Balance December 31, 2012
|
$
|
7,175
|
|
|
$
|
15,191
|
|
|
$
|
4,035
|
|
|
$
|
33,739
|
|
|
$
|
—
|
|
|
$
|
60,140
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net investment income
|
—
|
|
|
(103
|
)
|
|
(17
|
)
|
|
—
|
|
|
—
|
|
|
(120
|
)
|
||||||
Equity in earnings of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
6,877
|
|
|
—
|
|
|
6,877
|
|
||||||
Net realized investment gains (losses)
|
(44
|
)
|
|
(69
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(113
|
)
|
||||||
Included in other comprehensive income
|
1
|
|
|
(725
|
)
|
|
(61
|
)
|
|
—
|
|
|
—
|
|
|
(785
|
)
|
||||||
Purchases
|
—
|
|
|
9,470
|
|
|
1,356
|
|
|
24,567
|
|
|
—
|
|
|
35,393
|
|
||||||
Sales
|
(2,106
|
)
|
|
(1,629
|
)
|
|
(18
|
)
|
|
(14,632
|
)
|
|
—
|
|
|
(18,385
|
)
|
||||||
Transfers in
|
2,312
|
|
|
2,114
|
|
|
3,800
|
|
|
21,511
|
|
|
—
|
|
|
29,737
|
|
||||||
Transfers out
|
—
|
|
|
(10,073
|
)
|
|
(2,281
|
)
|
|
—
|
|
|
—
|
|
|
(12,354
|
)
|
||||||
Balance December 31, 2013
|
$
|
7,338
|
|
|
$
|
14,176
|
|
|
$
|
6,814
|
|
|
$
|
72,062
|
|
|
$
|
—
|
|
|
$
|
100,390
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6,877
|
|
|
$
|
—
|
|
|
$
|
6,877
|
|
|
December 31, 2012
|
||||||||||||||||||||||
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||||||||||
(In thousands)
|
State and Municipal Bonds
|
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Investment in Unconsolidated Subsidiaries
|
|
Other Investments
|
|
Total
|
||||||||||||
Balance December 31, 2011
|
$
|
7,200
|
|
|
$
|
8,082
|
|
|
$
|
—
|
|
|
$
|
23,841
|
|
|
$
|
15,873
|
|
|
$
|
54,996
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net investment income
|
—
|
|
|
14
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14
|
|
||||||
Equity in earnings of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
278
|
|
|
—
|
|
|
278
|
|
||||||
Net realized investment gains (losses)
|
—
|
|
|
10
|
|
|
—
|
|
|
—
|
|
|
(131
|
)
|
|
(121
|
)
|
||||||
Included in other comprehensive income
|
—
|
|
|
611
|
|
|
35
|
|
|
—
|
|
|
—
|
|
|
646
|
|
||||||
Purchases
|
—
|
|
|
3,136
|
|
|
6,734
|
|
|
11,008
|
|
|
—
|
|
|
20,878
|
|
||||||
Sales
|
(25
|
)
|
|
(1,951
|
)
|
|
(1,118
|
)
|
|
(1,388
|
)
|
|
—
|
|
|
(4,482
|
)
|
||||||
Transfers in
|
—
|
|
|
9,220
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,220
|
|
||||||
Transfers out
|
—
|
|
|
(3,931
|
)
|
|
(1,616
|
)
|
|
—
|
|
|
(15,742
|
)
|
|
(21,289
|
)
|
||||||
Balance December 31, 2012
|
$
|
7,175
|
|
|
$
|
15,191
|
|
|
$
|
4,035
|
|
|
$
|
33,739
|
|
|
$
|
—
|
|
|
$
|
60,140
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
278
|
|
|
$
|
(131
|
)
|
|
$
|
147
|
|
|
December 31, 2012
|
||||||||||
|
Level 3 Fair Value Measurements - Liabilities
|
||||||||||
(In thousands)
|
2019 Note Payable
|
|
Interest rate swap agreement
|
|
Total
|
||||||
Balance December 31, 2011
|
$
|
14,180
|
|
|
$
|
4,659
|
|
|
$
|
18,839
|
|
Total (gains) losses realized and unrealized:
|
|
|
|
|
|
||||||
Included in earnings as a part of:
|
|
|
|
|
|
||||||
Net realized investment (gains) losses
|
769
|
|
|
476
|
|
|
1,245
|
|
|||
Loss on extinguishment of debt
|
2,163
|
|
|
—
|
|
|
2,163
|
|
|||
Settlements
|
(17,112
|
)
|
|
(5,135
|
)
|
|
(22,247
|
)
|
|||
Balance December 31, 2012
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Change in unrealized (gains) losses included in earnings for the above period for Level 3 liabilities outstanding at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
December 31, 2013
|
|
December 31, 2012
|
||||||||||||
(In thousands)
|
Carrying
Value |
|
Fair
Value |
|
Carrying
Value |
|
Fair
Value |
||||||||
Financial assets:
|
|
|
|
|
|
|
|
||||||||
BOLI
|
$
|
54,374
|
|
|
$
|
54,374
|
|
|
$
|
31,085
|
|
|
$
|
38,656
|
|
Investment in unconsolidated subsidiaries
|
142,174
|
|
|
139,548
|
|
|
87,310
|
|
|
91,528
|
|
||||
Other investments
|
52,240
|
|
|
51,833
|
|
|
52,414
|
|
|
52,414
|
|
||||
Other assets
|
17,940
|
|
|
17,940
|
|
|
11,400
|
|
|
11,385
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Financial liabilities:
|
|
|
|
|
|
|
|
||||||||
Senior notes due 2023
|
$
|
250,000
|
|
|
$
|
262,500
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Revolving credit agreement
|
—
|
|
|
—
|
|
|
125,000
|
|
|
125,000
|
|
||||
Other liabilities
|
13,303
|
|
|
13,303
|
|
|
12,130
|
|
|
12,085
|
|
|
December 31, 2013
|
||||||||||||||
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
Fixed maturities
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
166,115
|
|
|
$
|
6,118
|
|
|
$
|
(1,519
|
)
|
|
$
|
170,714
|
|
U.S. Government-sponsored enterprise obligations
|
30,942
|
|
|
2,251
|
|
|
(425
|
)
|
|
32,768
|
|
||||
State and municipal bonds
|
1,116,060
|
|
|
46,533
|
|
|
(7,927
|
)
|
|
1,154,666
|
|
||||
Corporate debt
|
1,321,838
|
|
|
53,059
|
|
|
(13,744
|
)
|
|
1,361,153
|
|
||||
Residential mortgage-backed securities
|
230,861
|
|
|
7,608
|
|
|
(2,855
|
)
|
|
235,614
|
|
||||
Agency commercial mortgage-backed securities
|
27,268
|
|
|
343
|
|
|
(136
|
)
|
|
27,475
|
|
||||
Other commercial mortgage-backed securities
|
59,066
|
|
|
2,491
|
|
|
(167
|
)
|
|
61,390
|
|
||||
Other asset-backed securities
|
74,106
|
|
|
487
|
|
|
(324
|
)
|
|
74,269
|
|
||||
|
$
|
3,026,256
|
|
|
$
|
118,890
|
|
|
$
|
(27,097
|
)
|
|
$
|
3,118,049
|
|
|
|
|
|
|
|
|
|
||||||||
|
December 31, 2012
|
||||||||||||||
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
Fixed maturities
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury obligations
|
$
|
191,642
|
|
|
$
|
14,266
|
|
|
$
|
(51
|
)
|
|
$
|
205,857
|
|
U.S. Government-sponsored enterprise obligations
|
52,110
|
|
|
4,837
|
|
|
—
|
|
|
56,947
|
|
||||
State and municipal bonds
|
1,134,744
|
|
|
85,329
|
|
|
(94
|
)
|
|
1,219,979
|
|
||||
Corporate debt
|
1,375,880
|
|
|
96,187
|
|
|
(1,543
|
)
|
|
1,470,524
|
|
||||
Residential mortgage-backed securities
|
272,990
|
|
|
17,070
|
|
|
(210
|
)
|
|
289,850
|
|
||||
Agency commercial mortgage-backed securities
|
57,234
|
|
|
2,255
|
|
|
(25
|
)
|
|
59,464
|
|
||||
Other commercial mortgage-backed securities
|
69,062
|
|
|
5,049
|
|
|
(5
|
)
|
|
74,106
|
|
||||
Other asset-backed securities
|
70,670
|
|
|
1,203
|
|
|
(601
|
)
|
|
71,272
|
|
||||
|
3,224,332
|
|
|
226,196
|
|
|
(2,529
|
)
|
|
3,447,999
|
|
(In thousands)
|
Amortized
Cost |
|
Due in one
year or less |
|
Due after
one year through five years |
|
Due after
five years through ten years |
|
Due after
ten years |
|
Total Fair
Value |
||||||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury obligations
|
$
|
166,115
|
|
|
$
|
15,501
|
|
|
$
|
107,433
|
|
|
$
|
44,102
|
|
|
$
|
3,678
|
|
|
$
|
170,714
|
|
U.S. Government-sponsored enterprise obligations
|
30,942
|
|
|
3,226
|
|
|
21,564
|
|
|
7,759
|
|
|
219
|
|
|
32,768
|
|
||||||
State and municipal bonds
|
1,116,060
|
|
|
57,081
|
|
|
406,444
|
|
|
467,219
|
|
|
223,922
|
|
|
1,154,666
|
|
||||||
Corporate debt
|
1,321,838
|
|
|
124,080
|
|
|
578,894
|
|
|
627,496
|
|
|
30,683
|
|
|
1,361,153
|
|
||||||
Residential mortgage-backed securities
|
230,861
|
|
|
|
|
|
|
|
|
|
|
235,614
|
|
||||||||||
Agency commercial mortgage-backed securities
|
27,268
|
|
|
|
|
|
|
|
|
|
|
27,475
|
|
||||||||||
Other commercial mortgage-backed securities
|
59,066
|
|
|
|
|
|
|
|
|
|
|
61,390
|
|
||||||||||
Other asset-backed securities
|
74,106
|
|
|
|
|
|
|
|
|
|
|
74,269
|
|
||||||||||
|
$
|
3,026,256
|
|
|
|
|
|
|
|
|
|
|
$
|
3,118,049
|
|
(In thousands)
|
December 31,
2013 |
|
December 31,
2012 |
||||
Investments in LPs/LLCs, at cost
|
$
|
47,258
|
|
|
$
|
25,092
|
|
FHLB capital stock, at cost
|
3,449
|
|
|
4,278
|
|
||
Other, principally an annuity, at amortized cost
|
1,533
|
|
|
1,715
|
|
||
|
$
|
52,240
|
|
|
$
|
31,085
|
|
|
December 31, 2013
|
|
Carrying Value
|
|||||||||||
(In thousands)
|
Unfunded
Commitments* |
|
Percentage
Ownership |
|
December 31,
2013 |
|
December 31,
2012 |
|||||||
Investment in LPs/LLCs:
|
|
|
|
|
|
|
|
|
||||||
Tax credit partnerships
|
$
|
22,441
|
|
|
See below
|
|
$
|
142,174
|
|
|
$
|
87,310
|
|
|
Secured debt fund
|
27,000
|
|
|
<
|
20%
|
|
13,233
|
|
|
—
|
|
|||
Long equity fund
|
None
|
|
|
<
|
20%
|
|
6,574
|
|
|
—
|
|
|||
Long/Short equity funds
|
None
|
|
|
<
|
25%
|
|
28,385
|
|
|
17,115
|
|
|||
Non-public equity funds
|
87,603
|
|
|
<
|
20%
|
|
23,870
|
|
|
16,624
|
|
|||
|
|
|
|
|
|
$
|
214,236
|
|
|
$
|
121,049
|
|
||
|
|
|
|
|
|
|
|
|
||||||
* Unfunded commitments are included in the carrying value of tax credit partnerships, only.
|
|
December 31, 2013
|
||||||||||||||||||||||
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury obligations
|
$
|
47,668
|
|
|
$
|
(1,519
|
)
|
|
$
|
44,304
|
|
|
$
|
(1,182
|
)
|
|
$
|
3,364
|
|
|
$
|
(337
|
)
|
U.S. Government-sponsored enterprise obligations
|
6,640
|
|
|
(425
|
)
|
|
5,752
|
|
|
(321
|
)
|
|
888
|
|
|
(104
|
)
|
||||||
State and municipal bonds
|
203,970
|
|
|
(7,927
|
)
|
|
184,401
|
|
|
(6,640
|
)
|
|
19,569
|
|
|
(1,287
|
)
|
||||||
Corporate debt
|
349,277
|
|
|
(13,744
|
)
|
|
324,510
|
|
|
(12,061
|
)
|
|
24,767
|
|
|
(1,683
|
)
|
||||||
Residential mortgage-backed securities
|
93,608
|
|
|
(2,855
|
)
|
|
84,045
|
|
|
(2,393
|
)
|
|
9,563
|
|
|
(462
|
)
|
||||||
Agency commercial mortgage-backed securities
|
11,658
|
|
|
(136
|
)
|
|
11,082
|
|
|
(116
|
)
|
|
576
|
|
|
(20
|
)
|
||||||
Other commercial mortgage-backed securities
|
11,153
|
|
|
(167
|
)
|
|
10,215
|
|
|
(159
|
)
|
|
938
|
|
|
(8
|
)
|
||||||
Other asset-backed securities
|
25,539
|
|
|
(324
|
)
|
|
21,804
|
|
|
(77
|
)
|
|
3,735
|
|
|
(247
|
)
|
||||||
|
$
|
749,513
|
|
|
$
|
(27,097
|
)
|
|
$
|
686,113
|
|
|
$
|
(22,949
|
)
|
|
$
|
63,400
|
|
|
$
|
(4,148
|
)
|
Other investments
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Investments in LPs/LLCs carried at cost
|
$
|
14,752
|
|
|
$
|
(1,059
|
)
|
|
$
|
13,166
|
|
|
$
|
(1,018
|
)
|
|
$
|
1,586
|
|
|
$
|
(41
|
)
|
|
December 31, 2012
|
||||||||||||||||||||||
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury obligations
|
$
|
4,073
|
|
|
$
|
(51
|
)
|
|
$
|
4,073
|
|
|
$
|
(51
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
State and municipal bonds
|
11,234
|
|
|
(94
|
)
|
|
9,232
|
|
|
(65
|
)
|
|
2,002
|
|
|
(29
|
)
|
||||||
Corporate debt
|
90,154
|
|
|
(1,543
|
)
|
|
81,878
|
|
|
(1,377
|
)
|
|
8,276
|
|
|
(166
|
)
|
||||||
Residential mortgage-backed securities
|
10,721
|
|
|
(210
|
)
|
|
10,029
|
|
|
(205
|
)
|
|
692
|
|
|
(5
|
)
|
||||||
Agency commercial mortgage-backed securities
|
1,643
|
|
|
(25
|
)
|
|
498
|
|
|
(2
|
)
|
|
1,145
|
|
|
(23
|
)
|
||||||
Other commercial mortgage-backed securities
|
2,100
|
|
|
(5
|
)
|
|
1,103
|
|
|
(1
|
)
|
|
997
|
|
|
(4
|
)
|
||||||
Other asset-backed securities
|
10,746
|
|
|
(601
|
)
|
|
7,707
|
|
|
(20
|
)
|
|
3,039
|
|
|
(581
|
)
|
||||||
|
$
|
130,671
|
|
|
$
|
(2,529
|
)
|
|
$
|
114,520
|
|
|
$
|
(1,721
|
)
|
|
$
|
16,151
|
|
|
$
|
(808
|
)
|
Other investments
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Investments in LPs/LLCs carried at cost
|
$
|
9,474
|
|
|
$
|
(851
|
)
|
|
$
|
8,697
|
|
|
$
|
(688
|
)
|
|
$
|
777
|
|
|
$
|
(163
|
)
|
|
Year Ended December 31
|
|||||||||
(In thousands)
|
2013
|
|
2012
|
2011
|
||||||
Fixed maturities
|
$
|
122,065
|
|
|
$
|
133,088
|
|
$
|
140,897
|
|
Equities
|
9,454
|
|
|
6,947
|
|
1,808
|
|
|||
Short-term investments and Other invested assets
|
2,584
|
|
|
660
|
|
2,812
|
|
|||
Business owned life insurance
|
1,960
|
|
|
2,008
|
|
2,017
|
|
|||
Investment fees and expenses
|
(6,798
|
)
|
|
(6,609
|
)
|
(6,578
|
)
|
|||
Net investment income
|
$
|
129,265
|
|
|
$
|
136,094
|
|
$
|
140,956
|
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
2013
|
|
2012
|
|
2011
|
||||||
Total other-than-temporary impairment losses:
|
|
|
|
|
|
||||||
State and municipal bonds
|
$
|
(71
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
Residential mortgage-backed securities
|
—
|
|
|
(557
|
)
|
|
(782
|
)
|
|||
Corporate debt
|
—
|
|
|
(878
|
)
|
|
(505
|
)
|
|||
Other investments
|
—
|
|
|
(131
|
)
|
|
(3,827
|
)
|
|||
High yield asset-backed securities
|
—
|
|
|
—
|
|
|
(75
|
)
|
|||
Portion recognized in (reclassified from) Other Comprehensive Income:
|
|
|
|
|
|
||||||
Residential mortgage-backed securities
|
—
|
|
|
(201
|
)
|
|
(823
|
)
|
|||
Net impairment losses recognized in earnings
|
(71
|
)
|
|
(1,767
|
)
|
|
(6,012
|
)
|
|||
Gross realized gains, available-for-sale securities
|
18,130
|
|
|
18,645
|
|
|
14,625
|
|
|||
Gross realized (losses), available-for-sale securities
|
(7,031
|
)
|
|
(2,076
|
)
|
|
(1,754
|
)
|
|||
Net realized gains (losses), trading securities
|
20,444
|
|
|
1,485
|
|
|
2,212
|
|
|||
Change in unrealized holding gains (losses), trading securities
|
35,507
|
|
|
12,673
|
|
|
(3,188
|
)
|
|||
Decrease (increase) in the fair value of liabilities carried at fair value
|
—
|
|
|
(1,245
|
)
|
|
111
|
|
|||
Other
|
925
|
|
|
1,148
|
|
|
—
|
|
|||
Net realized investment gains (losses)
|
$
|
67,904
|
|
|
$
|
28,863
|
|
|
$
|
5,994
|
|
•
|
ProAssurance recognized impairment losses related to certain residential mortgage-backed securities in
2012
and
2011
because carrying values for those securities were greater than the future cash flows expected to be received from the securities.
|
•
|
ProAssurance recognized impairments related to corporate debt securities in
2012
and
2011
because the credit standing of the issuers had deteriorated.
|
•
|
ProAssurance recognized impairments in
2012
and
2011
related to an interest in an LLC, accounted for using the cost method, that was classified as a part of Other Investments. In 2011, the LLC announced a plan to convert to a publicly traded investment fund, and OTTI was recognized in subsequent periods in order to carry the interest at the NAV reported by the fund. The conversion occurred in 2012.
|
(In thousands)
|
2013
|
|
2012
|
2011
|
||||||
Balance January 1
|
$
|
3,301
|
|
|
$
|
5,870
|
|
$
|
4,446
|
|
Additional credit losses recognized during the period, related to securities for which:
|
|
|
|
|
||||||
OTTI has been previously recognized
|
—
|
|
|
268
|
|
1,424
|
|
|||
Reductions due to:
|
|
|
|
|
||||||
Securities sold during the period (realized)
|
(3,218
|
)
|
|
(2,837
|
)
|
—
|
|
|||
Balance December 31
|
$
|
83
|
|
|
$
|
3,301
|
|
$
|
5,870
|
|
|
Year Ended December 31
|
|||||||||
(In millions)
|
2013
|
|
2012
|
2011
|
||||||
Proceeds from sales (exclusive of maturities and paydowns)
|
$
|
593.3
|
|
|
$
|
500.2
|
|
$
|
424.8
|
|
Purchases
|
$
|
519.2
|
|
|
$
|
646.2
|
|
$
|
782.6
|
|
|
|
2013 Premiums
|
|
2012 Premiums
|
|
2011 Premiums
|
||||||||||||||||||
|
|
Written
|
|
Earned
|
|
Written
|
|
Earned
|
|
Written
|
|
Earned
|
||||||||||||
Direct
|
|
$
|
566,745
|
|
|
$
|
568,629
|
|
|
$
|
536,318
|
|
|
$
|
558,200
|
|
|
$
|
565,746
|
|
|
$
|
570,891
|
|
Assumed
|
|
802
|
|
|
804
|
|
|
113
|
|
|
116
|
|
|
149
|
|
|
154
|
|
||||||
Ceded
|
|
(42,365
|
)
|
|
(41,514
|
)
|
|
(8,133
|
)
|
|
(7,652
|
)
|
|
(7,388
|
)
|
|
(5,630
|
)
|
||||||
Net premiums
|
|
$
|
525,182
|
|
|
$
|
527,919
|
|
|
$
|
528,298
|
|
|
$
|
550,664
|
|
|
$
|
558,507
|
|
|
$
|
565,415
|
|
(In thousands)
|
|
2013
|
|
2012
|
||||
Deferred tax assets
|
|
|
|
|
||||
Unpaid loss discount
|
|
$
|
51,879
|
|
|
$
|
57,811
|
|
Unearned premium adjustment
|
|
21,861
|
|
|
20,497
|
|
||
Compensation related
|
|
18,172
|
|
|
14,634
|
|
||
Intangibles
|
|
2,074
|
|
|
2,214
|
|
||
Total deferred tax assets
|
|
93,986
|
|
|
95,156
|
|
||
Deferred tax liabilities
|
|
|
|
|
||||
Deferred acquisition costs
|
|
10,150
|
|
|
8,112
|
|
||
Unrealized gains on investments, net
|
|
32,127
|
|
|
78,284
|
|
||
Fixed assets
|
|
4,166
|
|
|
5,630
|
|
||
Basis differentials–investments
|
|
31,247
|
|
|
3,029
|
|
||
Intangibles
|
|
13,238
|
|
|
14,311
|
|
||
Other
|
|
1,301
|
|
|
375
|
|
||
Total deferred tax liabilities
|
|
92,229
|
|
|
109,741
|
|
||
Net deferred tax assets (liabilities)
|
|
$
|
1,757
|
|
|
$
|
(14,585
|
)
|
(In thousands)
|
|
2013
|
|
2012
|
|
2011
|
||||||
Balance at January 1
|
|
$
|
4,823
|
|
|
$
|
18,585
|
|
|
$
|
8,344
|
|
(Decreases) for tax positions taken during the current year
|
|
—
|
|
|
(10,206
|
)
|
|
—
|
|
|||
Increases for tax positions taken during prior years
|
|
—
|
|
|
—
|
|
|
18,585
|
|
|||
(Decreases) for tax positions taken during prior years
|
|
—
|
|
|
(3,556
|
)
|
|
—
|
|
|||
(Decreases) relating to settlements with taxing authorities
|
|
—
|
|
|
—
|
|
|
(8,344
|
)
|
|||
Balance at December 31
|
|
$
|
4,823
|
|
|
$
|
4,823
|
|
|
$
|
18,585
|
|
(In thousands)
|
|
2013
|
|
2012
|
|
2011
|
||||||
Computed “expected” tax expense
|
|
$
|
139,005
|
|
|
$
|
138,588
|
|
|
$
|
145,109
|
|
Tax-exempt income
|
|
(14,509
|
)
|
|
(14,374
|
)
|
|
(13,793
|
)
|
|||
Tax credits
|
|
(17,888
|
)
|
|
(10,005
|
)
|
|
(5,654
|
)
|
|||
Non-taxable gain on acquisition
|
|
(11,310
|
)
|
|
—
|
|
|
—
|
|
|||
Other
|
|
4,338
|
|
|
6,287
|
|
|
1,840
|
|
|||
Total
|
|
$
|
99,636
|
|
|
$
|
120,496
|
|
|
$
|
127,502
|
|
(In thousands)
|
2013
|
|
2012
|
|
2011
|
||||||
Balance, beginning of year
|
$
|
2,054,994
|
|
|
$
|
2,247,772
|
|
|
$
|
2,414,100
|
|
Less reinsurance recoverables on unpaid losses and loss adjustment expenses
|
191,645
|
|
|
247,658
|
|
|
277,436
|
|
|||
Net balance, beginning of year
|
1,863,349
|
|
|
2,000,114
|
|
|
2,136,664
|
|
|||
Net reserves acquired from acquisitions
|
126,007
|
|
|
22,464
|
|
|
—
|
|
|||
Net losses:
|
|
|
|
|
|
||||||
Current year
|
447,510
|
|
|
451,951
|
|
|
488,152
|
|
|||
Favorable development of reserves established in prior years, net
|
(222,749
|
)
|
|
(272,038
|
)
|
|
(325,865
|
)
|
|||
Total
|
224,761
|
|
|
179,913
|
|
|
162,287
|
|
|||
Paid related to:
|
|
|
|
|
|
||||||
Current year
|
(43,616
|
)
|
|
(38,439
|
)
|
|
(34,240
|
)
|
|||
Prior years
|
(345,197
|
)
|
|
(300,703
|
)
|
|
(264,597
|
)
|
|||
Total paid
|
(388,813
|
)
|
|
(339,142
|
)
|
|
(298,837
|
)
|
|||
Net balance, end of year
|
1,825,304
|
|
|
1,863,349
|
|
|
2,000,114
|
|
|||
Plus reinsurance recoverables on unpaid losses and loss adjustment expenses
|
247,518
|
|
|
191,645
|
|
|
247,658
|
|
|||
Balance, end of year
|
$
|
2,072,822
|
|
|
$
|
2,054,994
|
|
|
$
|
2,247,772
|
|
Operating Leases
|
|||
(In thousands)
|
|||
2014
|
$
|
3,039
|
|
2015
|
2,750
|
|
|
2016
|
2,553
|
|
|
2017
|
2,394
|
|
|
Thereafter
|
9,175
|
|
|
Total minimum lease payments
|
$
|
19,911
|
|
(In thousands)
|
December 31,
2013 |
|
December 31,
2012 |
||||
Senior notes due 2023, unsecured, interest at 5.3% annually
|
$
|
250,000
|
|
|
$
|
—
|
|
Revolving credit agreement, expires in 2016
|
—
|
|
|
125,000
|
|
||
|
$
|
250,000
|
|
|
$
|
125,000
|
|
(1)
|
ProAssurance is not permitted to have a leverage ratio of Consolidated Funded Indebtedness (principally, obligations for borrowed money, obligations evidenced by instruments such as notes or acceptances, standby and commercial Letters of Credit, and contingent obligations) to Consolidated Total Capitalization (principally, total non-trade liabilities on a consolidated basis plus consolidated shareholders’ equity, exclusive of accumulated other comprehensive income) greater than
0.35
to
1.0
, determined at the end of each fiscal quarter.
|
(2)
|
ProAssurance is required to maintain a minimum net worth of not less than the sum of
75%
of Consolidated Net Worth (consolidated shareholders’ equity, exclusive of accumulated other comprehensive income) at December 31, 2010, plus
50%
of consolidated net income earned each fiscal quarter, if positive, beginning with the quarter ending March 31, 2011, plus
100%
of net cash proceeds resulting from the issuance of ProAssurance capital stock.
|
(In thousands)
|
2013
|
|
2012
|
|
2011
|
||||||
Reclassifications from accumulated other comprehensive income to net income, available for sale securities:
|
|
|
|
|
|
||||||
Realized investment gains (losses)
|
$
|
11,375
|
|
|
$
|
17,350
|
|
|
$
|
13,101
|
|
Non-credit impairment losses reclassified to earnings, due to sale of securities or reclassification as a credit loss
|
(347
|
)
|
|
(2,417
|
)
|
|
(2,415
|
)
|
|||
Total amounts reclassified, before tax effect
|
11,028
|
|
|
14,933
|
|
|
10,686
|
|
|||
Tax effect (at 35%)
|
(3,860
|
)
|
|
(5,227
|
)
|
|
(3,740
|
)
|
|||
Net reclassification adjustments
|
$
|
7,168
|
|
|
$
|
9,706
|
|
|
$
|
6,946
|
|
|
|
Share-Based
Compensation Expense |
|
Unrecognized Compensation Cost
|
||||||||||||||
|
|
Year Ended December 31
|
|
December 31, 2013
|
||||||||||||||
|
|
2013
|
|
2012
|
|
2011
|
|
Amount
|
|
Remaining
Recognition Period |
||||||||
|
|
(In millions)
|
|
(In millions)
|
|
(Weighted average years)
|
||||||||||||
Stock Options
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
0.1
|
|
|
$
|
—
|
|
|
N/A
|
Restricted Share Units
|
|
1.6
|
|
|
1.6
|
|
|
1.3
|
|
|
2.1
|
|
|
1.7
|
||||
Performance Share Units
|
|
7.1
|
|
|
6.7
|
|
|
5.6
|
|
|
8.1
|
|
|
1.7
|
||||
Purchase Match Units
|
|
0.5
|
|
|
0.3
|
|
|
0.1
|
|
|
1.5
|
|
|
2.2
|
||||
Total share-based compensation expense
|
|
$
|
9.2
|
|
|
$
|
8.6
|
|
|
$
|
7.1
|
|
|
$
|
11.7
|
|
|
|
Tax benefit recognized
|
|
$
|
3.2
|
|
|
$
|
3.0
|
|
|
$
|
2.5
|
|
|
|
|
|
|
|
2013
|
|
2012
|
|
2011
|
|||||||||||||||
|
|
Options
|
|
Weighted
Average Exercise Price |
|
Options
|
|
Weighted
Average Exercise Price |
|
Options
|
|
Weighted
Average Exercise Price |
|||||||||
Outstanding, beginning of year
|
|
20,302
|
|
|
$
|
23.15
|
|
|
1,014,661
|
|
|
$
|
22.76
|
|
|
1,430,105
|
|
|
$
|
21.85
|
|
Granted
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Exercised
|
|
(2,220
|
)
|
|
24.28
|
|
|
(994,148
|
)
|
|
22.75
|
|
|
(412,695
|
)
|
|
19.61
|
|
|||
Forfeited or expired
|
|
—
|
|
|
—
|
|
|
(211
|
)
|
|
25.67
|
|
|
(2,749
|
)
|
|
25.36
|
|
|||
Outstanding at end of year
|
|
18,082
|
|
|
23.00
|
|
|
20,302
|
|
|
23.15
|
|
|
1,014,661
|
|
|
22.76
|
|
|||
Exercisable at end of year
|
|
18,082
|
|
|
23.00
|
|
|
20,302
|
|
|
23.15
|
|
|
959,889
|
|
|
22.59
|
|
|||
Outstanding at end of year,
vested or expected to vest |
|
18,082
|
|
|
23.00
|
|
|
20,302
|
|
|
23.15
|
|
|
1,014,064
|
|
|
22.75
|
|
|
|
2013
|
|
2012
|
|
2011
|
|||||||||||||||
|
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
Beginning non-vested balance
|
|
157,212
|
|
|
$
|
31.94
|
|
|
167,236
|
|
|
$
|
25.52
|
|
|
120,478
|
|
|
$
|
23.88
|
|
Granted
|
|
39,400
|
|
|
46.97
|
|
|
51,864
|
|
|
42.22
|
|
|
52,256
|
|
|
29.27
|
|
|||
Forfeited
|
|
(603
|
)
|
|
35.91
|
|
|
(2,823
|
)
|
|
35.23
|
|
|
(5,075
|
)
|
|
25.38
|
|
|||
Vested and released
|
|
(57,239
|
)
|
|
25.25
|
|
|
(59,065
|
)
|
|
22.61
|
|
|
(423
|
)
|
|
22.56
|
|
|||
Ending non-vested balance
|
|
138,770
|
|
|
38.92
|
|
|
157,212
|
|
|
31.94
|
|
|
167,236
|
|
|
25.52
|
|
|
|
2013
|
|
2012
|
|
2011
|
|||||||||||||||
|
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
Beginning non-vested balance
|
|
552,417
|
|
|
$
|
33.21
|
|
|
522,599
|
|
|
$
|
26.36
|
|
|
493,661
|
|
|
$
|
24.56
|
|
Granted
|
|
145,580
|
|
|
46.97
|
|
|
212,205
|
|
|
42.22
|
|
|
196,186
|
|
|
30.30
|
|
|||
Forfeited
|
|
(17,043
|
)
|
|
38.90
|
|
|
(20,492
|
)
|
|
31.44
|
|
|
(15,804
|
)
|
|
26.28
|
|
|||
Vested and released
|
|
(194,274
|
)
|
|
26.39
|
|
|
(161,895
|
)
|
|
23.13
|
|
|
(151,444
|
)
|
|
25.61
|
|
|||
Ending non-vested balance
|
|
486,680
|
|
|
39.86
|
|
|
552,417
|
|
|
33.21
|
|
|
522,599
|
|
|
26.36
|
|
|||
Common shares issued due to vesting of awards
|
|
135,044
|
|
|
|
|
114,884
|
|
|
|
|
112,822
|
|
|
|
|
|
2013
|
|
2012
|
|
2011
|
|||||||||||||||
|
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
Beginning non-vested balance
|
|
40,985
|
|
|
$
|
39.85
|
|
|
18,900
|
|
|
$
|
36.20
|
|
|
—
|
|
|
$
|
—
|
|
Granted
|
|
25,151
|
|
|
43.57
|
|
|
23,799
|
|
|
42.59
|
|
|
19,016
|
|
|
36.20
|
|
|||
Forfeited
|
|
(2,456
|
)
|
|
40.71
|
|
|
(1,610
|
)
|
|
37.72
|
|
|
(116
|
)
|
|
36.20
|
|
|||
Vested and released
|
|
(555
|
)
|
|
36.33
|
|
|
(104
|
)
|
|
36.20
|
|
|
—
|
|
|
—
|
|
|||
Ending non-vested balance
|
|
63,125
|
|
|
41.34
|
|
|
40,985
|
|
|
39.85
|
|
|
18,900
|
|
|
36.20
|
|
(In millions)
|
||||||||
Statutory Net Earnings
|
|
Statutory Capital and Surplus
|
||||||
2013
|
|
2012
|
|
2011
|
|
2013
|
|
2012
|
$256
|
|
$312
|
|
$291
|
|
$1,642
|
|
$1,499
|
|
|
2013
|
||||||||||||||
(In thousands, except per share data)
|
|
1st
|
|
2nd
|
|
3rd
|
|
4th
|
||||||||
Net premiums earned
|
|
$
|
134,578
|
|
|
$
|
130,352
|
|
|
$
|
133,598
|
|
|
$
|
129,392
|
|
Net losses and loss adjustment expenses:
|
|
|
|
|
|
|
|
|
||||||||
Current year
|
|
110,726
|
|
|
109,109
|
|
|
110,987
|
|
|
116,689
|
|
||||
Prior year
|
|
(53,100
|
)
|
|
(38,500
|
)
|
|
(49,350
|
)
|
|
(81,799
|
)
|
||||
Net income
|
|
112,850
|
|
|
50,451
|
|
|
63,357
|
|
|
70,864
|
|
||||
Basic earnings per share*
|
|
1.83
|
|
|
0.82
|
|
|
1.02
|
|
|
1.15
|
|
||||
Diluted earnings per share*
|
|
1.82
|
|
|
0.81
|
|
|
1.02
|
|
|
1.14
|
|
||||
|
|
2012
|
||||||||||||||
(In thousands, except per share data)
|
|
1st
|
|
2nd
|
|
3rd
|
|
4th
|
||||||||
Net premiums earned
|
|
$
|
136,659
|
|
|
$
|
131,266
|
|
|
$
|
127,125
|
|
|
$
|
155,615
|
|
Net losses and loss adjustment expenses:
|
|
|
|
|
|
|
|
|
||||||||
Current year
|
|
117,656
|
|
|
108,134
|
|
|
106,621
|
|
|
119,539
|
|
||||
Prior year
|
|
(47,457
|
)
|
|
(60,050
|
)
|
|
(50,000
|
)
|
|
(114,531
|
)
|
||||
Net income
|
|
55,645
|
|
|
58,453
|
|
|
60,106
|
|
|
101,266
|
|
||||
Basic earnings per share*
|
|
0.91
|
|
|
0.95
|
|
|
0.98
|
|
|
1.65
|
|
||||
Diluted earnings per share*
|
|
0.90
|
|
|
0.95
|
|
|
0.97
|
|
|
1.64
|
|
*
|
Quarterly and year-to-date computations of per share amounts are made independently; therefore, the sum of per share amounts for the quarters may not equal per share amounts for the respective year-to-date periods.
|
Type of Investment
|
|
Recorded
Cost Basis |
|
Fair
Value |
|
Amount Which is
Presented in the Balance Sheet |
||||||
(In thousands)
|
|
|
|
|
|
|
||||||
Fixed Maturities
|
|
|
|
|
|
|
||||||
Bonds:
|
|
|
|
|
|
|
||||||
U.S. Government or government agencies and authorities
|
|
$
|
197,057
|
|
|
$
|
203,482
|
|
|
$
|
203,482
|
|
States, municipalities and political subdivisions
|
|
1,116,060
|
|
|
1,154,666
|
|
|
1,154,666
|
|
|||
Foreign Governments
|
|
5,141
|
|
|
5,348
|
|
|
5,348
|
|
|||
Public utilities
|
|
95,943
|
|
|
98,501
|
|
|
98,501
|
|
|||
All other corporate bonds
|
|
1,220,604
|
|
|
1,250,311
|
|
|
1,250,311
|
|
|||
Certificates of deposit
|
|
150
|
|
|
6,993
|
|
|
6,993
|
|
|||
Mortgage-backed securities
|
|
391,301
|
|
|
398,748
|
|
|
398,748
|
|
|||
Total Fixed Maturities
|
|
3,026,256
|
|
|
3,118,049
|
|
|
3,118,049
|
|
|||
Equity Securities, available-for-sale
|
|
|
|
|
|
|
||||||
Common Stocks:
|
|
|
|
|
|
|
||||||
Banks, trusts and insurance companies
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Total Equity Securities, available-for-sale
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Equity Securities, trading
|
|
|
|
|
|
|
||||||
Common Stocks:
|
|
|
|
|
|
|
||||||
Public utilities
|
|
5,880
|
|
|
7,107
|
|
|
7,107
|
|
|||
Banks, trusts and insurance companies
|
|
68,596
|
|
|
81,536
|
|
|
81,536
|
|
|||
Industrial, miscellaneous and all other
|
|
128,832
|
|
|
164,898
|
|
|
164,898
|
|
|||
Total Equity Securities, trading
|
|
203,308
|
|
|
253,541
|
|
|
253,541
|
|
|||
Other long-term investments
|
|
320,850
|
|
|
317,816
|
|
|
320,850
|
|
|||
Short-term investments
|
|
248,605
|
|
|
248,605
|
|
|
248,605
|
|
|||
Total Investments
|
|
$
|
3,799,019
|
|
|
$
|
3,938,011
|
|
|
$
|
3,941,045
|
|
|
|
December 31
|
||||||
(In thousands)
|
|
2013
|
|
2012
|
||||
Assets
|
|
|
|
|
||||
Investment in subsidiaries, at equity
|
|
$
|
2,005,420
|
|
|
$
|
2,092,445
|
|
Fixed maturities available for sale, at fair value
|
|
86,603
|
|
|
249,318
|
|
||
Equity securities, trading, at fair value
|
|
12,043
|
|
|
10,487
|
|
||
Short-term investments
|
|
191,991
|
|
|
4,366
|
|
||
Cash and cash equivalents
|
|
37,459
|
|
|
29,397
|
|
||
Restricted cash
|
|
78,000
|
|
|
—
|
|
||
Due from subsidiaries
|
|
3,315
|
|
|
23,708
|
|
||
Other assets
|
|
255,313
|
|
|
7,747
|
|
||
Total Assets
|
|
$
|
2,670,144
|
|
|
$
|
2,417,468
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
|
||||
Liabilities:
|
|
|
|
|
||||
Other liabilities
|
|
$
|
25,730
|
|
|
$
|
21,888
|
|
Long-term debt
|
|
250,000
|
|
|
125,000
|
|
||
Total Liabilities
|
|
275,730
|
|
|
146,888
|
|
||
Shareholders’ Equity:
|
|
|
|
|
||||
Common stock
|
|
621
|
|
|
619
|
|
||
Other shareholders’ equity, including unrealized gains (losses) on securities of subsidiaries
|
|
2,393,793
|
|
|
2,269,961
|
|
||
Total Shareholders’ Equity
|
|
2,394,414
|
|
|
2,270,580
|
|
||
Total Liabilities and Shareholders’ Equity
|
|
$
|
2,670,144
|
|
|
$
|
2,417,468
|
|
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
|
2013
|
|
2012
|
|
2011
|
||||||
Net investment income
|
|
$
|
5,789
|
|
|
$
|
5,281
|
|
|
$
|
1,582
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
|
—
|
|
|
(728
|
)
|
|
(2,479
|
)
|
|||
Net realized investment gains (losses)
|
|
5,334
|
|
|
3,230
|
|
|
(141
|
)
|
|||
Other income (loss)
|
|
170
|
|
|
54
|
|
|
101
|
|
|||
|
|
11,293
|
|
|
7,837
|
|
|
(937
|
)
|
|||
Expenses:
|
|
|
|
|
|
|
||||||
Interest expense
|
|
2,747
|
|
|
1,534
|
|
|
1,833
|
|
|||
Other expenses
|
|
13,213
|
|
|
8,870
|
|
|
7,855
|
|
|||
|
|
15,960
|
|
|
10,404
|
|
|
9,688
|
|
|||
Income (loss) before income tax expense (benefit) and equity in net income of consolidated subsidiaries
|
|
(4,667
|
)
|
|
(2,567
|
)
|
|
(10,625
|
)
|
|||
Income tax expense (benefit)
|
|
(1,007
|
)
|
|
773
|
|
|
(3,209
|
)
|
|||
Income (loss) before equity in net income of consolidated subsidiaries
|
|
(3,660
|
)
|
|
(3,340
|
)
|
|
(7,416
|
)
|
|||
Equity in net income of consolidated subsidiaries
|
|
301,183
|
|
|
278,810
|
|
|
294,512
|
|
|||
Net income
|
|
$
|
297,523
|
|
|
$
|
275,470
|
|
|
$
|
287,096
|
|
|
|
Year Ended December 31
|
||||||||||
(In thousands)
|
|
2013
|
|
2012
|
|
2011
|
||||||
Net cash provided (used) by operating activities
|
|
$
|
(26,319
|
)
|
|
$
|
3,601
|
|
|
$
|
(3,982
|
)
|
Investing activities
|
|
|
|
|
|
|
||||||
Purchases of equity securities trading
|
|
(1,265
|
)
|
|
(364
|
)
|
|
(990
|
)
|
|||
Proceeds from sale or maturities of:
|
|
|
|
|
|
|
||||||
Fixed maturities, available for sale
|
|
224,993
|
|
|
150,192
|
|
|
19,398
|
|
|||
Equity securities trading
|
|
1,113
|
|
|
616
|
|
|
6,887
|
|
|||
Net decrease (increase) in short-term investments
|
|
(187,625
|
)
|
|
58,657
|
|
|
(28,708
|
)
|
|||
Dividends from subsidiaries
|
|
239,484
|
|
|
59,369
|
|
|
90,020
|
|
|||
Contribution of capital to subsidiaries
|
|
—
|
|
|
(184,330
|
)
|
|
(12,500
|
)
|
|||
Deposit made for future acquisition
|
|
(205,244
|
)
|
|
—
|
|
|
—
|
|
|||
(Increase) decrease in restricted cash
|
|
(78,000
|
)
|
|
—
|
|
|
—
|
|
|||
Funding for Syndicate 1729
|
|
(8,699
|
)
|
|
—
|
|
|
—
|
|
|||
Other
|
|
(20
|
)
|
|
(1
|
)
|
|
(3,070
|
)
|
|||
Net cash provided (used) by investing activities
|
|
(15,263
|
)
|
|
84,139
|
|
|
71,037
|
|
|||
Financing activities
|
|
|
|
|
|
|
||||||
Proceeds from long-term debt
|
|
250,000
|
|
|
125,000
|
|
|
—
|
|
|||
Principal repayment of debt
|
|
(125,000
|
)
|
|
(32,992
|
)
|
|
—
|
|
|||
Repurchase of common stock
|
|
(29,089
|
)
|
|
—
|
|
|
(21,005
|
)
|
|||
Subsidiary payments for common shares and share-based compensation awarded to subsidiary employees
|
|
6,258
|
|
|
7,066
|
|
|
6,071
|
|
|||
Excess of tax benefit from share-based payment arrangements
|
|
2,128
|
|
|
7,022
|
|
|
1,711
|
|
|||
Dividends to shareholders
|
|
(46,375
|
)
|
|
(200,118
|
)
|
|
(7,617
|
)
|
|||
Other
|
|
(8,278
|
)
|
|
(12,259
|
)
|
|
(2,561
|
)
|
|||
Net cash provided (used) by financing activities
|
|
49,644
|
|
|
(106,281
|
)
|
|
(23,401
|
)
|
|||
Increase (decrease) in cash and cash equivalents
|
|
8,062
|
|
|
(18,541
|
)
|
|
43,654
|
|
|||
Cash and cash equivalents, beginning of period
|
|
29,397
|
|
|
47,938
|
|
|
4,284
|
|
|||
Cash and cash equivalents, end of period
|
|
$
|
37,459
|
|
|
$
|
29,397
|
|
|
$
|
47,938
|
|
Significant non-cash transactions:
|
|
|
|
|
|
|
||||||
Securities transferred at fair value as dividends from subsidiaries
|
|
$
|
69,011
|
|
|
$
|
241,081
|
|
|
$
|
197,224
|
|
(In thousands)
|
|
2013
|
|
2012
|
||||
Senior notes due 2023, unsecured, interest at 5.3% annually
|
|
$
|
250,000
|
|
|
$
|
—
|
|
Revolving credit agreement, expires in 2016
|
|
—
|
|
|
125,000
|
|
||
|
|
$
|
250,000
|
|
|
$
|
125,000
|
|
(In thousands)
|
|
2013
|
|
2012
|
|
2011
|
||||||
Deferred policy acquisition costs
|
|
$
|
28,999
|
|
|
$
|
23,179
|
|
|
$
|
26,626
|
|
Reserve for losses and loss adjustment expenses
|
|
2,072,822
|
|
|
2,054,994
|
|
|
2,247,772
|
|
|||
Unearned premiums
|
|
256,255
|
|
|
233,861
|
|
|
251,155
|
|
|||
Net premiums earned
|
|
527,919
|
|
|
550,664
|
|
|
565,415
|
|
|||
Net investment income
|
|
129,265
|
|
|
136,094
|
|
|
140,956
|
|
|||
Losses and loss adjustment expenses incurred related to current year, net of reinsurance
|
|
447,510
|
|
|
451,951
|
|
|
488,152
|
|
|||
Losses and loss adjustment expenses incurred related to prior year, net of reinsurance
|
|
(222,749
|
)
|
|
(272,038
|
)
|
|
(325,865
|
)
|
|||
Paid losses and loss adjustment expenses, net of reinsurance
|
|
388,813
|
|
|
339,142
|
|
|
298,837
|
|
|||
Underwriting, policy acquisition and operating expenses:
|
|
|
|
|
|
|
||||||
Amortization of deferred policy acquisition costs
|
|
59,063
|
|
|
57,007
|
|
|
59,591
|
|
|||
Other underwriting, policy acquisition and operating expenses
|
|
88,754
|
|
|
78,624
|
|
|
76,830
|
|
|||
Net premiums written
|
|
525,182
|
|
|
528,298
|
|
|
558,507
|
|
(In thousands)
|
|
2013
|
|
2012
|
|
2011
|
||||||
Property and Liability
(1)
|
|
|
|
|
|
|
||||||
Premiums earned
|
|
$
|
568,629
|
|
|
$
|
558,200
|
|
|
$
|
570,891
|
|
Premiums ceded
|
|
(41,514
|
)
|
|
(7,652
|
)
|
|
(5,630
|
)
|
|||
Premiums assumed
|
|
804
|
|
|
116
|
|
|
154
|
|
|||
Net premiums earned
|
|
$
|
527,919
|
|
|
$
|
550,664
|
|
|
$
|
565,415
|
|
Percentage of amount assumed to net
|
|
0.15
|
%
|
|
0.02
|
%
|
|
0.03
|
%
|
(1)
|
All of ProAssurance’s premiums are related to property and liability coverages.
|
Exhibit Number
|
|
Description
|
|
|
|
2
|
|
Schedules to the following documents are omitted; the contents of the schedules are generally described in the documents; and ProAssurance will upon request furnish to the Commission supplementally a copy of any omitted schedule
|
|
|
|
2.1
|
|
Plan of Conversion of PICA as filed with the Illinois Director of Insurance on November 13, 2008 (1)
|
|
|
|
2.2
|
|
Stock Purchase Agreement executed by ProAssurance Corporation and PICA dated October 28, 2008 (1)
|
|
|
|
2.3
|
|
Agreement and Plan of Merger by and among ProAssurance Corporation, CA Bridge Corporation and American Physicians Service Group, Inc. dated August 31, 2010 (2)
|
|
|
|
2.4
|
|
Stock Purchase Agreement dated as of June 26, 2012, by and among ProAssurance Corporation, PRA Professional Liability Group, Inc. and Medmarc Mutual Insurance Company
|
|
|
|
2.5
|
|
Agreement and Plan of Merger by and among ProAssurance Corporation, PA Merger Company and Eastern Insurance Holdings, Inc., dated September 23, 2013 (3)
|
|
|
|
3.1(a)
|
|
Certificate of Incorporation of ProAssurance (4)
|
|
|
|
3.1(b)
|
|
Certificate of Amendment to Certificate of Incorporation of ProAssurance (5)
|
|
|
|
3.2
|
|
Third Restatement of the Bylaws of ProAssurance (6)
|
|
|
|
4.1
|
|
Indenture, dated November 21, 2013, between ProAssurance and Wilmington Trust Company (26)
|
|
|
|
4.2
|
|
First Supplemental Indenture, dated November 21, 2013, between ProAssurance and Wilmington Trust Company relating to the $250,000 5.30% Senior Notes due 2023 (26)
|
|
|
|
|
|
ProAssurance will file with the Commission upon request pursuant to the requirements of Item 601 (b)(4) of Regulation S-K documents defining rights of holders of ProAssurance’s long-term indebtedness that has not been registered. See also the documents related to long term indebtedness filed as material contracts under Exhibits 10.16(a), (b), (c) and (d), and 10.20(a), (b) and (c) to this Form 10-K
|
|
|
|
10.1(a)
|
|
Medical Assurance, Inc. Incentive Compensation Stock Plan (formerly known as the Mutual Assurance, Inc. 1995 Stock Award Plan) (7)*
|
|
|
|
10.1(b)
|
|
Amendment and Assumption Agreement by and between ProAssurance and Medical Assurance, Inc. (8)*
|
|
|
|
10.1(c)
|
|
Amendment and Assumption Agreement by and between Mutual Assurance, Inc. and MAIC Holdings, Inc. dated April 8, 1996 (4)*
|
|
|
|
10.2(a)
|
|
ProAssurance Corporation 2004 Equity Incentive Plan (9)*
|
|
|
|
10.2(b)
|
|
First amendment to 2004 Equity Incentive Plan (10)*
|
|
|
|
10.3(a)
|
|
Form of Release and Severance Compensation Agreement dated as of January 1, 2008 between ProAssurance and each of the following named executive officers (11):*
|
|
|
|
|
|
Edward L. Rand, Jr.
Howard H. Friedman
Jeffrey P. Lisenby
Frank B. O’Neil
|
|
|
|
|
|
|
10.4(a)
|
|
Employment Agreement between ProAssurance and W. Stancil Starnes dated as of May 1, 2007 (12)*
|
|
|
|
10.4(b)
|
|
Amendment to Employment Agreement with W. Stancil Starnes (May 1, 2007), effective as of January 1, 2008 (11)*
|
|
|
|
10.5
|
|
Consulting Agreement between ProAssurance and William J. Listwan (13)*
|
|
|
|
10.6
|
|
Deferred Compensation Plan and Agreement dated December 31, 2010 between ProAssurance and Victor T. Adamo (12)*
|
|
|
|
10.7
|
|
Form of Release and Severance Compensation Agreement dated as of September 1, 2011 between ProAssurance and Ross E. Taubman (18)*
|
|
|
|
10.8
|
|
Form of Indemnification Agreement between ProAssurance and each of the following named executive officers and directors of ProAssurance (18)*
|
|
|
|
|
|
Lucian F. Bloodworth
Samuel A. Di Piazza, Jr.
Robert E. Flowers
Howard H. Friedman
M. James Gorrie
Jeffrey P. Lisenby
William J. Listwan
John J. McMahon
Drayton Nabers
Frank B. O’Neil
Ann F. Putallaz
Edward L. Rand, Jr.
Frank A. Spinosa
W. Stancil Starnes
Ross E. Taubman
Anthony R. Tersigni
Adam P. Wilczek
Thomas A. S. Wilson, Jr.
|
|
|
|
10.9
|
|
ProAssurance Group Employee Benefit Plan which includes the Executive Supplemental Life Insurance Program (Article VIII) (21)*
|
|
|
|
10.10
|
|
Amendment and Restatement of the Executive Non-Qualified Excess Plan and Trust effective January 1, 2008 (10)*
|
|
|
|
10.11(a)
|
|
Director Deferred Compensation Plan as amended and restated December 7, 2011 (20)*
|
|
|
|
10.11(b)
|
|
Amendment No. 1 to the Amended and Restated Director Deferred Compensation Plan dated May 22, 2013 (22)*
|
|
|
|
10.12
|
|
ProAssurance Corporation 2008 Equity Incentive Plan (15)*
|
|
|
|
10.13
|
|
First Amendment to the 2008 Equity Incentive Plan (20)*
|
|
|
|
10.14
|
|
ProAssurance Corporation 2008 Annual Incentive Compensation Plan (16)*
|
10.15
|
|
ProAssurance Corporation 2011 Employee Stock Ownership Plan (11)*
|
|
|
|
10.16(a)
|
|
Revolving Credit Agreement, dated April 15, 2011, between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A. (17)
|
|
|
|
10.16(b)
|
|
Amendment No. 1 to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A. (19)
|
|
|
|
10.16(c)
|
|
Amendment No. 2 to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A. (25)
|
|
|
|
10.16(d)
|
|
Pledge and Security Agreement between ProAssurance and U.S. Bank National Association (17)
|
|
|
|
10.17
|
|
ProAssurance Corporation Amended and Restated 2014 Equity Incentive Plan (23)*
|
|
|
|
10.18
|
|
ProAssurance Corporation 2014 Annual Incentive Plan (24)*
|
|
|
|
10.19
|
|
Retention and Severance Compensation Agreement effective January 1, 2013, between ProAssurance and Mary Todd Peterson*
|
|
|
|
10.20(a)
|
|
Standby Letter of Credit Agreement, dated November 8, 2013, between ProAssurance and Wells Fargo Bank, National Association (25)
|
|
|
|
10.20(b)
|
|
Parent Guaranty, dated November 8, 2013, by ProAssurance in favor of Wells Fargo Bank, National Association (25)
|
|
|
|
10.20(c)
|
|
Pledge and Security Agreement dated November 8, 2013, between ProAssurance and Wells Fargo Bank, National Association (25)
|
|
|
|
10.21
|
|
Facility Agreement between ProAssurance and the Premiums Trust Fund of Syndicate 1729
|
|
|
|
10.22
|
|
Underwriting Agreement between ProAssurance and Goldman, Sachs & Co. and Wells Fargo Securities, LLC (26)
|
|
|
|
10.23
|
|
Retention and Severance Compensation Agreement effective January 1, 2014, between ProAssurance and Michael L. Boguski*
|
|
|
|
21.1
|
|
Subsidiaries of ProAssurance Corporation
|
|
|
|
23.1
|
|
Consent of Ernst & Young LLP
|
|
|
|
31.1
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC Rule 13a-14(a)
|
|
|
|
31.2
|
|
Certification of Principal Financial Officer of ProAssurance as required under SEC Rule 13a-14(a)
|
|
|
|
32.1
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as amended (18 U.S.C. 1350)
|
|
|
|
32.2
|
|
Certification of Principal Financial Officer of ProAssurance as required under SEC Rule 13a-14(b) and 18 U.S.C. 1350
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
*
|
Denotes a management contract or compensatory plan, contract or arrangement required to be filed as an exhibit to this report.
|
(1)
|
Filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for event occurring November 13, 2008 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(2)
|
Filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for event occurring August 31, 2010 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(3)
|
Filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring September 24, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(4)
|
Filed as an Exhibit to ProAssurance’s Registration Statement on Form S-4 (File No. 333-49378) and incorporated herein by reference pursuant to Rule 12b-32 of the Securities and Exchange Commission (SEC)
|
(5)
|
Filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2001 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(6)
|
Filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for the event occurring December 1, 2010 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(7)
|
Filed as an Exhibit to MAIC Holding’s Registration Statement on Form S-4 (File No. 33-91508) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(8)
|
Filed as an Exhibit to MAIC Holding’s Proxy Statement for the 1996 Annual Meeting (File No. 0-19439) is incorporated herein by reference pursuant to SEC Rule 12b-32
|
(9)
|
Filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-165333) on April 16, 2004 and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(10)
|
Filed as an Exhibit to ProAssurance’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2006 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32
|
(11)
|
Filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32
|
(12)
|
Filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2010 (File No. 001-16533) and incorporated herein by reference pursuant to Rule 12b-32
|
(13)
|
Filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for the event occurring May 12, 2007 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(14)
|
Filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for event occurring on September 13, 2006 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(14)
|
Filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2009 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32
|
(15)
|
Filed as an Exhibit to ProAssurance’s Registration Statement on Form S-8 (File No. 333-156645) and incorporated by reference pursuant to SEC Rule 12b-32
|
(16)
|
Filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-165333) on April 11, 2008 and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(17)
|
Filed as an Exhibit to ProAssurance’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(18)
|
Filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended June 30, 2012 (File
|
(19)
|
Filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(20)
|
Filed as an Exhibit to ProAssurance's Annual Report on Form 10K for the year ended December 31, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(21)
|
Filed as an exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2004 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(22)
|
Filed as an exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(23)
|
Filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for event occurring May 14, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(24)
|
Filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-165333) filed on April 22, 2013 and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(25)
|
Filed as an Exhibit to ProAssurance's Current Report on Form 8-K for even occurring November 8, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
(26)
|
Filed as an Exhibit to ProAssurance's Current Report on Form 8-K for even occurring November 21, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32
|
1
|
Definitions and interpretation
|
1.1
|
Definitions
|
1.2
|
Interpretation
|
(a)
|
a reference to this Deed (or any provision of it) or any other document is a reference to this Deed, that provision or that document as it is in force for the time being and as amended
,
varied or supplemented from time to time under its terms, or with the agreement of the relevant parties;
|
(b)
|
a reference to a person includes a corporate or unincorporated body;
|
(c)
|
a reference to a law is a reference to it as it is in force for the time being, including any amendment, extension, application or re-enactment and includes any subordinate legislation for the time being in force made under it;
|
(d)
|
a reference to writing includes faxes but not e-mail; and
|
(e)
|
clause headings are included for ease of reference only and shall not affect the interpretation of this Deed.
|
3
|
Purpose
|
3.1
|
The Borrower shall use the Facility either for the working capital requirements of Syndicate 1729 and/or for funding of the payment(s) of "shock" losses that may strain the Premiums Trust Fund of the underwriting members of Syndicate 1729.
|
3.2
|
The Lender is not obliged to monitor or verify how the Facility is used.
|
4
|
Interest
|
4.1
|
The Borrower shall pay interest on the amount from time to time drawn down under the Facility at the rate of 8.5 per cent per annum.
|
4.2
|
Interest shall be payable quarterly in arrears. Interest at the rate specified in Clause
|
7
|
Payments
|
7.1
|
All payments under this Deed shall be in Sterling and made:
|
(a)
|
in immediately available cleared funds on the due date; and
|
(b)
|
in full without any set-off or counterclaim and free and clear of any withholding or deduction (save as required by law) for any present or future taxes, duties or other charges.
|
7.2
|
If the Borrower is required by law at any time to make any deduction for any tax, levy, impost, duty, charge or fee or any deduction or withholding of a similar nature from any payment due under this Deed the amount payable by the Borrower to t
h
e Lender shall be increased to the amount which (after making such deduction or withholding) equals the full amount which would have been payable to the Lender if no such deduction or withholding had been required.
|
7.3
|
Time shall be of the essence in making each payment under this Deed.
|
8.1
|
Interest payable under this Deed shall accrue daily and will be calculated according to the number of days elapsed and a year of 365 days.
|
8.2
|
The Lender shall maintain in accordance with its usual practice accounts evidencing the amounts owed to it by the Borrower. Entr
i
es in those accounts shall be
prima facie
evidence of the existence and amount of the Borrower's obligations as recorded in them
.
|
8.3
|
Any certificate, determination or notification by the Lender of a rate or any amount payable under this Deed is (in the absence of manifest error) conclusive evidence of the matter to which it relates and shall contain reasonable details of the basis of determination.
|
9.1
|
Any amendment to this Deed shall be in writing and signed by or on behalf of each party.
|
9.2
|
Any waiver of any right or consent given under this Deed is only effective if it is in writing and signed by the waiving or consenting party. It only applies in the circumstances for which it is given and shall not prevent the party giving it from subsequently relying on the relevant provision.
|
9.3
|
No delay or failure to exercise any right under this Deed shall operate as a waiver of that right.
|
9.4
|
No single or partial exercise of any right under this Deed shall prevent any further exercise of the same right or any other right under this Deed.
|
9.5
|
Rights and remedies under this Deed are cumulative and do not exclude any rights or remedies provided by law or otherwise.
|
10
|
Severance
|
10.1
|
The invalidity, unenforceability or illegality of any provision (or part of a provision) of this Deed under the laws of any jurisdiction shall not affect the valid
i
ty, enforceability or legality of the other provisions.
|
10.2
|
If any invalid, unenforceable or illegal provision would be valid, enforceable and legal if some part of it were deleted, the provis
i
on shall app
l
y with whatever modification as is necessary to give effect to the commercial intention of the parties.
|
11
|
Counterparts
|
12
|
Third party rights
|
13
|
Notices
|
13.1
|
Each notice or other communication under this Deed shall be:
|
(a)
|
in writing, delivered personally or sent by pre-paid first-class letter or fax (confirmed by letter); and
|
(b)
|
sent:
|
(i)
|
to the Borrower at: The Trustees for the time being of the Premiums Trust Fund of the Underwriting Members of Syndicate 1729,
5th
Floor, Camomile Court, 23 Camomile Street, London, EC3A ?LL; Attention: Company Secretary
|
(a)
|
if sent by fax, with a confirmation of transmission, on the day it is transmitted;
|
(b)
|
if given by hand, on the day of actual delivery; and
|
(c)
|
if posted, on the second Business Day after the day on which it was sent by pre-paid first-class post.
|
13.3
|
A notice given as described in Clause 13.2(a) or Clause 13.2(b) on a day which is not a Business Day (or after normal business hours in the p
l
ace of receipt) shall be deemed to have been received on the next Business Day.
|
13.4
|
Any notice or other communication given to the Lender shall be deemed to have been given only on actual receipt.
|
14
|
Governing law and jurisdiction
|
14.1
|
This Deed and any dispute or claim arising out of or in connection with it or its subject matter (including any non-contractual disputes or claims) shall be governed by and construed in accordance with the laws of England and Wales.
|
14.2
|
The parties irrevocably agree that the courts of England and Wales shall have exclusive jurisdiction to settle any dispute or claim (including any non-contractual disputes or claims) that arises out of or in connection with this Deed or its subject matter.
|
|
|
|
EXECUTIVE:
|
||
|
||
|
||
Michael L. Boguski
|
||
|
||
PROASSURANCE CORPORATION
|
||
|
|
|
By:
|
|
|
|
|
Jeffrey P. Lisenby
|
Its:
|
|
Senior Vice President
|
|
||
PROASSURANCE GROUP SERVICES
CORPORATION
|
||
|
|
|
By:
|
|
|
|
|
Jeffrey P. Lisenby
|
Its:
|
|
President
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EXECUTIVE
|
||
|
|
|
|
|||||
Dated:
|
|
|
|
|
|
|
||
|
|
|
|
|
|
Michael L. Boguski
|
||
|
|
|
|
|||||
|
|
|
|
|
|
PROASSURANCE CORPORATION
|
||
|
|
|
|
|
||||
Dated:
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
Its:
|
|
|
|
|
|
For 2014 – Percentage of Base Salary =
|
|
10% (Threshold)
|
|
|
40%(Target)
|
|
|
70%(Maximum)
|
•
|
Target 89%
|
•
|
Pay target award (40% of base) for CCR of 89%
|
•
|
Adjust award percentage +/- 3% for each 1% decrease/increase in CCR
|
•
|
No award for CCR above 99%
|
•
|
Maximum award (70% of base) for CCR 79% or below
|
•
|
Threshold award if PRA achieves at least 75% of index performance
|
•
|
Target award if PRA achieves at least 10% better than the index
|
•
|
Maximum award if PRA achieves at least 20% better than the index
|
•
|
Threshold award for combined ratio 93% or lower
|
•
|
Target award for combined ratio 88%
|
•
|
Maximum award for combined ratio 83% or lower
|
|
|
|
|
|
|
|
|
|
|
89,679 + 22,870 + 38,427 + 893 – 12,938 – 8,921 – 1,327
|
|
|
|
128,683
|
|
|
|
|
|
|
|
=
|
|
|
|
=
|
|
88.19
|
%
|
|
|
|
|
|
|
|
|||
145,908
|
|
|
|
145,908
|
|
|
|
|
|
/s/ W. Stancil Starnes
|
W. Stancil Starnes
|
Chief Executive Officer
|
|
/s/ Edward L. Rand, Jr.
|
Edward L. Rand, Jr.
|
Chief Financial Officer
|
|
/s/ W. Stancil Starnes
|
W. Stancil Starnes
|
Chief Executive Officer
|
|
/s/ Edward L. Rand, Jr.
|
Edward L. Rand, Jr.
|
Chief Financial Officer
|